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Abstract
P2X7 is a unique member o f the P2X family o f membrane receptors for extracellular ATP. 
As well as being a non-selective cation channel, this membrane receptor is implicated in 
several biological functions, including cell death and proliferation. P2X7 expression, 
initially thought restricted to immune cells, also occurs in epithelial and other cell types. I 
hypothesised that P2X7 is functionally expressed in the renal tract, particularly in 
situations in which cell turnover is prominent. I have demonstrated expression o f P2X7 in 
both mouse and human kidney. During mouse nephrogenesis P2X7 was detected in the 
condensing mesenchyme in early metanephrogenesis and was subsequently restricted to 
derivatives o f the ureteric bud i.e. collecting duct and ureter. P2X7 was immunolocalised 
in regions o f cell turnover, consistent with a role for the nucleotide receptor in 
nephrogenesis. P2X7 was also detected in cystic collecting ducts o f both the cpk/cpk 
mouse model o f autosomal recessive polycystic kidney disease (ARPKD) and human 
ARPKD. Next I investigated the potential function o f  P2X7 in cystogenesis using a 3D 
suspension culture model from the cpk/cpk mouse. Exposure to agonists o f the P2X7 
receptor caused a significant reduction in numbers o f cysts forming in vitro. This was 
inhibited by P2X7 antagonists, and was greater than the response to other nucleotides, 
supporting a specific mediation by the P2X7 receptor. My study did not demonstrate a 
significant effect on markers o f cell proliferation, apoptosis or necrosis correlating with 
P2X7-mediated reduction in cyst numbers, suggesting an alternative function for the 
receptor in cyst formation.
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To further understand the molecular mechanisms by which P2X7 mediates its functions, 
particularly apoptosis, I have developed an in vitro expression system. Stable transfection 
o f a chicken lymphocytes with rat P2X7 enabled characterisation o f the receptor’s 
membrane properties, both ion fluxes and pore potential, and established a novel tool with 
which to further examine the mechanisms by which P2X7 mediates cell death. Further 
understanding o f the molecular mechanisms o f this unique nucleotide receptor, and its 
functional roles in the kidney, particularly in the setting o f polycystic kidney disease may 
in the future lead to a novel therapeutic target for the manipulation o f progression o f renal 
injury, via its apoptotic pathways, or other as yet undefined pathways.
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aa amino acid
ABC avidin-biotin peroxidase complex
ADPKD autosomal dominant polycystic kidney disease
ARPKD autosomal recessive polycystic kidney disease
AP alkaline phosphatase
ATP adenosine 5’- triphosphate
bp base pair
BCA bicinchoninic acid
Bcl-2 B-cell leukaemia / lymphoma gene - 2
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DBA dolichos biflorous agglutinin
DEPC diethylpyrocarbonate
DMEM Dulbecco's modified Eagle medium
DMSO dimethyl sulfoxide
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DNA deoxyribonucleic acid
DNAse deoxyribonuclease
E embryonic day (after vaginal plug)
ECL enhanced chemiluminescence
EDTA ethylenediamine tetraacetic acid disodium salt
EGTA ethyleneglycol-bis(P-aminoethylether)-N,N,N’,N ’-tetraacetic acid
Et Br ethidium bromide
FACS fluorescence activated cell sorting
FCS foetal calf serum
FITC fluoroscein isothiocyanate
g gram
H20 2 hydrogen peroxide
HBSS Hanks' balanced salts solution
HEPES N-2-hydroxyethylpiperazine-N’-2-ethane sulphonic acid
HRP horseradish peroxidase
IgG immunoglobulin G
II- 1 p interleukin - 1P
ITS insulin transferring selenium
kb kilobase
kDa kilodalton
L litre
LDH lactate dehydrogenase
M Molar i.e. concentration in moles per litre
pg microgram
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|Lll microlitre
pm micrometre
ml millilitre
mg milligram
mRNA messenger RNA
n number
ng nanogram
NP40 nonidet P 40
nt nucleotide
oATP oxidized ATP
PAS periodic acid Schiff
PBS phosphate-buffered saline
PCNA proliferating cell nuclear antigen
PCR polymerase chain reaction
PFA paraformaldehyde
PI propidium iodide
PMSF phenyl-methyl-sulfonyl-fluoride
PVDF polyvinyl difluoride
RNA ribonucleic acid
RNase ribonuclease
rpm revolutions per minute
RT-PCR reverse transcriptase polymerase chain reaction
SDS sodium dodecylsulphate
SDS-PAGE SDS-polyacrylamide gel electrophoresis
SE standard error o f mean
T3 3,3’,5-triiodo -L-thyronine
TAE tris-acetate / EDTA electrophoresis buffer
TEMED N,N,N*,N* -tetramethylethylenediamine
Tris tris(hydroxymethyl)methylamine
UTP uridine 5’- triphosphate
UV ultraviolet radiation
V volts
x g times gravity
zVAD-fmk z-Val-Ala-Asp-CH2F
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Chapter 1. Introduction
Aims of this thesis
The aims o f this thesis are, firstly, to investigate the potential expression and function of 
P2X7 receptor in the mouse kidney, with emphasis on normal and abnormal epithelial 
tubulogenesis or cystogenesis, in kidney development, and secondly, to use a unique 
expression system to study the molecular mechanisms o f the receptor. As a background to 
this study, this chapter reviews the current understanding o f the P2X7 receptor, describes 
the models o f normal and abnormal renal tube morphogenesis used in the experiments (i.e. 
normal mouse nephrogenesis and cyst formation in the cpk/cpk model o f autosomal 
recessive polycystic kidney disease), and discusses the pathways involved in apoptotic cell 
death, a process both induced by P2X7 receptor activation and with important roles in 
these renal models. It also addresses the requirement for novel systems for the detailed 
investigation o f P2X7 function and signalling pathways.
Hypotheses
The current data on the expression and biological function o f P2X7, or other members of  
this receptor family, in the renal tract, is limited to the lower urinary tract and in vitro 
studies o f renal cell lines. There is no systematic description o f the expression o f the 
protein in the normal intact kidney or in the abnormal phenotype o f  the polycystic kidney.
The following hypotheses are tested in this thesis:
1) P2X7 is expressed in the normal developing mouse kidney, and hence may be 
important in kidney development.
2) P2X 7 is expressed in abnormal, cystic development o f the mouse and human 
recessive forms o f polycystic kidney disease, and here may exert a biological 
effect in modulation o f this renal phenotype.
3) Manipulation o f the P2X7 receptor signalling in cultures derived from the cpk/cpk 
mouse may alter the potential for cyst development in this in vitro system.
4) The expression o f P2X7 protein in a novel cell line will facilitate further study of  
the mechanisms by which the molecule mediates its cellular signals, in particular 
those involved in the induction o f apoptosis.
21
Biology of the P2X7 receptor
Nucleotides as extracellular signalling molecules
The idea o f a role for extracellular nucleotides as membrane signalling molecules, in 
addition to their ubiquitous function in intracellular energy metabolism, was first 
suggested by Drury and Szent-Gyorgi’s pioneering demonstration o f the activity o f 
nucleotides in the cardiovascular system in 1929: perfusion o f adenosine or adenosine 5’- 
monophosphate induced hypotension and bradycardia in the guinea pig [Drury, 1929]. The 
initial proposal that signalling via extracellular nucleotides was involved in the autonomic 
nervous system [Bumstock, 1972] heralded the beginning o f the rapidly expanding field o f  
work on purinergic signaling. ATP and other nucleotides have now been implicated in a 
wide variety o f membrane-mediated responses, induced by discrete families o f receptors, 
with widespread distribution in many species.
ATP release
Initial opposition to the concept o f a functional role for extracellular nucleotides, involved 
the argument that conditions under which there would be sufficient concentrations o f ATP 
to bind receptors, would be extremely rare and short-lived [Gordon, 1986]. However, it is 
now recognized that virtually all cell types possess mechanisms for the release o f their 
main intracellular energy source [Schwiebert, 1999]. Once in the extracellular 
environment, ATP can ligate available purinergic receptors, but is rapidly hydrolyzed by 
powerful, ubiquitous ecto-ATPases [Plesner, 1995]. The down-regulation o f these ATP- 
hydrolyzing enzymes in stressed conditions, for example ischaemia and reperfusion
[Candinas et ah, 1996], may contribute to high levels o f extracellular ATP, albeit for short 
periods o f time, in the extracellular milieu.
The release o f ATP from injured or dying cells, or ‘lytic’ release, is now well documented, 
and in the case o f those undergoing necrosis and release o f cell contents, may increase 
local pericellular levels up to around five millimolar [Schwiebert, 2001]. There is also 
growing evidence for non-lytic release o f nucleotides, via exocytosis and plasma 
membrane transporters from a number o f cells types [Schwiebert, 1999;Schwiebert, 2001]. 
ATP release has been documented in response to various stimuli, for example, osmotic 
stress, or sudden reduction in extracellular osmolality [Jans et al., 2002;Taylor et al., 
1998], neurohormonal factors and mechanical stretch. Whether the sudden swelling of 
cells in response to falling extracellular osmolality causes mechanical perturbation and 
damage o f the membrane sufficient to release ATP, or results in activation o f transporters 
is not established. An example o f mechanical induction o f nucleotide release in the urinary 
tract, is the epithelial release o f ATP by the distended guinea pig ureter which occurs in 
the absence o f cellular damage, as assessed by lactate dehydrogenase release [Knight et 
al., 20 0 2 ].
In the kidney, ATP has been shown to be released both physiologically from the tubular 
epithelium [Schwiebert, 2001;Schwiebert and Kishore, 2001], in concentrations up to 10 
micromolar and interestingly, in greater quantity from epithelia o f abnormal cystic 
epithelia [Schwiebert et al., 2001]. Evidence now exists for the occurrence o f basal and 
stimulated nucleotide release from normal renal epithelia, and from abnormal cystic 
epithelia, and will be discussed in more detail in a later chapter.
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ATP release has also been implicated in the tubulo-glomerular feedback response, 
whereby the glomerular vasculature responds to changes in distal tubular fluid 
composition, sensed at the macula densa. Using patch-clamp methods, macula densa cells 
have been shown to release up to 10 micromolar ATP, measured by ATP bioassay, via a 
maxi-anion channel at their basolateral membrane, when subjected to an increase in 
luminal sodium chloride concentration [Bell et al., 2003].
Purinergic receptors
It was the discovery and cloning o f surface receptors for the nucleotide molecules that 
stimulated further research into the purinergic signalling system [Abbracchio and 
Bumstock, 1994], The receptors are classified into two distinct groups, P2X and P2Y. The 
P2Y receptors have seven membrane-spanning domains and are G-protein coupled; to 
date, mammalian expression o f P2Yi, P2Y2, P2Y4, P2Y6, P2Yn and P2Yi2 has been 
documented [Shaver, 2001]. In contrast, the P2X family is the most recently described 
group o f ligand-gated ion channels, others being nicotinic, glutamate and GABA receptors 
[Khakh et al., 2001]. The seven P2X receptors all have two membrane-spanning domains, 
a large extracellular loop with 10 conserved cysteine-rich regions and intracellular N- and 
C-terminals (Fig.l); this topology is reminiscent o f various membrane receptors found in 
lower organisms, o f note members o f the degenerin / epithelial sodium channel 
(DEG/EnaC) superfamily. The latter includes the mechanosensitive receptor of 
Escherichia coli, degenerins in Caenorhabditis elegans as well as the vertebrate epithelial 
sodium channel (ENaC) [Mano and Driscoll, 1999]. Members o f this superfamily are 
expressed in diverse tissues, respond to diverse stimuli and participate in varied biological 
processes including; mechanosensation, proprioception, epithelial sodium transport and
(neuronal) degeneration [Kellenberger and Schild, 2002], As well as suggesting an 
evolutionary link with this superfamily, the similarity o f membrane topology between 
groups may further our understanding of the biological consequences of activation of the 
P2X receptors. It is, perhaps, not unexpected that the P2X molecules tend to form 
functional hetero or homo-dimers [Torres et al., 1999] and that the documented functions 
o f the P2X receptors to date include the rapid opening o f a non-selective cation channel 
[North, 2002] and in the case of P2X7, the latest member to be cloned, the induction of 
cell death [Surprenant et al., 1996], A summary of P2X receptor channel properties is 
shown in Table 1.
Receptor Amino
acids
Rank order of agonist 
activity
Antagonists Ion flux Desensitisation
P2 X! 399 2-MeS-ATP>ATP>a,P-meATP TNP-ATP lNa+/K+/Ca2+ Rapid
P2X2 472 2-MeS-ATP>ATP>cx,p-meATP PPADS lNa+/K+ Slow
P2X3 397 2-MeS-ATP>ATP>a,p-meATP TNP-ATP lNa+/K+/Ca2+ Rapid
P2X4 388 ATP>2-MeS-ATP>a,p-meATP None lNa+/K+ Slow
P2X5 417 ATP>2-MeS-ATP>ADP 
(a,P-meATP inactive)
None lNa+/K+/Ca2+ Slow
P2X6 379 ATP>2-MeS-ATP>ADP 
(a,p-meATP inactive)
None lNa+/K+/Ca2+ Slow
P2X7 595 BzATP>ATP>2-MeS-ATP>ADP 
(UTP inactive)
oATP, PPADS 
KN-62, 
Brilliant blue 
G,
lNa+/K+/Ca2+
Pore
formation
Slow
Table 1.1Properties o f  P2X receptors
A summary of the size and channel properties of cloned P2X receptors. (oATP: oxidised 
ATP, TNP-ATP. 2 ’,3’-0-(2,4,6-Trinitrophenyl)adenosine-5,-triphosphate, PPADS: 
pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid. I Na+/K+/ca2+ : ion fluxes of 
Na+/K+/Ca2+. Rapid desensitisation of channel activity: <50-300 ms). Unique features of 
P2X7 are shown in red.
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extracellular
M2Ml
intracellular
Figure 1. P2X7 receptor structure
The transmembrane structure of the P2X7 protein is shown, the red segment 
representing its unique, long, intracellular C-terminus . M l and M2 represent 
transmembrane domains, Y are putative glycosylation sites and = disulphide 
bonds at conserved cysteine-rich regions.
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P2Z/P2X7 receptor
P2X7 was first characterized in immune cells such as monocytes and macrophages [Di 
Virgilio, 1995;Falzoni et al., 1995], and cloned from a rat cDNA brain library [Surprenant 
et al., 1996]. This most recently-cloned member o f the P2X family is intriguing in that, in 
addition to several features common to the P2X family, particularly its function as a 
rapidly opening non-selective cation channel, this molecule has several unique properties. 
For this reason, prior to cloning and identification o f significant similarities to other P2X 
members, P2X7 was priginally classified as a distinct receptor, P2Z [Gordon, 1986]. 
P2Z/P2X7 or P2X7 has extremely low affinity for ATP in physiological conditions, its 
active ligand being the fully ionized form ATP4' (EC50 o f 0.1-1.0 mM versus 1-10 pM for 
other P2X receptors). Despite early reports that P2X7 expression was limited to cells of 
immune origin [Chiozzi et al., 1996;Collo et al., 1997;Humphreys and Dubyak, 1996] 
[Mutini et al., 1999], it is now known that P2X7 has wide expression pattern in many cell 
types, particularly epithelial cells, although less is known currently o f its functional status 
in many sites: P2X7 receptor has been localized at the RNA or protein level in: brain 
microglial cells [Collo et al., 1997], renal mesangial cells [Schulze-Lohoff et al., 1998] 
and epithelia o f the gastrointestinal tract [Groschel-Stewart et al., 1999b], uterus [Slater et 
al., 2000], skin and salivary glands [Tenneti et al., 1998]. The expression pattern o f P2X7 
is summarized in Table 2.
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Organ /  System Cell type Species mRNA Protein References
Immune system M onocytes / THP-1 human + [Humphreys and Dubyak, 1996], [Collo et al., 1997]
Macrophages human + + [Chiozzi et al., 1997], [Ferrari et al., 1997b]
Lymphocytes rat, mouse, human + + [Collo et al., 19971, [Wiley et al., 19981
Dendritic cells mouse + + [Coutinho-Silva et al., 1999], [Mutini et al., 1999]
Granulocytes human + [Collo et al., 19971
Thymocytes mouse + [Freedman et al., 1999]
Brain Microglial cells / NTW8 rat, mouse + + [Collo et al., 1997], [Ferrari et al., 1997a]
Astrocytes rat + [K im et al., 2001b]
Kidney Whole kidney human, rat + [Rassendren et al., 1997]
Mesangial cells rat + + [Schulze-Lohoff et al., 1998], [Harada et al., 2000]
Bladder / Ureter Urothelium rat + [Lee et al., 2000]
Gastrointestinal tract Duodenal villus enterocytes rat + [Groschel-Stewart et al., 1999b]
Reproductive tract Vaginal epithelium rat + [Bardini et al., 2000]
Uterine epithelium rat + [Slater et al., 2000]
Skin Stratified squamous epithelium rat + [Groschel-Stewart et al., 1999a]
Fibroblast human + + [Solini et al., 19991
Vascular system Endothelial cells human + [von Albertini et al., 1998]
Salivary glands Parotid acinar cells rat + [Tenneti et al., 1998]
Submandibular ductal cells rat + [Alzola et al., 19981
Eye Retinal ganglion cells rat + [Brandle et al., 1998]
Retinal Muller cells human + + [Pannicke et al., 20001
Ear Organ o f  Corti, vestibular organ, spiral 
ganglion
rat + [Brandle et al., 1999]
Bone Osteoblasts human + [Gartland et al., 2001]
Osteoclasts rat + [Naemsch et al., 2001]
Table 2. P2X 7 expression
The wide pattern of mRNA or protein expression o f P2X7 is shown. The expressing cell types and species in which studies were carried out are listed.
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P2X7: Structural properties and pore formation
Following the cloning o f the rat P2X7 receptor, human and mouse P2X7 receptors have 
also been cloned, from monocytes and microglial cells respectively, and demonstrate 80 - 
85% homology to the rat receptor [Chessell et al., 1998b;Rassendren et al., 1997]. At the 
structural level, rat P2X7 shows around 40% sequence homology to other P2X group 
members at the N-terminal 395 amino acids, but has a significantly longer C-terminal 
(Fig.l) which is encoded by exons 12 and 13; the resulting 200 amino acid intracellular 
component o f the P2X7 molecule has been shown to confer the ability o f the molecule to 
form a large permeabilising ‘pore’ structure [Di Virgilio, 1995;Ferrari et al., 
1996;Rassendren et al., 1997;Surprenant et al., 1996]. In addition, recent demonstration 
that the C-terminal contains several protein-protein and protein-lipid interaction motifs 
and a conserved lipopolysaccharide (LPS) binding site, suggests that this region may also 
directly coordinate many pore-independent signal transduction events and possibly 
interact with cytoskeletal components to facilitate localization and trafficking o f the 
receptor [Denlinger et al., 2001]. Recently, mutations in the extracellular domain o f  
human P2X7 have also been shown to cause loss o f function and probable failure o f 
correct assembly within the membrane [Gu et al., 2001;Turco et al., 1996].
Pore formation
Generally, the P2X7 receptor, with sustained or repetitive high concentrations o f agonist
exposure, is able to confer membrane permeability to molecules up to 900 Daltons (Da).
The receptor demonstrates progressive loss o f cation selectivity, with a sustained non-
selective conductance, eventually allowing entry o f N-methyl-D-glucosamine (NMDG+),
large monovalent organic cations and fluorescent dyes [Surprenant et al., 1996]. This
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feature is however variable, in terms o f both occurrence and pore size in individual 
natively expressing and transfected cell lines. In some cells, such as transfected Xenopus 
oocytes, human monocytes and mouse thymocytes no pore formation is seen [Humphreys 
et al., 1998], whereas in those that do demonstrate pore formation, such as lymphocytes, 
macrophages, microglial cells and human embryonic kidney cells (HEK 293), the size of 
the pore varies from around 314 Da in lymphocytes [Wiley et al., 1998] to 900 Da in HEK 
293 cells [Ferrari et al., 1996;Surprenant et al., 1996;Virginio et al., 1999a;Wiley et al., 
1996]. These variations add to the current controversy surrounding the mechanisms of 
P2X7-mediated pore formation. Possible explanations include a progressively dilating 
channel or small structural change o f the existing cation channel [Lester and Karschin, 
2000], larger structural changes in conformation such as oligomerisation [Tatham and 
Lindau, 1990] or interactions with a protein partner i.e. another, as yet unidentified, pore 
protein [Nuttle and Dubyak, 1994;Schilling et al., 1999a;Schilling et al., 1999b]. 
Membrane assembly
Whether dimerisation is involved in pore formation or not, it is clear that P2X7, like other 
members o f the P2X family, can form homodimers within the cell membrane [Torres et 
al., 1999] [Kim et al., 2001b]. It is however unusual in that it appears not to form 
oligomeric complexes with other P2X molecules [Torres et al., 1999]. Current opinion is 
that P2X7 forms homodimeric complexes o f at least three subunits [Nicke et al., 1998] 
[North and Surprenant, 2000], but that it is likely that there is tissue-specific differential 
assembly [Kim et al., 2001b]. In certain cell types, such as rat peritoneal macrophages and 
HEK293 cells, the P2X7 receptor forms a component o f a larger signalling complex, in 
association with molecules that are involved in intracellular downstream signalling such as 
phosphatidylinositol 4-kinase 230 (P14K) and receptor protein tyrosine phosphatase p
(RPTPP), but also structural molecules that mediate cellular cytoskeletal rearrangements, 
such as the extracellular laminin a3, transmembrane integrin p2 and cytoskeletal p-actin, 
a-actinin 4, supervillin, membrane-associated guanylate cyclase P55 (MAGuK), and the 
heat shock proteins, Hsp 90, Hsp 70 and Hsc c71 [Kim et al., 2001a].
P2X7 functions
The membrane functions o f P2X7 are similar to the other family; ligand-binding leads to 
rapid membrane depolarization, cation influx, particularly Ca2+ and equilibration o f 
sodium and potassium gradients. However, pore formation, induced by exposure to high 
levels or repeated pulses o f ATP, appears to be related to the unique C-terminal o f the 
molecule although it should be noted that pore formation has also recently been 
documented in cells made to over-express P2X2 and P2X4, molecules lacking the long C- 
terminus [Virginio et al., 1999b]. The physiological importance o f this pore-function is not 
known, but it clearly leads to a lytic cell death if  allowed to persist for more 1 0 - 1 5  
minutes in most cell types [Ferrari et al., 1997a].
In addition to these physiological membrane responses, the P2X7 receptor also activates a 
broad range o f downstream intracellular signals. For example, P2X7 stimulation leads to 
phospholipase D stimulation [Gargett et al., 1996], cytokine release e.g. interleukin-lp 
[Ferrari et al., 1996;Ferrari et al., 1997b;Solle et al., 2001], interleukin-6 [Solini et al., 
1999;Solle et al., 2001] and metalloprotease-mediated shedding o f surface L-selectin [Gu 
et al., 1998;Jamieson et al., 1996]. Many o f these molecules are involved in mediating 
inflammatory responses. Several structural responses and changes in cell morphology 
have been observed such as membrane blebbing [Virginio et al., 1999a],
microvesiculation and surface sprouting in fibroblasts [Solini et al., 1999;Solini et al., 
2000] and macrophage fusion during multinucleated giant cell formation [Chiozzi et al., 
1997;Falzoni et a l, 1995;Falzoni et al., 2000]. In the latter situation, P2X7 molecules are 
seen clustering at sites o f adjacent cell membrane contact [Falzoni et al., 2000], 
reminiscent o f the function o f putative ‘fusion pores’ in the formation o f synaptic vesicles, 
and o f the formation o f gap-junctions [Monck and Fernandez, 1996]. Membrane blebbing, 
initially thought to be an unequivocal indication o f apoptosis, can actually be reversible in 
HEK 293 cells if  ATP exposure is less than 15 minutes [Morelli et al., 2003]. The changes 
in cell morphology induced by P2X7 appear unique to this family member. The lack of  
such effects with activation o f other P2X receptors suggest that these events are not 
directly dependent on ion fluxes, although extracellular calcium is required for membrane 
blebbing [Morelli et al., 2003], but more likely mediated by the coupling o f P2X7 with 
other cytoskeletal proteins, as identified by Kim et al, 2001 [Kim et al., 2001a].
There is also growing interest in the role o f P2X7 in intracellular bacterial killing, 
particularly mycobacteria [Kusner and Adams, 2000;Lammas et al., 1997]. Various 
transcription factors have been linked to P2X7 activation, for example NFkB and NFAT 
[Ferrari et al., 1997d;Ferrari et al., 1999b].
In several cell types P2X7 has been shown to mediate alterations o f cell survival, both 
necrotic and apoptotic cell death, and there is also one report o f P2X7-mediated 
proliferation o f lymphocytes [Baricordi et al., 1999]. The activation o f the P2X7 receptor 
has been shown to induce many o f the features typical o f  apoptotic cell death induced by 
pro-apoptotic receptors such as Fas and the type ITNF receptor: membrane blebbing, 
phosphatidylserine exposure, cell shrinkage, caspase-1, 3 and 8 activation, cleavage of 
caspase substrates PARP and lamin B, chromatin condensation, DNA fragmentation and
apoptotic body formation [Ferrari et al., 1997a;Ferrari et al., 1999a] [Humphreys et al., 
2000]. P2X7-induced apoptosis has been demonstrated in a number o f endogenously 
expressing cell types such as thymocytes, B lymphocytes (J774) [Chiozzi et al., 1996], 
dendritic cells [Coutinho-Silva et al., 1999], microglial cells [Ferrari et al., 1997a] and 
renal mesangial cells [Harada et al., 2000;Schulze-Lohoff et al., 1998]. There is, however, 
currently little known about the signalling pathways involved in the induction o f apoptosis 
by this receptor: although early studies demonstrate the activation o f the cysteine-protease 
caspase-3 [Ferrari et al., 1999a;Humphreys et al., 2000;Solini et al., 2000], the 
requirement for caspase-3 for P2X7-induced apoptosis has not yet clear. The use o f a 
caspase-3 inhibitor inhibits apoptotic, but not necrotic cell death o f myeloic cells [Ferrari 
et al., 1999a] but only partially blocks ATP-induced apoptosis in dendritic cells 
[Coutinho-Silva et al., 1999], suggesting caspase-independent pathways are involved in 
P2X7-mediated cytotoxicity. The activation o f stress-activated protein kinase (SAPK/JNK) 
may be a component o f an alternative apoptotic pathway as demonstrated in macrophages 
[Humphreys et al., 2000].
P2X7 pharmacology: agonists and antagonists
The P2X family o f molecules were initially characterized in terms o f their responses to a 
panel o f nucleotide agonists such as adenosine 5 ’-triphosphate (ATP), 2 ’,3’-(benzoyl-4- 
benzoyl)-ATP (BzATP), 2-methylthio-ATP (2-MeSATP), adenosine 5 ’-0-(3- 
thiotriphosphate) (ATPyS) and adenosine 5’-diphosphate (ADP). The nucleotide potency 
profile o f P2X7 differs from the other P2X molecules, the more potent agonists being
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shown first: BzATP »  ATP >2-MeSATP > ATPyS »  ADP [Surprenant et al., 1996], 
and this can, to some extent, aid with investigation o f its expression and function in vivo. 
The EC50 o f ATP for the P2X7 receptor is approximately 500 pM, whereas the EC50 of 
BzATP is 50 pM. Adenosine and uridine 5’-triphosphate (UTP), potent agonists for other 
PI and P2Y receptor subtypes respectively, are ineffective for P2X7 [Surprenant et al., 
1996]. In addition to this unique agonist profile, there is also considerable species 
difference in P2X7 receptor itself, with agonist potency being much greater at rat and 
human than mouse receptors [Chessell et al., 1998a;Rassendren et al., 1997].
In common with other members o f the P2X family, the P2X7 receptor has so far, few 
known antagonists, leading to difficulties in the study o f its function. Until the recent 
development o f a blocking monoclonal antibody to the human P2X7 receptor [Buell et al., 
1998], the list o f specific blockers o f this receptor has been limited in number and 
selectivity and, like the agonists, the antagonist potencies are also species-dependent. 
Oxidised ATP is selective, irreversible antagonist o f the receptor [Murgia et al., 1993], 
pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid (PPADS) [Rassendren et al., 1997] 
and suramin [Wiley et al., 1993] block P2X in general and there is a growing list o f  
compounds which have variable efficacy in different model systems, including 
calmidazolium [Virginio et al., 1997], Coomassie Brilliant Blue G [Jiang et al., 2000] and 
KN-62 [Gargett and Wiley, 1997]. The latter exhibits higher potency at human than rat 
receptors [Chessell et al., 1998a;Humphreys et al., 1998] whereas PPADS possesses 
higher potency at human than mouse P2X7 receptors [Chessell et al., 1998a;Hibell et al., 
2001].
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Regulation of P2X7 function
In view o f its wide distribution and potentially dramatic biological consequences, there 
must be levels o f regulation ofP2X 7by which cells are protected against uncontrolled 
lysis or apoptosis. It is known that under physiological conditions the receptor has low  
affinity for its active ligand as well as a more effective agonist BzATP, but that 
manipulation o f its extracellular environment in vitro can alter its agonist affinity and 
maximum responses 5- to 100- fold. For example, when monitoring membrane 
depolarization, alterations o f extracellular divalent cation concentrations such as reduction 
of magnesium concentration or increase in sodium concentration can shift the dose 
response curve to the left [Gudipaty et al., 2001;Surprenant et al., 1996]. 
Dephosphorylation o f the membrane P2X7 molecule occurs on ligand-binding, and this 
leads to marked inhibition o f ATP-induced currents and also retards membrane blebbing, 
i.e. both physiological and cytoskeletal responses o f P2X7 activation [Kim et al., 2001a]. 
Mutagenesis studies have been used to identify Tyr343 in the second transmembrane 
domain as the site o f phosphorylation. Interestingly, one o f  the molecules identified within 
the P2X7 membrane signalling complex, receptor protein phosphatase (3 (RPTB0), appears 
to exert feedback control on the P2X7 receptor via dephosphorylation. There is a tonic low  
level o f  dephosphorylation o f unliganded P2X7 under control experimental conditions, but 
this activity is much increased upon receptor activation, leading to strong run-down o f the 
current and reduced ability to mediate cytoskeletal changes and membrane blebbing [Kim 
et al., 2001a].
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Factors influencing the cellular localization o f the molecule also alter the cell membrane 
responses to the ligand, particularly in terms o f altering receptor density in the membrane 
as well as its assembly into putative functional units [Solini et al., 2000]. There is 
evidence that many cell types have significant intracellular P2X7 protein, although precise 
locations are not yet defined, and factors inducing its transit to the surface will be 
important in altering the cells’ sensitivity to extracellular ATP. A good example o f  
alterations in surface assembly is the recent finding that increasing the extracellular 
glucose concentration surrounding cultured fibroblasts results in P2X7 molecules forming 
ring-like structures within the membrane [Solini et al., 2000]. Such positional changes 
may explain a cells ability to adapt its responsiveness to ATP in the short term, perhaps as 
a result o f exposure to abnormal, even catastrophic perturbations o f its close environment, 
such as would be expected if  proximate cells undergo death and lytic release of 
intracellular contents. In addition, there is evidence for a trafficking domain in the 
intracellular C-terminus o f the receptor, between residues 551 and 581 [Smart et al.,
2003], and a recently described polymorphism of the human P2X7 gene, resulting in a 
change from isoleucine to asparagine at amino acid position 568, has been shown to 
interrupt normal surface expression o f P2X7: transfection experiments reveal complete 
lack o f membrane trafficking o f the mutated molecule, thus supporting the importance o f  
this trafficking domain [Wiley et al., 2003].
A more long-term up-regulation o f receptor function results from an increase in 
transcription, such as is seen in response to a range o f inflammatory mediators including 
bacterial lipopolysaccharide, tumour necrosis factor a  (TNFa) and interferon-y (IFNy) 
[Falzoni et al., 1995;Ferrari et al., 1997c;Humphreys and Dubyak, 1996;Humphreys and
36
Dubyak, 1998]. Hence, there are several levels at which the close control o f P2X7 
activation can be breached, particularly if  the cell is exposed to a wide range o f extreme 
environmental conditions.
Implications of P2X7 signalling in disease
Current knowledge o f the regulation and biological consequences o f P2X7 signalling 
support a role for this receptor in a range o f diseases, particularly those in which 
inflammation, alterations o f cell proliferation and apoptosis are involved. Studies to date 
have concentrated on the immune system and intracellular bacteriocidal killing by 
macrophages, but it is conceivable that conditions in which cell proliferation or apoptosis 
are abundant may also feature P2X7 signalling. In addition to the P2X7 molecule playing a 
role in the pathogenesis o f disease, it has been suggested that polymorphisms in the P2X7 
gene may confer differential susceptibility to conditions in which inflammation or cell 
turnover are important. Examples o f conditions in which P2X7 has been suggested to 
modulate the progression or phenotype o f disease are discussed below.
Inflammation
The role o f P2X7 in mediating inflammatory responses o f  cells in vitro has been extended 
to in vivo work. The leukocytes o f P2X7 null-mutant mice, demonstrate absent shape 
changes, L-selectin shedding or cytokine release when exposed to LPS, as compared with 
wild type cells [Labasi et al., 2002;Solle et al., 2001]. After induction o f monoclonal anti­
collagen induced arthritis, wild type mice challenged with LPS develop acute arthritis,
however P2X7 null mutants demonstrate markedly lower incidence and severity o f disease
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[Labasi et al., 2002]. Thus, P2X7 mediates inflammatory responses in this mouse model.
In rats, the role o f P2X7 in nociception in an arthritic model has been investigated: 
oxidized ATP, a P2X7 inhibitor appears to reduce the pain signal in the course o f  
peripheral inflammation o f unilaterally affected paws [Dell’Antonio et al., 2002]. 
Bacterial killing
Macrophage killing o f intracellular mycobacteria is mediated by P2X7 receptors, as 
demonstrated by the blocking o f effect by known P2X7 inhibitors, and the mimicking of 
effect using BzATP, a potent agonist [Lammas et al., 1997]. The mechanisms by which 
P2X7 effects bactericidal activity are not fully identified but involve release o f  
phospholipase D [Kusner and Adams, 2000]. The original study o f P2X7 activity in 
mycobacterial killing also revealed a heterogeneity o f response o f human macrophages to 
P2X7 agonists [Lammas et al., 1997], suggesting the occurrence o f genetic 
polymorphisms, that may prove prognostic in terms o f susceptibility to disease. A recent 
study o f polymorphisms o f the P2X7 gene has identified a single nucleotide polymorphism 
in the promotor sequence that confers a significant protective effect against tuberculosis in 
a Gambian population [Li et al., 2002].
Chronic lymphocytic leukaemia (CLL)
Human lymphocytes are known to express the P2X7 receptor, and several groups have 
investigated the hypothesis that the receptor may be an important mediator o f cell turnover 
in malignant conditions o f this cell type. Initial suggestion that P2X7-mediated apoptosis 
may be an important regulator o f disease progression came from the finding o f a group of 
patients with CLL, expressing non-fimctional P2X7 receptors [Gu et al., 2000].
Subsequent studies o f the gene, have isolated a polymorphism at position 1513 (A->C), 
leading to a point mutation that results in a change from glutamic acid to alanine at amino
acid 496 in the intracellular C-terminus: this causes loss o f function o f the receptor 
without affecting membrane localization and appears to have a three times higher 
prevalence in patients with CLL [Wiley et al., 2002]. This suggests that P2X7 behaves as 
an pro-apoptotic tumour-suppressing gene, the result o f the point mutation being reduced 
apoptotic rates, and greater numbers o f B cells, and thus a role in the pathogenesis o f this 
proliferative condition. However, so far, larger studies o f the effect o f this polymorphism 
on progression o f CLL have been inconclusive. A retrospective study o f survival rates in a 
cohort o f  CLL patients also demonstrating mutations o f the prognostic immunoglobulin 
heavy chain variable Vh gene, suggested that the 1513(A—»C) polymorphism actually 
increases survival rates in [Thunberg et al., 2002].
Further evidence for a disease-promoting function o f the P2X7 receptor is that patients 
with evolutive, or progressive forms o f chronic lymphocytic leukaemia (CLL), have 
higher levels o f intracellular calcium, and higher P2X7 expression, assessed by both RT- 
PCR and western blot, as compared with patients with indolent disease [Adinolfi et al., 
2002]. This group documented a proliferative advantage o f transfecting P2X7 into human 
B lymphoblastoid cells lacking it constitutively [Baricordi et al., 1999], but in the study o f  
evolutive CLL patients, presumed to demonstrate higher levels o f proliferation, this group 
found that cells also exhibited higher sensitivity to the cytotoxic effects o f  ATP [Adinolfi 
et al., 2002]. Clearly, prospective studies are required to define the importance o f P2X7 in 
CLL risk and progression, and also further investigation o f the functional properties o f 
polymorphisms o f the receptor gene in these affected lymphocytes, to determine the 
effects o f P2X7 on cell turnover in CLL.
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Neurodegeneration
In view o f the central role o f interleukin lp  in neurodegeneration, and the ability o f P2X7 
to mediate its processing and release, there is growing interest in the potential role o f P2X7 
in neuronal cell death. There is experimental evidence for microglia-induced cortical cell 
death in rats, associated with superoxide production [Parvathenani et al., 2003] and 
interestingly, an up-regulation o f the receptor protein has been seen around the p-amyloid 
plaques, regionally localized with activated microglia and astrocytes, in a transgenic 
mouse model o f Alzheimer’s disease (Tg2756) [Parvathenani et al., 2003]. However, 
functional studies have excluded a primary role for P2X7 in ischaemia-induced brain 
injury; P2X7 null mutant mice exhibit the same response to temporary cortical ischaemia 
as wild-types, and treatment with P2X7 antagonists made no difference to excitotoxicity in 
this mouse model [Le Feuvre et al., 2003].
The demonstration o f P2X7 receptor expression in a wide range o f tissues, make it a 
potential key molecule in the modulation o f responses to many insults, particularly those 
involving the inflammatory cascades or cell turnover. Whether acting as the primary 
underlying defect, or as a modifying factor in the case o f other abnormalities, further 
understanding o f the function o f the P2X7 molecule may in the future provide a useful 
therapeutic target in a range o f diseases. In the next section, evidence supporting a role for 
P2X7 in the kidney is discussed, and the rationale for the experimental strategy used in this 
study. It should be mentioned at this point that subsequent to the main work o f this thesis, 
P2X7 knockout mice have been developed with no apparent renal phenotype. This perhaps 
arguing against a major role for the receptor in renal development and normal function, 
although these animals have not been studied in detail, or in response to renal insults.
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Chapter 2. Role of P2X7 signalling in the kidney
Extracellular ATP signalling in renal physiology and pathophysiology
The focus o f this thesis, in addition to study o f the receptor protein in a unique cell system, 
is the investigation o f possible functional roles, both physiological and pathological, of 
purinergic signalling, particularly via P2X7, in the kidney. Studies describing the basal and 
stimulated release o f ATP within the kidney support a role for nucleotides in signalling in 
this organ; recent work by Schwiebert et al demonstrates ATP release from primary 
cultures and cell lines derived from defined nephron segments, with greatest 
concentrations being released by the proximal tubule: under basal conditions high 
nanomolar concentrations are released and up to 5 pM after stimulation with hypotonicity 
[Schwiebert, 2001;Schwiebert et al., 2002;Schwiebert and Kishore, 2001]. Lower 
nanomolar concentrations are released by thick ascending limb cell models and by 
collecting duct cell models [Schwiebert, 2001] (see Fig. 2). ATP and metabolites can also 
be detected in urine, proving that active molecules can exist in this luminal milieu, along 
the entire renal tract despite the existence o f hydrolyzing enzymes [Schwiebert and 
Kishore, 2001]. Once within a lumen, ATP can theoretically bind purinergic receptors 
expressed on the apical surface o f epithelial cells and can then be postulated to regulate 
ion transport across this surface in addition to affecting other P2-related signalling 
pathways. It can also be conceived that purinergic signalling, via its impact on ion and 
water transport may be important in pathological states such as hypertension or even the 
luminal volume changes occurring in the setting o f cystic diseases.
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Figure 2. ATP release by different nephron segments
Concentrations o f ATP in conditioned media from cell lines and primary cultures 
derived from known nephron segments and grown in vitro in 35 mm dishes, 
correlated with a standard curve with known ATP concentrations. All cell types 
released ATP under basal conditions: concentrations shown are estimates o f in 
vivo stimulated release. CCD, cortical collecting duct; TLs, thin limbs; mTAL, 
thick ascending limb o f Henle’s loop; OMCD and IMCD, outer and inner 
medullary collecting ducts; PCT and DCT, proximal and distal convoluted tubule; 
PST, proximal straight tube. Adapted from Schwiebert and Kishore (2001).
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Although studies have concentrated on luminal release [Schwiebert et al., 2001] there is 
also growing evidence for a role for ATP signalling within the renal interstitium, with 
recent documentation o f ATP release in the interstitial space between the macula densa 
and glomerulus; macula densa cells have been shown to release up to 10 micromolar ATP, 
measured by ATP bioassay, via a maxi-anion channel at their basolateral membrane, when 
subjected to an increase in luminal sodium chloride concentration [Bell et al., 2003]. 
Signalling in this location in vivo is postulated to be important in the control o f glomerular 
filtration rate. Two groups have reported ATP-mediated mitogenic effects in cultured 
mesangial cells [Harada et al., 2000;Schulze-Lohoff et al., 1998], supporting a potential 
role o f this signalling system in modulation o f cell turnover in normal and aberrant renal 
physiology.
P2X7 in the kidney
To date, although there is growing in vitro and in vivo evidence for functional P2Y
receptor signalling in nephron epithelia [Bailey et al., 2000;Deetjen et al., 2000] less is
known about the expression or roles o f the P2X family in renal tissue. Expression and
physiological function has been clearly documented in renal cell lines suggesting that
various P2X receptors might play a role in tubular physiology. RT-PCR has been used to
demonstrate expression o f P2X4 channel in mouse proximal tubule (NF-5), and collecting
duct (OMCT) epithelial cell lines [Takeda et al., 1998], a P2Xi-like receptor in porcine
LLC-PK1 cells, a proximal tubule-like line [Filipovic et al., 1998], and P2X3 and P2X4
receptor expression in mouse inner medullary collecting duct cell line (mIMCD-K2)
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[McCoy et al., 1999]. In native tissue, P2Xi protein has been immunolocalised to the renal 
vasculature, specifically the afferent glomerular arteriole [Chan et al., 1998].
The evidence for P2X7 expression in the renal tract prior to the initiation o f my thesis was 
limited, involving mainly in vitro studies, and there was no detailed description o f its 
localization or potential function in the intact kidney. Interestingly, studies by our group 
and others have recently implicated P2X7 itself in the induction o f ATP-induced apoptosis 
in cultured mesangial cells [Harada et al., 2000;Schulze-Lohoff et al., 1998]. The wide 
range o f biological signals associated with the P2X7 receptor, particularly those involved 
in the inflammatory response, cell turnover and solute and fluid fluxes, suggest it may 
have roles in many renal conditions in which these biological processes are important.
In order to investigate the expression and function o f P2X7 in the kidney in a systematic 
fashion, my work used predominantly murine models, which facilitate both the 
examination o f specific time points in normal or abnormal development o f the renal tract, 
and also the study o f large numbers at these specific time points, when compared with the 
limited availability o f human tissue.
My study aims to describe the expression pattern o f P2X7 in kidneys in vivo, and 
investigate the potential functions o f the receptor in renal cell biology, particularly in the 
context o f normal and abnormal tubulogenesis. This molecule mediates a wide range o f  
cellular events, several o f which could be o f importance in these renal models.
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Renal tubulogenesis and cystogenesis
To study the potential role o f receptor signalling proteins in the pathogenesis o f  
tubulogenesis in the normal kidney, or in polycystic kidney diseases, it is important to 
have an overview o f the general biological processes involved in epithelial tube 
morphogenesis, and also their deregulation to produce cysts. Recent investigation o f tube 
formation and growth using cell culture systems, genetic model organisms and human 
diseases, such as polycystic kidney disease, has led to a paradigm o f tubulogenesis, 
involving apical processes, which, although not fully understood at the molecular level, 
can be considered as three important steps [Lubarsky and Krasnow, 2003].
Firstly, cells must form aggregates, undergo uniform apico-basal polarity, such that cells 
have their apical surface facing inside the aggregate. Secondly, aggregates must undergo 
initiation o f the lumen. At this point, specialized vesicles are generated and targeted into 
the apical membrane, where they undergo fusion, hence expanding the apical surface 
[Wang et al., 1994]. The orchestration o f cell polarity and subsequent vesicular trafficking 
involves a highly conserved membrane protein complex, the exocyst [Lipschutz et al., 
2000]. As well as adding to the luminal surface, exocytosis o f vesicles may also expose 
molecules vital to maintenance o f lumen patency, such as ion pumps to drive osmotic 
forces to fill and expand the cavity, or anti-adhesive factors. Apoptosis is thought to occur, 
particularly in clearance o f residual cells left within the lumen, but it is probably not a 
critical component o f the cavitation process: lumens still form when apoptotic pathways 
are blocked [Debnath et al., 2002;Lin et al., 1999]. Thirdly, growth or expansion o f the 
tube, or cavity occurs. This occurs in a regulated way, involving further fluid shifts with
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stretching or expansion o f the apical surface as described, and in some cases, including the 
kidney, proliferation o f the epithelial cells.
According to this paradigm, any defect in mechanisms sensing the lumen size, or inducing 
expansion arrest, will result in the uncontrolled growth o f the tube, by a combination of 
the mechanisms described above, and will be discussed later in the context o f polycystic 
kidney disease.
The development o f the mammalian kidney involves two distinct forms o f tube formation: 
the collecting ducts and distal tubules arise by sprouting form existing tubes i.e. the 
ureteric buds, whereas proximal tubules arise from de novo tubes forming from 
condensations o f mesenchymal cells, which subsequently connect to the distal network. 
The cellular interactions underlying nephrogenesis, and their molecular basis will be 
discussed in further detail.
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Normal kidney development
The diverse functions o f the mature adult kidney are reflected in the complex mechanisms 
involved in is development, a process conventionally called ‘nephrogenesis’, although this 
term more correctly refers to the development and differentiation o f the nephron units. In 
view o f the role o f P2X7 in the modulation o f cell turnover, it is important to emphasize 
here that development o f the kidney is a balance between the processes o f proliferation 
and cell death [Bard, 2002]. Quantitative data on growth and apoptosis rates in the 
developing rat kidney were first published by Coles et al. who documented 3% mitotic 
rate in the E14.5 kidney, with a 3% apoptotic rate in the cortex [Coles et al., 1993], 
suggesting that approximately 50% of the cells o f the developing kidney die during 
maturation o f the organ. Recent confocal examination o f the developing mouse kidney 
however suggests a lower rate o f apoptosis [Bard, 2002]. Further data supporting the 
dramatic proliferation rates in the rat metanephros is the demonstration that, between E l3
and E l 5 in the development o f the rat metanephros, cell numbers increase 100-fold; cells 
of the condensing mesenchyme, precursor o f the nephron, and loose mesenchyme, 
precursor o f the interstitium also demonstrate apoptotic cell death in this model [Welham 
et al., 2002].
Before investigating the temporal and spatial expression o f molecules o f interest during 
kidney development, it is necessary to understand the cellular events underlying the 
structural changes taking place. The following sections reviews these events in human and 
animal kidney development, most o f the experimental detail derived from animal models.
An overview o f the cell lineages involved in kidney development is shown in Figure 3. In 
my study, P2X7 expression has been investigated in normal mouse kidney development, 
and therefore, comparisons between human and mouse nephrogenesis will be made.
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Figure 3: Cell lineages in nephrogenesis. In the metanephros from El 1 in mouse and 5 weeks gestation in human, there is mutual 
induction between ureteric bud (black) and the mesenchyme (grey). Serial arborisation of the ureteric bud gives rise to the 
collecting ducts and urothelium of ureter and trigone of the bladder, and the condensing mesenchyme undergoes differentiation 
and polarisation to form nephrons, interstitial cells and endothelia. Adapted from Woolf (1997).
There are three pairs o f ‘kidneys’ in human and other mammalian embryos: the 
pronephros, mesonephros and metanephros, arising sequentially form the intermediate 
mesoderm on the dorsal body wall. The pronephros and mesonephros degenerate during 
foetal life whereas the metanephros develops into the adult kidney. The anatomy o f these 
structures has been described by several authors [Potter, 1972], and the timing o f  
important events in human and mouse kidney development shown in Table 3.
Pronephros
The human pronephros appears at the 10 somite stage, 22 days after fertilization, 
morphologically equivalent to embryonic day 9 (E9) in the mouse. It is comprised o f a 
small group o f ‘nephrotomes’, nonfunctional structures with segmental condensations, 
grooves and vesicles, located between the second and sixth somite. These are thought to 
represent vestiges o f the pronephric kidney o f lower vertebrates, but are essential for 
subsequent mammalian kidney development: the pronephric duct develops from the 
intermediate mesoderm lateral to the notochord, elongates caudally to reach the cloacal 
wall on day 26, and is then renamed the mesonephric, or Wolffian duct, as mesonephric 
tubules develop. The nephrotomes and pronephric part o f the duct involute and cannot be 
identified by 25 days gestation.
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Human Mouse
Pronephros
Appears at 22 days 9 days
Regresses by 25 days 10 days
Mesonephros
Appears at 24 days 10 days
Regresses by 16 weeks 14 days
Metanephros appears 28-32 days 11 days
Renal pelvis 33 days 12 days
Collecting tubules and 44 days 13 days
nephrons
Glomeruli 8-9 weeks 14 days
Nephrogenesis ceases 34-36 weeks 7-10 days after birth
Length o f  gestation 40 weeks 20-21 days
Table 3. Nephrogenic time-table: human versus mouse
Summary o f  timing o f  nephrogenesis events, comparing human and mouse. All 
times are embryonic days (i.e. in utero) apart from the end o f  nephrogenesis in the 
mouse, which occurs after birth.
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The mesonephros
In humans, the mesonephros appears 24 days after fertilization and consists o f the 
mesonephric duct and adjacent mesonephric tubules. This solid cylinder o f cells fuses with 
the cloaca and then canalizes in the caudocranial direction. Mesonephric tubules develop 
medial to the duct by ‘mesenchymal to epithelial’ transformation from the intermediate 
mesoderm, a phenotypic transformation reiterated during metanephric nephron 
development. In humans a total o f around 40 pairs o f mesonephric tubules are produced 
although cranial tubules regress as caudal ones are formed, so that numbers at any time do 
not exceed 30 pairs. The tubules consist o f a medial cup-shaped sac encasing a knot o f  
capillaries, apparently analogous to the Bowman’s capsule and glomerulus o f the adult 
kidney, and a lateral portion in continuity with the mesonephric duct. Other segments 
resemble mature proximal and distal tubules, although there is no loop o f Henle. In the 
human, the mesonephros is functional, producing small volumes o f urine between 6 and 
10 weeks o f gestation, which drains into the mesonephric duct. The mouse mesonephros is 
more rudimentary with less well-differentiated glomeruli. Mesonephric structures involute 
during the third month o f human gestation.
The metanephros
Human metanephric development starts at day 28 after fertilization when the ureteric bud 
sprouts from the distal part o f the mesonephric duct. Four days later, the tip o f the bud 
penetrates a region o f sacral intermediate mesenchyme, the metanephric blastema. The 
adult human kidney develops as a result o f complex, reciprocal interactions between these 
two cell lineages, the epithelial cells o f the ureteric bud and mesenchymal cells o f the
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metanephric mesenchyme. The mesenchyme condenses around the tip o f the ureteric bud, 
which itself undergoes sequential branching. This branching morphogenesis leads to 
formation o f the ureter, renal pelvis, calyces and collecting tubules, whereas condensing 
mesenchyme undergoes an epithelial conversion to form nephrons, from the glomerulus 
up to and including the distal tubule. The stalk o f the ureteric bud, at its junction with the 
mesonephric duct becomes incorporated into the cloaca, eventually forming the trigone o f  
the urinary bladder.
Differentiation o f the ureteric bud and its derivatives
As the epithelial ureteric bud grows into the metanephric blastema, it becomes invested 
with condensed mesenchyme, interactions between the two cell types resulting in 
proliferation and branching o f the bud and its derivatives. Both the branch tips and 
surrounding nephrogenic mesenchyme are highly proliferative [Winyard et al., 
1996a;Winyard et al., 1996b]. The process o f branching occurs repeatedly during 
nephrogenesis, particularly in the outer (‘nephrogenic’) cortex, where new nephron units 
develop up to 36 weeks o f human gestation. This leads to an arborised collecting duct 
system connected to nephrons that develop concurrently from the mesenchymal 
condensates adjacent to the ampullary tips. The collecting ducts drain into calyces, renal 
pelvis and ureter, all derived from the ureteric bud.
Formation o f this collecting system requires remodeling o f many o f the early branches, in 
regions historically described ‘vestigial’ and ‘provisional’ zones. The number o f  
generations o f branches that are remodeled is not known, although Potter (1972) estimated 
that the first three to five generations from the pelvis and the next three to five give rise to
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the minor calyces and papillae [Potter, 1972]. Nephrons originally connected to these 
branches are thought to degenerate during development, or transfer to a later branch.
Mature collecting ducts, derived from the ureteric bud, contain three functionally distinct 
cell types, principal cells, a - and p-intercalated cells. Principal cells have relatively few 
organelles, whereas the intercalated cells contain a high density o f mitochondria. Principal 
cells are involved in sodium (Na+) transport, with sodium reabsorption occurring via 
apical amiloride-sensitive Na+ channels driven by basolateral Na/K-ATPase. Fine 
regulation o f water reabsorption by the antidiuretic hormone arginine vasopressin (AVP) 
also occurs in principal cells o f the collecting duct, and is largely dependent on regulation 
o f the aquaporin-2 (AQP2) water channel [Deen et al., 1994].
The intercalated cells modulate acid-base homeostasis in the collecting duct, and exist in a
range o f morphological forms, the most extreme being the a  and p forms. The ex-
intercalated cells acidify urine, having apical H+ATPase and secreting protons, and a
basolateral, modified version o f the red cell Cl' -HCO3' exchanger, kAEl [Wainwright et
al., 1989]. The p cells reabsorb protons and secrete HCO3' having the transporters on the
opposite membranes: H+ATPase is expressed basolaterally and kAEl is expressed
apically. At least in mice, collecting duct cells demonstrate phenotypic plasticity, as p-
intercalated cells can give rise to both a-intercalated cells and principal cells in vitro,
although principal cells do not give rise to intercalated phenotypes [Fejes-Toth and Naray-
Fejes-Toth, 1992]. Further studies suggest that this conversion o f P- to a-intercalated
phenotype bears the hallmarks o f terminal differentiation, cells assuming a columnar
appearance with exuberant microvillar structure. These phenotypic changes are induced by
the hensin protein [al Awqati et al., 1998], and dependent on interaction between hensin
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and galectin 3 [Hikita et al., 2000]. It has been postulated that intercalated cells may be the 
progenitor or stem cells in the ureteric bud branches, although this has not been confirmed 
in vivo, or in human cells.
Differentiation o f the mesenchyme and its derivatives
Each nephron develops from mesenchyme that has condensed around the ampullary tips 
of the ureteric bud. The condensed mesenchyme undergoes phenotypic transformation into 
epithelial renal vesicles, which then elongate to form a comma shape, before folding back 
on themselves to form S-shaped bodies. The distal part o f this structure elongates further 
and differentiates into the proximal convoluted tubule, the descending and ascending 
limbs o f the loop o f Henle, and the distal convoluted tubule, which fuses with the adjacent 
branch o f the ureteric bud to form a continuous functional unit. The proximal S shape 
differentiates into the glomerular epithelium, and capillaries develop in the glomerular 
crevice. During the condensation o f metanephric mesenchyme around ureteric bud 
branches, cells o f the condensates tend to be highly proliferative, expressing survival 
molecules such as PAX2 and BCL2 [Sorenson et al., 1995;Torban et al., 2000;Winyard et 
al., 1996b]. The fate o f these cells is to integrate into the developing nephron, but those 
that do not, undergo apoptosis [Coles et al., 1993;Koseki et al., 1992;Winyard et al.,
1996b; W oolf etal., 1995].
The first vascularised metanephric glomeruli are formed around 8 to 9 weeks o f  human 
gestation, new nephron formation ceasing by around 34 weeks o f gestation. The number
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o f nephrons, as assessed by counting glomeruli, varies between species, a result o f the 
number o f branches o f the ureteric bud required to induce nephron formation, and provide 
their collecting systems. It has been calculated that, in mice, 9 to 10 rounds o f branching 
occur, giving rise to 1 0 - 2 0  000 nephrons per kidney, and a further 10 rounds o f  
branching in humans, generating approximately one million nephrons per kidney [Ekblom 
etal., 1994a].
Further differentiation o f the nephron is outlined below.
Glomerulus
The proximal end o f the S-shaped tubule invaginates into a cup shape and forms 
Bowman’s capsule that encases a tuft o f capillaries to form the glomerulus. Other cell 
types within the glomerulus include podocytes, or visceral epithelia, that possess foot 
processes in contact with the glomerular basement membrane, forming a size-dependent 
barrier to ultrafiltration. Parietal epithelia lines Bowman’s capsule. The capillaries are 
lined by endothelia, first thought to arise by ingrowth from the dorsal aorta, or 
angiogenesis, although it appears some o f these cells may develop in situ by 
vasculogenesis [Woolf and Loughna, 1998]. Capillary loops are supported by surrounding 
mesangial cells, also important in modulation o f surrounding extracellular matrix.
Proximal tubule
The proximal tubule derives from the middle part o f the S-shaped body and consists o f a 
proximal convoluted portion, the pars convoluta that is a continuation o f the parietal 
epithelium o f Bowman’s capsule, and a straight portion, the pars recta. Proximal tubular 
epithelial cells have characteristic morphology, with a well-developed brush border and
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high number o f mitochondria and lysosomes reflecting their high metabolic rate. The main 
role o f this segment is reabsorption o f minerals, ions, water and organic solutes such as 
amino acids and glucose, approximately two thirds o f the ultrafiltrate being reabsorbed 
here.
Loop o f Henle
The loop o f Henle extends deep into the medulla and is essential for generation o f the 
osmolar gradient that permits reabsorption o f water by the collecting ducts. It is composed 
o f the straight portion o f the pars recta, the thin limb segments, and the straight portion of 
the distal tubule (thick ascending limb). Elongation and maturation o f the loops occurs 
postnatally.
Distal segments
The distal tubules consist o f the thick ascending limb o f the loop o f Henle, involved in 
active ion transport (particularly Cl*) and the distal convoluted tubule. This includes the 
macula densa, a specialized portion sensing sodium delivery to the distal tubule and 
subsequently modulating renin secretion via the juxtaglomerular apparatus.
\
Connecting tubule
The connecting tubule provides continuation between the distal tubule and the collecting 
duct, although its precise derivation is not clearly defined. Originally thought to derive 
from renal mesenchyme, there is some experimental evidence suggesting the connecting 
tubule is a ureteric bud derivative [Howie et al., 1993]. Human data, comparing expression 
o f blood group antigen, Tamm-Horsfall protein and cytokeratin, perhaps support the
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theory that the connecting tubule is similar to the collecting duct, hence derived from the 
ureteric bud [Howie et al., 1993]. It has, however, been demonstrated in mice, that LacZ- 
tagged metanephric mesenchymal cells have the ability to differentiate into both nephrons 
and the collecting system, such that the connecting tubule may arise from both cell 
lineages [Qiao et al., 1995].
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Molecular control of kidney development
Recent studies have described numerous regulatory systems involved in the inductive 
events underlying coordination o f branching morphogenesis o f the ureteric bud, formation 
o f the renal vesicle and glomerulus. Genetic and tissue culture approaches have identified 
many genes, molecules and receptors that regulate renal pattern formation, differentiation 
and cell turnover, and which are common to mesenchymal-epithelial inductive 
mechanisms in other organ development including limb bud, neural tissues, lung and gut 
[Burrow, 2000a].
In order to understand the potential roles o f receptor molecules such as P2X7, in the 
normal development o f the kidney, it is necessary, first, to describe what is currently 
understood o f the reciprocal signalling events between mesenchyme and ureteric bud, and 
their downstream events. These events can be considered in two sections, firstly, the 
signalling from the metanephric mesenchyme that induces ingrowth and branching o f the 
ureteric bud, and secondly, the signal from the ureteric bud itself, that induce condensation 
of the metanephric mesenchyme resulting in sequential formation and maturation o f renal 
vesicles to form nephrons. However, in this summary I shall discuss the molecules 
expressed during nephrogenesis in the following broad categories, although several o f the 
key molecules in kidney development display functions o f more than one category:
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• Transcription factors
• Survival / proliferation factors
• Growth factors and their receptors
•  Cell adhesion molecules
Transcription factors
Transcription factors regulate the expression o f other genes, interaction o f  their DNA  
binding domains with the gene in question causing up or down-regulation o f mRNA 
transcription. It is the sequential expression and activity o f these factors that directs the 
normal program of development o f any organ system.
These factors are classified into families, defined by their DNA-binding protein motifs and 
domains, for example; the homeodomain o f Hox transcription factors, paired box domain 
of Pax transcription factors and the zinc-finger motif characteristic o f the WT1 
transcription factor.
Hox genes
Vertabrate Hox genes encode the homeodomain transcription factors, which specify 
positional information along the antero-posterior axis. Hoxa-11 and Hoxd-11 are 
functionally complementary during kidney development: homozygous mutation o f either 
gene in mice causes no renal phenotype, whereas double mutants have rudimentary, 
hypoplastic, or even absent kidneys [Davis et al., 1995]. The ureteric buds are found to be 
unbranched, or atypical with absent terminal branches in the midventral renal cortex, 
implicating defects in ureteric bud branching morphogenesis as the cause o f failed renal 
development in this knock out [Patterson et al., 2001]. There is attenuation o f normal 
gene expression (e.g. Bf2 and GDNF) in the ventral mesenchyme with no detectable
change in cell proliferation or apoptosis, and interestingly, Hoxa-11 expression is 
restricted to early metanephric mesenchyme. These findings suggest that one function o f  
Hoxa-11 and Hoxd-11 is to regulate the differentiation necessary for mesenchymal to 
epithelial reciprocal inductive interactions [Patterson et al., 2001]. Molecular 
characterization o f a triple mutant, also null for the paralogous Hoxc-11 and with absent 
kidneys, shows that, in these animals, in which early metanephric blastema condenses and 
early patterning genes are expressed normally (e.g. Pax2, Wtl), expression o f GDNF, 
required for ureteric bud branching, is absent [Wellik et al., 2002]. This is thought to 
signify the role o f the pax-eya-six regulatory cascade in Hox function in normal kidney 
development.
Pax genes
Pax genes are highly conserved transcription factors containing a paired-box DNA  
binding domain [Gruss and Walther, 1992]. The roles o f specific Pax genes in organ 
development o f many species have been defined, but in this section I shall discuss those 
implicated in kidney development. Pax-2 and Pax-8 are structurally similar, with a 
truncated homeodomain and conserved octapeptide region, and are the only Pax genes 
expressed in kidney development [Dressier et al., 1990;Plachov et al., 1990]. The 
regulatory targets for Pax-8 are not completely understood, although it is thought to play 
role in the establishment o f the Xenopus embryonic kidney, the pronephros. In order for 
Pax-8  to direct cells to form pronephric kidneys, however, cofactors are required, one of 
which is the homeobox transcription factor lim-1. These two genes are initially expressed 
in overlapping domains in late gastrulae, and cells expressing both genes will go on to 
form the kidney. Ectopic expression o f either gene alone has a moderate effect on 
Xenopus pronephric patterning, while co-expression o f Pax-8 plus lim-1 results in the
development o f embryonic kidneys o f up to five times normal complexity and also leads 
to the development o f ectopic Xenopus pronephric tubules [Carroll and Vize, 1999]. Pax-8 
has also been implicated in regulation o f WT1 function [Fraizer et al., 1997].
Pax-2 is expressed in early kidney development in the mouse, mRNA expressed in 
mesonephric duct, tips o f the ureteric bud and condensing mesenchyme [Dressier et al., 
1990]. Protein expression persists in nephron precursors up to the S-shaped bodies, but is 
the down regulated in more mature epithelia deriving from these structures [Dressier and 
Douglass, 1992]. There is little expression in ureteric bud derivatives in the mature 
kidney, other than low levels in the collecting ducts. The function o f this transcription 
factor in renal development has been investigated in a series o f experiments. Firstly, the 
use o f Pax-2 antisense oligonucleotides, to reduce protein function in mouse kidney organ 
cultures, causes failure o f mesenchyme to aggregate and undergo the sequential 
morphological changes characteristic o f epithelial cell formation [Rothenpieler and 
Dressier, 1993], suggesting a role in early mesenchyme to epithelial transformation. 
Secondly, over expression o f Pax-2 in mice leads to neonatal nephrotic syndrome, again 
suggesting a role in differentiation o f renal epithelia [Dressier et al., 1993]. Over­
expression may also lead to cystic renal development. Lack o f the functional protein in 
null mutant mice can also lead to aberrant renal phenotype, with absent kidneys in 
homozygous knock out mice, due to failure o f the ureteric bud to grow out from the 
Wolffian duct [Torres et al., 1995].
Further data supporting the critical regulatory role o f Pax-2 and Pax-8 in specification of 
nephric lineage comes from transgenic mouse studies. In Pax-2 and Pax-8 double-mutant 
mouse embryos, the intermediate mesoderm does not undergo the mesenchymal-epithelial 
transitions required for nephric duct formation, fails to initiate the kidney-specific
62
expression o f Liml and c-Ret, and is lost by apoptosis one day after failed pronephric 
induction [Bouchard et al., 2002]. Conversely, retroviral misexpression o f Pax-2 can 
induce ectopic nephric structures in the intermediate mesoderm and genital ridge o f chick 
embryos [Bouchard et al., 2002]. Together, these data identify Pax2 and Pax8 as critical 
regulators that specify the nephric lineage. That Pax-2 acts as an anti-apoptotic factor, has 
been demonstrated by recent studies: firstly, a large number o f ureteric bud cells undergo 
apoptosis in the spontaneously occurring Pax-2 mutant mouse (INeu), with resulting 
reduction o f normal ureteric bud branching, loss o f nephron number and renal hypoplasia 
[Porteous et al., 2000], and secondly, endogenous Pax-2 expression in inner medullary 
collecting duct cells (mIMCD-3) in vitro protects cells against apoptotic cell death 
[Torban et al., 2000].
WT-1
The Wilms’ tumour suppressor gene-1 (WT-1) encodes a transcription factor protein 
containing four zinc-finger motifs, important for DNA binding. WT-1 is known to be 
important in mammalian development, including the urinary tract [Pritchard-Jones et al., 
1990]. mRNA is expressed specifically in the condensed mesenchyme, renal vesicle and 
glomerular epithelium o f the developing kidney, in the related mesonephric glomeruli and 
in cells approximating these structures in tumours. There is no expression in the branching 
ureteric bud. As the comma and S-shaped bodies mature, WT-1 levels increase and 
become restricted to visceral glomerular epithelia in the mature kidney. As in studies of 
other transcription factors, the role o f this molecule has been investigated using transgenic 
mice. Homozygous null-mutants o f WT-1 exhibit renal agenesis and die at approximately 
E14 [Kreidberg et al., 1993]. Specifically, at day 11 o f gestation, the cells o f the 
metanephric blastema undergo apoptosis, the ureteric bud fails to grow out from the
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Wolffian duct, and the inductive events that lead to formation o f the metanephric kidney 
do not occur. More recently it has been reported that initial differentiation o f the 
metanephric mesenchyme is not dependent on WT-1 or the ureteric bud, as the null- 
mutant metanephric blastema expresses factors such as Pax-2, Six-2 and GDNF, and that 
the first event that does depend on this factor is the outgrowth o f the ureteric bud from the 
Wolffian duct [Donovan et al., 1999].
Several other transcription factors have been implicated in renal development, for example 
BF-2, in formation o f interstitial cells from mesenchyme [Hatini et al., 1996], and N-myc, 
which is expressed in the uninduced mesenchyme and appears to be confined to regions 
exhibiting high rates o f proliferation [Bates et al., 2000].
Survival factors
Proliferation o f cells and their subsequent survival are events central to the organized 
development o f an organ. A number o f key genes have been identified that influence these 
processes during renal development. These include B-cell lymphoma / leukaemia-2 (Bel- 
2), which I shall describe in further detail. In addition, p53, a tumour suppressor gene, 
normally expressed in the comma and S-shaped bodies has been shown to cause reduction 
in nephron number when over-expressed [Godley et al., 1996]. Defective differentiation o f  
the ureteric bud is thought to be the primary defect in this transgenic mouse, with 
secondary apoptosis o f metanephric mesenchymal cells and fewer cells ultimately 
converting to tubular epithelium. p57-kip2 is a cyclin-dependent kinase cell cycle 
inhibitor, required for regulation o f cell proliferation, and is expressed in the podocytes,
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and in stromal cells between renal tubules during renal development. Null mutant mice 
display fewer renal tubules and small inner medullary pyramids [Zhang et al., 1997a]. 
Bcl-2
The BCL-2 gene, discovered in human follicular B-cell lymphomas with a translocation 
between chromosome 14 and 18, is now recognized as a member o f a large family o f  
genes involved in the control o f apoptotic cell death. Members o f this family are either 
apoptosis repressors {Bcl-2, Bcl-Xi,, Mcl-1 m & A -l) whereas others promote apoptosis 
{Bax, Bcl-Xs, Bad and Bak). The critical balance between these functions is modulated by 
homo- and hetero-dimerisation between the related genes [Korsmeyer et al., 1993].
The Bcl-2 protein is located in several intracellular sites including the outer mitochondrial 
membrane, nuclear membrane and endoplasmic reticulum, and evidence from targeting 
experiments in Madin Darby canine kidney (MDCK) cells, a collecting duct cell line, 
suggest that the main site o f the anti-apoptotic effects o f Bcl-2 is the mitochondria [Zhu et 
al., 1996]. During kidney development Bcl-2 is up regulated in the condensing 
mesenchyme, and persists in the developing nephrons [Novack and Korsmeyer, 1994]. 
Functional data from transgenic mouse experiments supports a critical role for Bcl-2 in the 
control o f cell turnover during kidney development. The null-mutant mice survive until 
birth, after which time they exhibit growth retardation and reduced lifespan, ranging from 
two to 10 weeks [Veis et al., 1993]. The most significant organ defects occur in the 
haematopoeitic system, with apoptotic involution o f the thymus and spleen, the hair, 
showing hypopigmentation, and the kidney. Original reports were o f proximal tubule 
dilatation with hyperproliferation o f epithelia and interstitium, but later studies by 
Sorensen et al (1995) reported hypoplastic kidneys at birth, with fewer nephrons and 
smaller nephrogenic zones. The metanephroi o f null mutants exhibited increased rates of
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apoptosis and associated retardation in culture [Sorenson et al., 1995]. Postnatally, these 
null mutants develop cysts, derived from all tubular segments [Sorenson et al., 1996]. 
Cystogenesis is accompanied by enhanced proliferation o f  cells within cortex and 
medulla, and apoptosis o f cells within cysts and in the renal interstitium. These findings 
support a role for Bcl-2 and control o f apoptosis in normal kidney development, and also 
the theory that abnormal regulation o f apoptosis may accompany cystogenesis in bcl-2(-/-) 
mice during postpartum kidney development. The constitutive expression o f Bax in the 
distal tubules may enhance this apoptotic death [Sorenson et al., 1996].
Growth factors and their receptors
Growth factors display a wide range o f  actions during kidney development, including 
induction o f  cell turnover, differentiation and possibly motility. The balance between these 
processes is critical in determining normal morphogenesis, and is thought to be controlled 
by interactions between cells, mediated by extracellular matrix and diffusible peptide 
growth hormones [Burrow, 2000a]. Growth factors bind to cell-surface receptors, o f  
which the largest class is the receptor tyrosine kinase family. Ligand binding induces 
receptor dimerisation, autophosphorylation and subsequent intracellular signaling. They 
may act in a paracrine or autocrine fashion, or by juxtacrine signalling, which involves 
insertion o f the growth factor into the membrane o f the synthesizing cell and subsequent 
interaction with receptors on adjoining cells.
Studies to identify the key molecules with growth factor roles in metanephrogenesis have, 
in many cases, exploited the ability o f  the metanephros to grow in defined serum-free 
media in vitro [Avner et al., 1983]. The functional roles o f  endogenously produced growth 
factors have been investigated by blockade using neutralising antibodies, or by
perturbation o f gene expression by antisense oligonucleotides. Important molecules 
identified include; TGF-a, the embryonic homologue o f EGF, hepatocyte growth factor / 
scatter factor (HGF / SF), bone morphogenetic protein (BMP), glial cell line-derived 
neurotrophic factor (GDNF), amongst others, that modulate cell survival, differentiation 
and morphogenesis. The exact roles o f some o f these factors will be discussed in further 
detail.
EGF
EGF and its embryonic form, TGF-a, are renal mitogens, inducing epithelial hyperplasia 
and proximal tubular cyst formation [Avner and Sweeney, Jr., 1990]. They bind the EGF- 
receptor (EGF-R) to initiate an intracellular cascade o f phosphorylation events via tyrosine 
kinase activity, ultimately transducing signals to the nucleus resulting in DNA synthesis 
and cell division. The use o f synthetic tyrosine kinase inhibitors to block EGF-R activity 
reduces the hyperproliferation and cystic dilatations o f proximal tubules, with reduced 
distal nephron differentiation. EGF-R null-mutant mice exhibit variable cystic renal 
phenotype, depending on background [Threadgill et al., 1995]. The production o f TGF-a 
by El 3 rat metanephroi has been shown in vitro, and blockade o f its function using 
blocking antibodies results in perturbation o f renal morphogenesis: arborisation o f the 
ureteric bud, and tubulogenesis within the metanephric blastema are inhibited by the 
addition o f anti-TGF-a antibodies to organ cultures [Rogers et al., 1992]. The mitogenic 
role o f EGF in kidney development is further supported by the demonstration that it 
inhibits cell death in developing kidneys in vivo [Coles et al., 1993], and also rescues 
isolated renal mesenchyme from apoptosis in vitro [Koseki et al., 1992].
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HGF / SF
Soluble HGF / SF, secreted by embryonic fibroblasts, and its met protooncogene receptor, 
are known to be important in renal development. HGF /SF is found in metanephric 
mesenchyme and blastema, whilst its receptors are expressed both in ureteric bud and the 
mesenchyme [Woolf et al., 1995]. Anti-HGF / SF antibodies inhibit mesenchymal 
differentiation into epithelial nephron precursors, increase cell death within the 
mesenchyme and perturb branching morphogenesis o f the ureteric bud [Woolf et al., 
1995]. This suggests an autocrine and /or paracrine role for the HGF / SF -  met signalling 
system in nephrogenesis.
GDNF
Glial derived neutotrophic factor (GDNF) is the ligand for the receptor tyrosine kinase, ret 
[Vega et al., 1996]. Null mutants o f either GDNF [Sanchez et al., 1996] or its receptor 
[Schuchardt et al., 1994] exhibit renal agenesis, hence their interaction is essential for 
normal nephrogenesis. The demonstration o f defective ureteric bud branching in 
heterozygous GDNF mutants reveals this as the major process induced by the GDNF-ret 
signaling pathway. Ret mRNA is expressed in the mesonephric duct and branching tips o f  
the ureteric bud in the metanephros and GDNF is expressed in adjacent mesenchyme. 
Functional studies demonstrate that in organ culture, GDNF significantly increases 
branching morphogenesis o f the E l 1.5 metanephros, and induces the formation o f ectopic 
ureteric buds from the base o f the bud and from the Wolffian duct. In addition, primary 
ureteric bud cells in vitro exhibited increased proliferation and survival when exposed to 
GDNF [Towers et al., 1998]. Conversely treating rat embryonic kidney organ cultures 
with a ret-Ig fusion protein to disrupt normal signalling pathways, results in decreased 
branching o f the ureteric bud. This is accompanied by down regulation o f expression o f
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Wnt-11 and Wnt-4 genes, suggesting a role for these gene products downstream o f the ret 
signaling complex. Upstream, Pax-2 has been demonstrated to bind regulatory elements in 
the GDNF promotor region and activate its expression. The functional dependence o f  
GDNF-induced ureteric bud branching on Pax-2 has been demonstrated: GDNF 
replacement in organ culture is not sufficient to stimulate ureteric bud outgrowth from 
Pax2 mutant nephric ducts [Brophy et al., 2001].
BMP
The bone morphogenetic proteins are members o f  the TGF-p superfamily o f growth 
factors, several o f which have a role in kidney development. In vitro, BMPs 2 ,4  and 7 
have direct or indirect roles in regulation o f ureteric branching morphogenesis and branch 
formation. In vivo, renal phenotypes have been reported in BMP-7 homozygous null 
mutant mice and BMP-4 heterozygous null mutant mice. BMP-7 is expressed during 
kidney development, in branches o f the ureteric bud, the metanephric mesenchyme and 
then the early tubules derived from mesenchyme [Dudley and Robertson, 1997]. Its role as 
an anti-apoptotic factor is supported by in vitro and in vivo studies: BMP-7 signalling can 
prevent apoptosis in explants o f metanephric mesenchyme where, in conjunction with 
FGF2, BMP-7 promotes growth and maintains competence o f the mesenchyme. BMP-7 
null mutant mice have markedly impaired nephrogenesis, with reduced nephron number 
due to failed differentiation o f metanephric mesenchyme, and reduced ureteric bud 
branching [Luo et al., 1995]. Further data indicate that BMP-7 expression in the epithelial 
components o f the kidney is not dependent on cell-cell or cell-ECM interactions with the 
metanephric mesenchyme, but BMP-7 expression in the metanephric mesenchyme is 
dependent on proteoglycans and possibly Wnt signalling [Godin et al., 1998]. Thus, BMP-
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7 acts as a survival factor for nephrogenic mesenchyme, although its role in maturing 
epithelial structures is not clearly defined.
BMP-4 applied to organ cultures results in an indirect reduction o f ureteric bud branching 
via interference o f normal metanephric mesenchyme differentiation [Raatikainen-Ahokas 
et al., 2000]. BMP-4 heterozygous null mutant mice display abnormal renal and ureteric 
phenotypes, with reduced ureteric branching within the kidney, and ectopic ureteral 
budding from the Wolffian duct and accessory budding o f the ureter. It therefore appears 
that BMP-4 functions firstly to inhibit ectopic budding from the Wolffian duct or the 
ureter stalk by antagonizing inductive signals from the metanephric mesenchyme to 
incorrect sites, and secondly to promote the elongation o f  the branching ureter within the 
metanephros, thereby promoting kidney morphogenesis [Miyazaki et al., 2000].
Cell adhesion molecules
Adhesion o f cells, both to other cells and the extracellular matrix, is essential for normal 
development o f the kidney; increased adhesion o f cells to each other and the basement 
membrane occur early in the mesenchyme to epithelial conversion required for 
tubulogenesis. Many cell adhesion proteins have been shown to be expressed during early 
stages o f kidney tubulogenesis, including: cadherins, cell surface proteoglycans, cell 
adhesion molecules o f the immunoglobulin superfamily and extracellular matrix 
components such as laminins, collagens and their surface receptors. A brief review o f the 
adhesion molecules important in kidney development is given below.
Uninduced metanephric mesenchyme expresses collagen I, III and fibronectin in the 
mouse [Ekblom, 1981;Ekblom et al., 1981]. These cells also express surface NCAM, with
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down regulation o f expression occurring after induction, as the nephrons mature [Klein et 
al., 1988a] [Lackie et al., 1990]. At the stage o f early induction o f mesenchymal to 
epithelial transition, cells express a proteoglycan syndecan, a receptor for interstitial 
matrix molecules [Vainio et al., 1989]. At this early stage o f mesenchyme induction, there 
is also expression o f laminin B1 and B2 (or p and y) chains [Ekblom 1990 Cell]. As 
epithelia undergo polarisation, collagen I and III and fibronectin expression is lost and 
cells begin to express basement membrane components, including collagen IV and 
laminin A chain (a l)  [Ekblom et al., 1990;Ekblom, 1981;Ekblom et al., 1981;Vestweber 
et al., 1985]. There has been a review o f nomenclature for members o f the laminin family, 
the old nomenclature used in these early studies are also shown as their new names, in 
brackets for clarity.
The functional importance o f the laminins in kidney development is demonstrated by
antibody blocking experiments. Epithelial cells express three major laminin types;
laminin-1 (a lp ly l) ,  laminin-5 (a3p3y2) and laminin-10 (a 5 p iy l). Early studies o f
laminin-1 chains demonstrated that application o f antibodies to fragments E3 and E8 of
the A (a l)  chain to mouse metanephric organ cultures causes blocking o f conversion of
mesenchymal cells to polarized epithelia [Klein et al., 1988b]. The result is a perturbation
o f tubule formation. The receptors for the individual laminins have been identified as the
integrins and also other proteins such as dystroglycan and nidogen. The E8 chain binds
a 6 pi integrin, antibodies to which perturb the formation o f kidney tubules in vitro [Falk
et al., 1996;Sorokin et al., 1990]. E3 fragment binds the dystroglycan complex: antibodies
directed against the E3 fragment itself causes a minor perturbation o f tubulogenesis, and
antibodies blocking binding o f E3 to the dystroglycan complex also result in abnormal
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epithelial development in kidney organ culture [Durbeej et al., 1995;Sorokin et al., 1992]. 
Other epithelial laminins have also been implicated in tubulogenesis: laminin 5 is 
expressed by the developing ureteric bud and studies using organ culture and isolated 
ureteric bud culture show it is necessary for branching morphogenesis, via its receptors 
a 3 p l and a6p4 integrins [Zent et al., 2001]. Other integrins the are also important in 
nephrogenesis, an example being integrin a 8 , expressed in early nephrogenesis, knock out 
o f which results in reduced renal mass in affected mice, or even renal agenesis [Hartner et 
al., 2 0 0 2 ].
The cell adhesion molecule nidogen, a binding molecule that links basement membranes, 
is expressed during early epithelial cell development in the kidney and other organs. 
Nidogen, produced by the mesenchyme, is found in the basement membranes o f the 
ureteric bud, primitive vesicle and S-shaped bodies, always co-localised with laminin B2 
(y l) chain [Katz et al., 1991]. The binding o f nidogen to this laminin chain occurs at 
domain III, and is essential for normal basement membrane formation in early 
nephrogenesis. Blocking this nidogen binding site perturbs epithelial development in 
kidney organ cultures [Ekblom et al., 1994b]. In vivo, the targeted inactivation o f  nidogen 
alone does not affect renal phenotype, but selective deletion o f the nidogen binding site in 
the laminin y l (yl III 4) chain causes renal agenesis in mice homozygous for the mutation. 
Microscopic examination o f the mice, which die at birth, reveals abnormal basement 
membrane o f the elongating Wolffian ducts [Willem et al., 2002].
Various other cell adhesion molecules have been shown to play important roles in early
kidney development, including proteoglycans such as syndecan, chondroitin and heparan
sulfate, and the lectin, galectin-3, but will not be discussed in detail in this thesis.
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Other molecules involved in kidney development
In addition to the categories described above, there are many other molecules with 
important functional roles in kidney development. These include: TNF-a, an 
inflammatory cytokine that modulates cell proliferation, apoptosis and biogenesis o f the 
extracellular matrix [Cale et al., 1998;Vassalli, 1992]; retinoic acid receptors (RAR) that 
are important in renal morphogenesis [Mendelsohn et al., 1994]: retinoids in the kidney 
maintain c-ret expression by the ureteric bud tips, are involved at sites o f epithelial- 
mesenchymal interactions and also affect other downstream molecules including midkine, 
sonic hedgehog, Hoxd-11 and matrix metalloproteinases and their inhibitors [Batourina et 
al., 2001;Burrow, 2000b]; the Wnt family o f secreted growth and differentiation factors: 
wnt-1, wnt-4 and wnt-11 are all expressed in metanephric kidneys and have been 
implicated in kidney morphogenesis [Herzlinger et al., 1994;Majumdar et al., 2003;Stark 
et al., 1994].
It is likely that the introduction o f new techniques to screen for differentially regulated 
genes during development, will identify a greater number o f molecules important in 
kidney development, lead to further understanding o f the temporal expression o f these 
molecules, and facilitate the investigation o f the functional relationships o f the encoded 
proteins and identification o f additional downstream targets.
In this study I investigated the potential involvement o f P2X7 in the developing kidney. 
This molecule exhibits a broad range o f biological functions, many o f which support a role
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in nephrogenesis or tubulogenesis, in particular modulation o f cell turnover, proliferation 
and apoptosis, important functions of many o f the molecules documented above. In 
addition, in certain cell types, the P2X7 molecule is known to form a membrane signalling 
complex with various other molecules [Kim et al., 2001b] implicated both in its multiple 
downstream signalling pathways but also in rearrangements o f the cytoskeleton: one o f  
these is the extracellular matrix protein laminin a3, a component o f laminin-5, known to 
bind integrins a 3 p l, a6p4 and a 6 p i, implicated in nephrogenesis as described above 
[Kim et al., 2001a] [Zent et al., 2001].
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Polycystic kidney diseases
Mechanisms o f renal cyst development
The development o f polycystic disease o f the kidney must involve abnormal renal tube 
morphogenesis. As described earlier, tube morphogenesis can be considered as three 
major steps: cells must first form aggregates, undergo uniform apico-basal polarity, such 
that cells have their apical surface facing inside the aggregate. Secondly, aggregates must 
undergo initiation o f the lumen and finally growth or expansion o f the tube, or cavity 
occurs (see Fig. 4). The pathogenesis o f polycystic kidney diseases must involve abnormal 
regulation o f  one or more o f these steps, presumably including failed size-sensing and 
uncontrolled tube expansion to form cysts. In most models o f polycystic kidney disease 
the early stages o f nephrogenesis are unremarkable with inductive interactions between 
ureteric bud and metanephric mesenchyme to generate normal nephrons and collecting 
ducts. The recent advances in characterization o f the molecular abnormalities in human 
and animal models o f polycystic diseases are beginning to provide insight into the sensing 
mechanisms in renal tubules, and have highlighted the role o f cell proliferation and 
apoptosis in the pathogenesis o f polycystic kidney diseases [Winyard et al., 1996a;Woo, 
1995]. The ability o f P2X7 to modulate cell survival might support a functional role for the 
receptor in this form o f abnormal renal development.
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Figure 4. Paradigm for the morphological formation of lumen, tubes 
and cysts
Schematic representation o f  the three steps o f  cellular events involved in 
initiation and formation o f  lumen, tubes and cysts. 1: cells initially 
aggregate and 2 : receive polarising signals to set apico-basal polarity. 
Vesicles carrying apical membrane antigens are targeted to the prospective 
apical region and fuse with existing membrane or each other to form a 
lumen. Apoptosis o f  interior cells that fail to receive the polarising signal, 
along with continued vesicle fusion and apical secretion expand the lumen. 
3. Subsequent expansion is a regulated process, dependent on the balance 
o f  proliferation and apoptosis o f  epithelial cells and the net flux o f  fluid 
into the lumen. In tube formation expansion occurs until it is inhibited by a 
size sensor, failure o f  which may result in abnormal tube and cyst 
expansion. Cells undergoing apoptosis are depicted in red, and 
proliferation in green. Adapted from Lubarsky and Krasnow (2003).
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Figure 4. Paradigm for the morphological formation of lumen, tubes and cysts
The two main forms o f human polycystic kidney disease will be discussed, autosomal 
dominant polycystic kidney disease (ADPKD) and ARPKD, the latter being the focus o f  
later experiments.
ADPKD is the commonest genetic form of polycystic kidney disease with a prevalence o f  
approximately 1 in 1000  births, featuring multiple cysts arising from the glomeruli, along 
the length o f proximal tubules to collecting ducts, leading to end stage renal failure, 
typically by late middle age [Gabow et al., 1992]. Mutations in at least two different genes 
can cause ADPKD, and the cloning o f two o f these has provided valuable insight into the 
pathogenesis o f the condition. The majority o f cases are caused by mutations in PKD1 on 
chromosome 16pl3.3 [The European Polycystic Kidney Disease Consortium, 1994], that 
encodes polycystin 1, a large, transmembrane glycoprotein. Polycystin 2, encoded by 
PKD2 on chromosome 4q21-q23 [Mochizuki et al., 1996]is a smaller membrane 
associated glycoprotein with cation channel properties [Cai et al., 1999]. Evidence for a 
third locus, PKD3 has been postulated but the gene has yet to be identified [Ariza et al., 
1997;Turco et al., 1996]. Many o f these dominant mutations have been found to be loss o f 
function alleles, and disease induction in heterozygotes require a second, acquired somatic 
mutation, inactivating the wild type copy o f an ADPKD gene in a cell, thus eliminating 
gene function in that cell and its progeny [Brasier and Henske, 1997;Pei et al., 
1999;Watnick et al., 1998]. This is known as a ‘two hit’ mechanism. Clones o f abnormal 
renal tubule cells form local expansions that progress, and often separate form the tubule 
to form large, fluid filled cysts [Qian et al., 1996].
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Autosomal recessive polycystic kidney disease
In this study I have focused on the recessive form o f PKD. Human ARPKD is less 
common that ADPKD, with an incidence o f  approximately 1 in 20 000 live births, and a 
heterozygous carrier state frequency o f 1 in 70 [Zerres et al., 1998]. Of those patients 
surviving the neonatal period, most will reach end stage renal failure by the end o f the first 
decade, and this accounts for approximately 5% o f children requiring renal replacement in 
the USA [McEnery et al., 1993]. In addition to the renal abnormalities, ARPKD always 
features hepatic abnormality, for example biliary dysgenesis and congenital hepatic 
fibrosis [Lonergan et al., 2000], and the gene is now known: polycystic kidney hepatic 
gene 1 (PKHD1) on chromosome 6p21.1 -p 12 encodes fibrocystin [Onuchic et al., 
2002;Ward et al., 2002].
ARPKD represents a disease o f tubular malformation, with non-obstructive collecting duct 
ectasia occurring bilaterally and affecting between 10 -  90% of ducts [Blyth and 
Ockenden, 1971]. The clinical course o f the disease is variable, renal progression 
dependent on the percentage o f ducts affected. In severely affected newborns, the kidneys 
can weigh up to 300 grams, 12 times the normal weight, and have a sponge-like 
appearance on sectioning (see Fig. 5). The large size o f the kidneys and reduced renal 
function in utero both contribute to oligohydramnios and pulmonary hypoplasia, babies 
often dying shortly after birth. With lesser degree o f collecting duct involvement kidneys 
are less enlarged, amniotic fluid levels are nearer normal and individuals tend to present 
later in childhood with renal impairment and hypertension, or, in some cases with liver 
involvement [Blyth and Ockenden, 1971]. In mildly affected individuals, renal
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involvement can be detected by the appearance o f cysts on ultrasound, or in the absence of 
cysts, as striations on an excretory urogram, representing pooling o f contrast material in 
dilated, radially orientated collecting ducts [Lonergan et al., 2000].
Histological analysis reveals foetal proximal tubular [Nakanishi et al., 2000] and 
collecting duct dilatation, but as disease progresses the ectatic collecting ducts dominate 
the phenotype, as confirmed by microdissection and lectin staining [Verani et al., 1989]. 
The cortical collecting ducts can be seen as elongated structures extending radially from 
the cortico-medullary region to the subcapsular cortex. This is accompanied by tubular 
atrophy and interstitial fibrosis, and with progressive loss o f functioning renal tissue 
[Kissane, 1990].
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Figure 5. Macroscopic appearance o f autosomal recessive 
polycystic kidneys (ARPKD)
Gross appearance of a kidney removed from a patient with ARPKD. 
A: Macroscopic appearance o f a grossly enlarged polycystic kidney 
that in cross-section (B) reveals the sponge-like appearance of 
multiple collecting duct cysts (*) throughout the cortex and medulla, 
with loss of cortico-medullary differentiation. (Adapted from 
Potter’s Atlas o f Fetal and Infant Pathology).
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Despite the different genetic basis o f these conditions, there appear to be many similarities 
in the abnormalities o f renal cell biology, although it is not clear which represent primary, 
gene-related, cyst causing changes, or which are secondary to cyst formation. In both 
ADPKD and ARPKD abnormalities o f cell turnover are documented, with deregulation o f 
proliferation and apoptosis o f cystic epithelia [Lanoix et al., 1996;Nadasdy et al., 
1995;Winyard et al., 1996a;Woo, 1995], abnormal cell-cell and cell-matrix interactions 
[Wilson and Burrow, 1999] and altered polarity o f cyst epithelia. The latter is associated 
with mislocalisation o f membrane proteins, proposed to mediate a flux o f fluid into the 
cyst lumen [Avner et al., 1992]. The expression o f a number o f molecules, for example 
growth factors and oncogenes, are known to be abnormal within cystic epithelia. The 
oncogene c-myc, implicated in both proliferation and apoptosis, is up regulated in 
ADPKD [Lanoix et al., 1996] and in the cpk/cpk mouse model o f ARPKD [Cowley, Jr. et 
al., 1991]. Treatment o f this murine model with c-myc antisense results in amelioration of 
disease [Ricker et al., 2002]. Imbalance o f expression o f growth factors such as EGF 
[Gattone et al., 1990] and HGF [Horie et al., 1994] have also been documented in 
polycystic kidney disease.
Further understanding o f the relative importance o f these alterations in renal cell biology 
will be achieved by study o f the recently described genetic forms o f human and animal 
PKD. The identification o f the abnormal proteins in ADPKD and ARPKD now support 
the role o f abnormal size sensing, and dysregulated epithelial biology, underlying these 
forms o f PKD. Mouse null mutants o f the Pkdl and Pkd2 genes are embryonic lethal, but 
the proximal renal tubules do appear to form normally initially, and then, from E l5,
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undergo cystic change late in embryogenesis [Lu et al., 1997;Wu and Somlo, 2000]. This 
data suggest that, at least in these genetic forms o f polycystic kidney disease, the genes are 
not necessary for renal tubulogenesis, but appear to regulate subsequent growth and size 
o f the tubular structures.
Thus, considering the paradigm o f lumen and tube formation and subsequent regulation o f  
size described earlier, it is likely that in human PKD, loss o f gene function exerts critical 
effects on factors either sensing the size o f the tubular lumen, or causing the ‘brake’ in 
cyst growth, either by fluid shifts or cell turnover. One theory is that PKD genes are 
tumour suppressor genes, the ‘two hit’ inactivation causing increased proliferation within 
the cyst epithelia. Evidence for abnormal cell turnover, including proliferation and 
apoptosis, has been described above.
An alternative model is that the PKD genes are directly involved in the regulation o f renal 
tubular size, and this theory is supported by the recent molecular characterization o f the 
gene products. Polycystin 1 and polycystin 2 are believed to interact to form a heteromeric 
polycystin complex: homology studies suggest that polycystin 1 may be involved in cell­
cell or cell-matrix interaction, whereas polycystin 2  is the prototype o f a subclass o f the 
transient receptor potential (TRP) superfamily o f calcium channel proteins [Koulen et al.,
2002]. The polycystins accumulate to high levels in the primary cilium extending from the 
apical surface o f renal epithelial cells [Yoder et al., 2002a], and a polycystin 1 / 
polycystin-2 -  dependent calcium channel is postulated to be a component o f the ciliary 
transduction process. Renal cell cilia sense apical surface and luminal events, such as 
expansion via the bending o f the cilia, which evokes a calcium signal [Praetorius and
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Spring, 2001;Praetorius and Spring, 2003]. Gene mutations underlying mouse models o f 
polycystic disease are also postulated to be involved in ciliary function: the Tg737 gene 
encoding polaris, is required for ciliary formation [Yoder et al., 2002b], and cystin, 
mutated in the cpk/cpk mouse is also cilia-associated [Hou et al., 2002].
Thus, the genetic and molecular data support the role o f these PKD genes in 
mechanosensitive calcium signalling in renal cell cilia, to inhibit excessive tubular 
expansion. Disruption o f  components o f this signalling pathway would result in unabated 
expansion o f renal tubules and subsequent cyst formation.
As stated, dysregulation o f the apical membrane biogenesis, possibly including epithelial 
proliferation, de novo, or as a consequence o f failed feedback signalling via ciliary 
mechanisms, may be the driving force in cyst expansion. Mechanisms by which there is 
net flux o f fluid into the lumen, are essential to maintain the expansion o f cystic structures, 
as otherwise proliferating cells would simply fill the tubules to form solid tumours. These 
however are not clearly understood at present and appear to differ between PKD types, 
possibly as a result o f their differing tubular origins. Evidence from animal models o f 
ADPKD and the human disease suggest abnormal transepithelial fluid secretion may be 
involved. The Na/K-ATPase, normally localized to the basolateral membrane o f adult 
renal epithelial cells, is mislocated in epithelial cells from ADPKD cysts, to the apical 
surface, and both apical a l  and 02  isoforms functionally transport sodium from the 
basolateral to luminal compartments [Wilson et al., 1991]. These cells also express the 
cystic fibrosis transmembrane conductance regulator CFTR, and cAMP induced chloride 
(C1‘) transport has been documented [Davidow et al., 1996;Hanaoka et al., 1996;Sullivan 
and Grantham, 1996;Wallace etal., 1996].
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Less is known o f the transport characteristics o f cystic epithelium in ARPKD: the cysts in 
this condition are dilated ecstatic collecting ducts, remaining contiguous with the nephron, 
a l  and (32 subunits o f Na/K-ATPase localize to the apical surface o f collecting duct cysts 
in ARPKD, and there is enhanced sodium absorption shown by conditionally 
immortalized cells derived from ARPKD cysts, that is only partially amiloride-sensitive. 
These cells also demonstrate up-regulation o f the a-subunit o f  the epithelial sodium 
channel (EnaC), which may mediate sodium absorption in this model [Rohatgi et al.,
2003]. Hence, sodium transport in foetal ARPKD cyst-lining principle cells appears to be 
retained in the absorptive direction, in contrast to the reversed polarity o f vectorial 
transport in ADPKD [Wilson et al., 1991]. The importance o f the CFTR-dependent 
chloride and fluid secretion in cystogenesis in ARPKD has also been addressed: Nakanishi 
et al. [Nakanishi et al., 2001] cross-bred CFTR-deficient mice with mice homozygous for 
a cystic gene (bpk). Double-mutant offspring, with no functional CFTR on the apical 
surface o f  cystic epithelia, were not protected against disease progression, in fact their life 
span was reduced by 50 %, suggesting that in this model o f ARPKD, CFTR is not 
essential for cyst development. Further study is required to elucidate the mechanisms o f  
fluid shifts into expanding renal cyst, particularly in the case o f ARPKD, where luminal 
sodium or chloride fluxes via known channels have not been demonstrated.
Modifying factors
Understanding these gene-related effects may not lead to complete understanding o f the 
factors determining cyst development and expansion. In many forms o f human polycystic 
kidney disease, there is considerable variability o f renal phenotype, even between
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members o f the same family. This, along with the identification o f various gene loci that 
alter renal phenotype in mouse models o f PKD [Guay-Woodford et al., 2000;Iakoubova et 
al., 1999;Woo et al., 1997], has led to the idea that ‘modifying factors’ may exert 
important influences on the polycystic phenotype.
The gene products o f the ‘modifying’ loci in murine models o f PKD have not yet been 
identified, although evidence links some o f these to roles such as polycystin binding, for 
example the G-protein coupled RGS7 [Guay-Woodford et al., 2000]. Modifying factors do 
not need to act directly via interaction with known gene products; effects at any stage in 
the normal biology o f tubulogenesis, such as the stages o f cell aggregation, polarisation, 
lumen formation or expansion, could potentially modify progression o f polycystic renal 
disease.
In addition to genetic modifiers, there may also be ‘epigenetic’ modifying factors, such as 
toxins or other environmental influences (See Fig. 6). In both mouse and rat models o f  
PKD dietary protein restriction has been found to ameliorate progression o f polycystic 
kidney disease [Aukema et al., 1992;Tomobe et al., 1994]. The conversion o f casein-based 
rodent diet to an isocaloric (20 %) soy protein diet has also been shown to dramatically 
ameliorate both epithelial and interstitial pathology [Ogbom et al., 1998], with reduction 
in cyst number and size, lower proliferation levels and less interstitial fibrosis [Aukema 
and Housini, 2001;0gbom et al., 2000]. Conversely, the use o f  a diet with high protein 
content (50 %), supplemented NH4C1 and potassium restriction, results in more aggressive 
polycystic kidney disease in the Han:SPRD rat [Cowley, Jr. et al., 1996]. Although the 
cellular mechanisms involved in these modifying effects are not clearly defined, the diet in
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the latter study was designed to promote tubular cell growth and proliferation. High 
dietary fat content has also been shown to increase disease progression in the Han:SPRD 
rat [Jayapalan et al., 2000], In rats the administration o f acidifying reagents has been 
found to worsen the progression o f polycystic kidney disease, whereas alkalinizing 
reagents appear to be protective [Tanner et al., 2000;Tanner and Tanner, 2000;Tanner and 
Tanner, 2003;Torres et al., 2001].
Various toxins have been implicated as modifying agents in the progression o f polycystic 
kidney diseases. Bacterial infection, for example, has long been thought to potentiate the 
progression o f renal cystic disease, although it has proved difficult to isolate organisms to 
support this theory. Initial evidence for the role o f bacteria in the increased progression 
rate o f polycystic kidney disease came from the demonstration that rodent models o f  
polycystic disease, such as the CFWwd mouse or nordihydroguaiaretic acid (NDGA) -  fed 
Sprague-Dawley rat, progressed far slower in a germ-free environment, than when 
exposed to the ambient environment [Gardner, Jr. et al., 1986;Werder et al., 1984]. 
Exposure studies o f the germ-free rat model suggest that bacterial endotoxins rather than 
the bacterial colonization itself are the main factors in modulating disease progression 
[Gardner, Jr. et al., 1987]. Bacterial endotoxins can be found in human cyst fluid, and 
Nanobacterium sanguineum, or its antigen has been detected in cyst fluid, in addition to 
antigens from Escherichia coli, Bacteroides ffagilis [Hjelle et al., 2000]. However, the 
mechanism by which bacteria or endotoxin affects disease progression is yet to be 
elucidated.
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In this study, I have postulated the role o f the ATP receptor, P2X7, in modifying the 
phenotype o f ARPKD. The wide range o f biological signals associated with this 
membrane receptor, in particular trans membrane calcium flux, the regulation o f  cell 
proliferation and apoptosis and possibly its role in cell-cell interactions, make it an 
interesting potential modifier in the complex cellular events leading to cystogenesis. The 
majority o f this work has been undertaken using a rodent model with many similarities to 
human ARPKD, the cpk/cpk mouse. An overview o f the current understanding o f the 
biological mechanisms o f disease progression in this widely used model will be given in 
the following section.
Figure 6. Summary of the factors affecting progression of human and 
animal polycystic kidney diseases
Major gene mutations have been identified in human and rodent models o f  
polycystic kidney disease. In addition to germline mutations it is suggested 
that a ‘second hit’ in the remaining wildtype copy may be required for cyst 
development. The variable phenotype in patients with these mutations has 
led to the idea o f  ‘modifying genes’ and this has been supported by the 
effect o f  background strain on progression o f  the rodent models. 
Epigenetic, or environmental factors also modulate progression rates o f  
polycystic kidney disease.
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Major germ line m uta t ions
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•ADPKD (PKD1, PKD2  - polycystins) 
•ARPKD (PKHD1 - fibrocystin)
•TS ( TSC1, TSC2 - tuberins)
Rodent:
•cpk mouse (cystin)
•orpk (Tg737 polaris)
•Inversin mouse (inversin)
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Figure 6. Summary of the factors affecting progression of human and animal polycystic kidneys diseases
The cpk/cpk mouse
The ideal animal model for study o f P2X7 expression and function in human ARPKD 
would have the orthologous gene defect. Pkhdl, the mouse orthologous gene has recently 
been defined [Nagasawa et al., 2002], but this information was not available for the 
purposes o f my study. I therefore used the C51BV61-cpk/cpk mouse, one o f the most 
extensively studied models o f ARPKD. The cpk (congenital polycystic kidney) mouse 
arose as a result o f a spontaneous mutation on the C57B1/6J background, and was 
identified at the Jackson Laboratories, Bar Harbor, USA, in 1977 [Russel, 1971]. Since the 
start o f my thesis, the mutated gene has been identified: cpk on chromosome 12, encoding 
cystin, another cilia-associated protein [Hou et al., 2002]. The renal phenotype o f the 
cpk/cpk mouse is strikingly similar to human ARPKD, although there is no hepatic 
involvement on the C57B1/6J background. The heterozygotes have phenotypically normal 
kidneys, assessed by light microscopy. However, cpk/cpk mice exhibit initial proximal 
tubule dilatation from E l7, and postnatally, mainly ectatic cystic structures derived from 
collecting ducts, and retaining continuity with the nephron [Avner et al., 1987]. By three 
weeks o f age there are very few intact glomeruli, and proximal tubules have degenerated. 
Affected mice reproducibly die o f presumed uraemia by four weeks o f  age, with 
massively enlarged, cystic kidneys that take up most o f the abdominal cavity.
The cloning o f the cpk gene and identification o f cystin, as previously mentioned, have 
focused attention on the epithelial single cilium: cystin is a novel hydrophilic protein o f  
145 amino acids, that when expressed in polarized mCCD cells localizes to the single
91
apical cilia axenomes [Hou et al., 2002]. It is postulated to function as part o f a molecular 
‘scaffold’ that stabilizes microtubule assembly within the ciliary axenome. The previous 
demonstration o f attenuation o f cystic disease in the cpk/cpk mouse treated with paclitaxel, 
an agent promoting microtubule assembly [Woo et al., 1994], supports this hypothesis. 
Earlier work has also provided detailed description o f a number o f cellular and 
extracellular matrix abnormalities in the cpk/cpk kidney. The cpk/cpk mouse therefore 
provides a useful model, firstly for the investigation o f the role o f ciliary function in 
polycystic kidney disease and also, the molecular interactions between the cilia and 
processes vital to normal organogenesis and cystogenesis, such as differentiation, 
epithelial polarization, regulation o f cell turnover and luminal fluid secretion. Several cell 
and extracellular matrix abnormalities have been identified that suggest that the cpk/cpk 
kidneys are unable to complete the terminal phases o f tubuloepithelial differentiation. 
These are summarized in the following list [Hou et al., 2002]:
• Enhanced expression o f proto-oncogenes: c-myc, c-fos, c-Ki-ras
•  Up-regulation o f growth factor expression
• Apical mislocalisation o f functional EGF receptor
• Increased expression o f basement membrane constituents
• Overexpression o f basement membrane remodeling enzymes, matrix 
metalloproteinases (MMPs) and their inhibitors (TIMPs)
• Abnormal expression o f epithelial cell adhesion molecule
• Altered steroid metabolism and lipid composition
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There is also evidence for up regulated cell turnover in the cpk/cpk mouse kidney, 
compared with the phenotypically normal littermates. Previous reports have observed 
excess epithelial proliferation at the onset o f cystogenesis, which is less apparent later in 
the disease [Avner et al., 1987;Cowley, Jr. et al., 1991;Gattone et al., 1988]. In addition, 
the loss o f tissue between cysts, contributing to loss o f renal function, involves apoptosis 
[Ali et al., 2000;Winyard et al., 1996b], with up regulation o f caspase 4, bax and Bcl-2 
[Ali et al., 2000] as well as the proto-oncogene c-myc [Cowley, Jr. et al., 1991]. 
Interestingly, bcl-2 deficient mice demonstrate fulminant apoptosis and cystogenesis, 
strongly suggesting that cyst formation may be secondary to the apoptosis itself [Sorenson 
et al., 1996;Veis et al., 1993]. The importance o f apoptosis and Bcl-2 in renal cyst 
formation is also supported by the demonstration that overexpression o f Bcl-2 in MDCK 
cells prevents apoptosis-induced epithelial cyst formation [Lin et al., 1999]. However, the 
SBM mouse, a transgenic model of polycystic kidney disease, that over expresses both 
bcl-2  and c-myc also undergoes apoptosis and cystogenesis, suggesting that in this model 
apoptosis is via bcl-2 independent pathways [Trudel et al., 1997].
Another interesting finding is that reducing the Pax2 transcription factor gene dosage o f  
the cpk/cpk homozygotes, i.e. ablating one o f two alleles, results in inhibition o f renal cyst 
growth with more widespread normal renal architecture, this being caused not by reduced 
proliferation o f the cystic epithelium, but by increased cell death [Ostrom et al., 2000].
Although its exact role remains unclear, emerging evidence supporting the functional 
importance o f an imbalance between the opposing processes o f proliferation and apoptosis 
in rodent models o f polycystic disease, suggests that manipulation o f the apoptotic 
pathway may prevent loss o f renal function. Molecules involved in induction o f  apoptosis,
93
such as P2X7, may be potential modifying factors in these genetic diseases, and thus 
provide therapeutic targets. This study aims to determine the expression o f P2X7 in this 
model and investigate its functional importance. In addition to descriptive study o f P2X7 
in the cpk/cpk mouse kidney, this work also utilizes in vitro methods for further study o f 
the functional role o f the membrane protein in cyst development.
Development o f  in vitro techniques to study cystogenesis
In vitro techniques for the study o f cystogenesis involve the use o f cell lines, for example 
the Madin Darby canine kidney (MDCK) cell line, or epithelial cells derived from animal 
or human forms o f polycystic kidney disease.
The MDCK cell line is an extensively studied epithelial cell type that forms polarized 
cystic structures when cultured with collagen type I [McAteer et al., 1987]. These cells 
also mimic some o f the normal morphologic events o f normal kidney development, with 
the formation o f branching tubules, if  exposed to conditioned media or HGF [Montesano 
et al., 1991]. The spherical cysts consist o f polarized epithelia with apical surface facing 
the lumen and basolateral surface in contact with the gel, and can grow up to 800 microns 
in diameter. This system provides a model o f in vitro tubulogenesis and cystogenesis that 
can be easily manipulated, and has been used to investigate many o f the mechanisms 
postulated to be important in lumen formation and expansion. Cyst enlargement in this 
model involves both epithelial proliferation and fluid entry secondary to net solute 
accumulation [Grantham et al., 1989] [Tanner et al., 1992]. These cells also form cysts 
when grown in suspension culture, but the polarity o f epithelial cells in these structures is
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the reverse o f that seen on collagen gels [Wang et al., 1990a]. However, polarity is rapidly 
reversed, without cell dissociation, if  cysts formed in suspension are transferred onto 
collagen [Wang et al., 1990b].
Other studies have used cell lines derived from polycystic kidneys, which can be grown 
either as monolayers [van Adelsberg, 1994;Wilson et al., 1986] or three dimensional 
suspension cultures. Suspension cultures o f epithelial cells derived from the cpk/cpk 
mouse kidney undergo spontaneous cyst formation, which can be inhibited by the 
microtubule stabilizer paclitaxel, as well as ouabain and amiloride, suggesting that fluid 
accumulation is integral to cyst formation [Woo et al., 1994]. This study also excluded a 
role for proliferation in cyst formation in the in vitro model, as inhibitors o f DNA, RNA or 
protein synthesis did not affect cyst formation.
The first part o f my study will focus on P2X7 expression in the cpk/cpk mouse, as a model 
of recessive polycystic kidney disease, and the in vitro model as described above, will be 
used to investigate potential functional importance o f this receptor in the pathogenesis of 
cyst formation.
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Chapter 3. Molecular studies of P2X7 function
The cloning o f P2X7 has facilitated the accurate study o f receptor expression at the mRNA 
and protein levels, and has revealed a far wider expression pattern o f the receptor than 
originally thought. Initially thought restricted to cells o f the immune system, it is now 
clear that P2X7 is expressed in many cell types, particularly epithelial cells, in many 
systems. This wide expression suggests an important physiological importance o f the 
receptor and has led to a growing interest in the study o f P2X7 functions. In early studies 
o f purinergic receptors, characterisation o f the P2X7 receptor in native and transfected cell 
lines was based on membrane physiology. Techniques have included: electrophysiological 
study o f membrane biophysics; fluorimetric analysis o f signal transduction, e.g. calcium 
influx and dye uptake to demonstrate membrane ‘pore* opening [Nihei et al., 2000]. 
Analysis o f downstream consequences o f receptor activation, such as cytokine release and 
cytotoxicity have also been undertaken, and described in earlier sections, although the 
signalling pathways involved in these events, particularly apoptosis are not clearly 
defined.
Studies o f P2X7 function have been carried out using endogenously expressing cells, such 
as dendritic cells [Coutinho-Silva et al., 1999], microglial cells [Ferrari et al., 1997c] and 
THP 1 monocytes [Humphreys and Dubyak, 1998], and also using transfection expression 
systems. Several such cell lines have been used as model systems for the study o f function 
of P2X7, including HEK 293 [Chessell et al., 1998a;Humphreys and Dubyak, 1998] and 
Xenopus oocytes [Nihei et al., 2000;Petrou et al., 1997]. O f note, the membrane
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electrophysiological properties o f P2X7 and its pore-forming capacity have been found to 
vary considerably, between species and also between cell types.
The lack o f specific antagonists for the individual P2X receptors, and the cross-reactivity 
o f available nucleotide analogues have impeded functional studies o f the receptor 
functions in vitro. The possibility o f additional P2X or P2Y responses to the commonly 
used agonist ATP, or even the relatively specific BzATP, can be overcome by expressing 
the P2X 7 receptor in the absence o f other known family members. In this study I have 
used a novel cell line, the wild type exhibiting no physiological responses to BzATP or 
ATP and hence considered a ‘null’ background for the examination o f the transfected 
receptor.
DT40 Cell line
In this study I have examined the functional properties o f  the rat P2X7 receptor at the 
cellular level, using its stable transfection into a novel cell line, the DT40 cell. This is an 
avian pre-leukaemic B lymphocyte, which has grown in popularity over the last few years 
as a consequence o f its remarkable genetic tractability [Winding and Berchtold, 2001]. As 
a result o f its constant re-arrangement o f native immunoglobulin elements, the cell line 
shows an extremely high ratio o f targeted to random reinsertion into its genome, greater 
than 1:2, higher than in any known mammalian system. Advantage o f this has been taken 
to study a range o f cellular functions including B cell receptor signalling, but also 
properties common to all cells, for example regulation o f  cell cycle, DNA repair and
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apoptotic pathways [Hawkins et al., 2002;Lahti et al., 1997]. The aim o f this study was to 
utilize this tractability firstly, to achieve stable expression o f P2X 7, and subsequently 
investigate its regulatory mechanisms and downstream signalling events.
In describing functions o f rat P2X7 in this model system, it is hypothesized that the 
receptor will demonstrate similar membrane properties to the receptor in other cell types, 
for example, inducing a large, rapid influx o f Ca2+, inhibited by known antagonists, and 
the possibility o f the formation o f a large, membrane-permeabilising pore. Having 
determined the stable transfection o f the DT40 cell, standard techniques can be applied to 
this novel cell expression. Further studies o f the function o f the receptor, particularly the 
downstream signalling events secondary to receptor activation, will be possible using this 
system. In addition to providing important information regarding the pathways involved 
in, for example apoptosis, this unique expression system may also provide a useful tool for 
the future development and assessment o f pharmacological tools for manipulation o f P2X7 
signalling in vivo.
The wide range o f biological functions o f the P2X7 receptor has made it a focus o f interest 
in many organ systems, particularly the immune system. Many o f these functions render 
this an interesting molecule to study in the context o f renal physiology and pathology, for 
example, the transmembrane ion fluxes and modulation o f the inflammatory response. 
However, the hypothesis o f this thesis is that P2X7 - induced apoptosis may be important 
in normal kidney development, and also in various aspects o f renal disease, particularly 
polycystic kidney disease.
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Apoptosis
In view o f the prominent role o f apoptosis in the renal models investigated, and the 
implication o f the membrane receptor P2X7, in induction o f this process, a brief overview 
o f the biological mechanisms involved in apoptosis is required. In 1972, a Kerr, Wyllie 
and Currie first described the existence o f a clear distinction between cell death that 
occurs in normal tissue development and homeostasis and some pathological states, 
named apoptosis by this group, and pathological cell death resulting from cell stress or 
injury [Kerr et al., 1972]. The latter process, necrotic cell death, involves organelle 
swelling and rupture, the subsequent leakage o f cellular contents often inducing an 
inflammatory response and surrounding oedema. Cells undergoing apoptosis, in contrast, 
shrink and condense, retaining integrity o f the plasma membrane and then undergo 
phagocytosis by neighbouring cells, hence avoiding an inflammatory reaction. The 
characteristic morphological changes observed, are a result o f  the orchestrated digestion o f 
chromatin and fragmentation o f DNA. A non-lysosomal calcium- and magnesium- 
dependent endonuclease digests chromatin into oligonucleosome fragments, visible as 
condensation and fragmentation o f the nucleus under light and electron microscopy 
[Wyllie, 1993].
It was the early recognition that apoptotic cells looked similar in a variety o f tissues that 
suggested the existence o f a common intracellular death program that can be activated by 
diverse stimuli. It was then, through studies o f genes o f C. Elegans (Horvitz 1982 
Neurosci comment) [Ellis and Horvitz, 1986;Horvitz et al., 1994] and later, their
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mammalian counterparts [Hengartner and Horvitz, 1994;Yuan et al., 1993], that the idea 
of the intracellular death program gained a molecular basis; these studies also indicate that 
the pathways involved are highly conserved through evolution.
The components o f the death program can be considered in three parts: initiation o f  
apoptosis, genetic regulation and effector mechanisms. Initiators include molecules that 
activate ‘death receptors’ such as Fas [Itoh et al., 1991] or tumour necrosis factor receptor 
[Laster et al., 1988], deprivation o f various survival factors such as interleukin-1, 
ultraviolet radiation and exposure to cytotoxic drugs [Kuida et al., 1995]. Multiple 
pathways are then utilized to generate orchestrated gene expression patterns involving pro- 
and anti-apoptotic genes; the B-cell leukaemia / lymphoma-2 (Bcl-2) family is best 
studied, including both death and survival genes, bcl-2 itself being an anti-apoptotic gene 
and bax a pro-apoptotic gene [Korsmeyer, 1992;Korsmeyer et al., 1993]. The bcl-2 family 
mediates a mitochondrial pathway. p53, a tumour suppressor gene is a well characterized 
pro-apoptotic molecule [Haupt et al., 2003]. These genes regulate the function o f effector 
proteins, the main family being the caspases, cysteine aspartyl-specific proteases 
[Salvesen and Dixit, 1997].
To date there are two main pathways that have been elucidated in detail, by which the 
caspases can be activated, and these are sometimes referred to as extrinsic and extrinsic. 
The extrinsic pathway is induced by members o f the TNF family o f cytokine receptors, 
e.g. TNFR1 and Fas, recruiting adaptor proteins such as Fadd, to their cytosolic death 
domains (DDs) and subsequently, via their death effector domains (DEDs), bind and 
activate the caspases via caspase 8 . In contrast, the intrinsic pathway, triggered in response
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to DNA damage, involves the mitochondria: cytochrome c release is induced by stimuli 
such as pro-apoptotic members o f the Bcl-2 family, e.g. Bax, and then activates apoptotic 
protease-activating factor-1 (Apaf-1) in the cytosol, allowing it to activate caspase 9. The 
complex o f cytochrome c, Apaf-1 and pro-caspase 9 is termed the apoptosome [Nicholson 
and Thomberry, 2003]. Caspase 8 and 9 can both cleave and activate the main effector 
protease, caspase 3 [Salvesen and Dixit, 1997]. This is an over simplification as there is in 
fact considerable cross-communication between the two pathways [Reed, 2000]. Indeed, 
recent studies now suggest the two pathways are converging rather than distinct [Gross et 
al., 1999;Li et al., 1998] (see Fig. 7).
Apoptosis is identified by morphological assessment with or without the use o f fluorescent 
dyes to stain nuclei, but in addition there are now numerous markers for the various stages 
o f apoptotic death, such as antibodies to effector proteins and detection o f fragmented 
DNA by terminal transferase mediated dUTP-biotin nick end labeling (TUNEL), 
facilitating more detailed in-situ observations, as well as increasing knowledge o f the 
biochemical pathways involved in specific situations. This knowledge will facilitate 
therapeutic strategies for altering cell survival in a wide range o f diseases in which 
apoptosis is thought to play either a pathological or beneficial role.
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Figure 7. Convergence of the intrinsic and extrinsic pathways of caspase 
activation.
The two pathways o f  the caspase cascade are shown. Apoptotic stimuli such 
as irradiation and etoposide, trigger the intrinsic, or mitochondrial pathway 
(right). Binding o f  death ligands to death receptors activates the death 
receptor pathway (left). The convergence o f  the two pathways via bid is 
shown. DD, death domain; DED, death effector domain; FLIP, FLICE 
inhibitory protein; Apaf-1, apoptotic protease-activating factor-1, Cyto C, 
cytochrome c; Bcl-2, B-cell leukaemia /  lymphoma-2. Dotted arrows 
indicate inhibitory effects. Adapted from Haupt (2003).
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Figure 7. Convergence o f the intrinsic and extrinsic pathways of caspase activation.
Chapter 4. Materials and Methods
Experimental Strategy
The aims o f this thesis were to investigate the biology o f P2X7, a cell-surface ATP 
receptor, in normal and cystic kidney development, with particular emphasis on autosomal 
recessive polycystic kidney disease (ARPKD), and to further understand the mechanisms 
by which P2X7 functions as a cellular signalling molecule.
Previous documentation o f renal expression o f the P2X family o f receptors was limited to 
a small number o f cell line studies, and my first aim was to investigate its expression in 
development o f the normal urinary tract. This systematic approach was then applied to 
ARPKD, using animal and human models o f the disease. Finally, the potential functions 
o f P2X 7 in the context o f cystogenesis were investigated using an in vitro model; cysts 
were grown in suspension culture and the P2X7 receptor manipulated pharmacologically. 
The mechanisms by which P2X7 may affect cellular processes was investigated both in 
this animal model o f ARPKD, but also using an expression system, the DT40 cell line.
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Summary
In this thesis I planned to:
1. Document the temporal and spatial expression o f P2X7 in the urinary tract during 
normal murine development.
2. Investigate P2X7 expression in the cpk/cpk mouse model o f ARPKD as well as 
human ARPKD.
3. Use an in vitro model o f cpk/cpk cyst formation to further elucidate the potential 
functional role o f P2X7 in this condition.
4. Characterise the stable transfection o f the DT40 cell line with the rat P2X7, 
providing a useful tool for the further study o f receptor functions.
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Materials
Animal Husbandry
In this thesis I used the normal mouse strain C57 B1 / 6J (Charles River mouse farms, UK) 
and the cpk/cpk mouse model o f ARPKD. Heterozygous cpk/+ mice were obtained from 
the Jackson Laboratories (Bar Harbor, Maine, USA). Affected homozygous recessive 
mice {cpk/cpk) were raised by the mating o f  two heterozygotes, hence the FI progeny. 
Statistically one quarter o f the FI generation will be affected homozygotes, one quarter 
will be normal and half the offspring will be heterozygotes with normal phenotype. At the 
time o f tissue collection there was no genetic test for the mutation, and hence the breeding 
colony was generated by trial and error mating, eventually producing 30 young breeding 
pairs o f known heterozygotes and those found to be heterozygous by producing affected 
offspring during trial and error mating. Mice were weaned from their mothers at 21 days 
after birth. Animal protocols were approved by the Home Office and the Institute o f Child 
Health Animal Welfare Committee.
All kidneys were retrieved by TM Johnson or PJD Winyard. For studies o f in utero 
nephrogenesis, pregnant C57B1 / 6J normal mice were killed by cervical dislocation, 
embryos removed under aseptic conditions on embryonic day l l ( E l l ) t o E 1 9  and kidneys 
dissected. Kidneys were removed from cpk/cpk homozygous offspring and phenotypically 
normal littermates at 1, 2, 3 and 4 weeks o f age and from normal mice o f the same ages. 
Dissected kidneys for immunohistochemical analysis were fixed in 4%  paraformaldehyde, 
and samples for later extraction o f protein or RNA stored in liquid nitrogen.
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Human tissues
Human tissues were provided by Dr PJD Winyard at the Institute o f Child Health, 
London. Mid-gestation tissue was obtained from terminations at the Elizabeth Garrett 
Anderson Hospital, University College London (UCL). Consent to use foetal material for 
medical research was obtained from the mothers, by hospital staff, prior to the 
termination. Collection and further use o f the samples was approved by the Joint UCL / 
University College Hospital (UCH) Committee on the Ethics o f Human Research. Tissue 
is stored in the Medical Research Council (MRC) funded human embryo bank at the 
Institute o f Child Health.
Histology and immunohistochemistry
Sigma Chemical Company supplied: bovine serum albumin (BSA), citric acid, 
diaminobenzidine (DAB), haematoxylin, hydrogen peroxide, periodic acid Schiff and 
streptavidin-conjugated horseradish peroxidase antibody.
Other companies supplied the following: DAKO (High Wycombe, UK) supplied 
EnVision+ mouse kit, ABC kit and other secondary antibodies, Citifluor™ was purchased 
from Chemical Labs (Chemical Labs, University o f Kent, Canterbury, UK), Gibco BRL 
(Paisley, UK) supplied fetal calf serum (FCS), National Diagnostics (Atlanta, Georgia, 
USA) supplied histoclear, Oxoid (Basingstoke, UK) supplied phosphate buffered saline 
(PBS) tablets.
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Microscopy
Light microscopy was performed using a Zeiss Axiophot microscope (Carl Zeiss, 
Oberkochen, Germany) using objective lenses o f 5x, lOx, 20x, 40x magnification and 63x 
with oil immersion. Specimens were photographed using Fuji Super G 100 colour 
negative, or taken digitally using either a Progress 5012 or Olympus Camedia C-3030 
digital camera from Olympus (Middlesex, UK).
Confocal fluorescent microscopy was performed, with the aid o f PJD Winyard, on a Leica 
Aristoplan microscope and computer confocal lasar scanning system (Aristoplan-Leica, 
Heidleberg, Germany) with oil immersion objective lenses o f 25x, 40x, 63x and lOOx with 
additional software interpolation o f intermediate magnifications.
Images were saved as tagged image format (TIF) files, and imported into Adobe 
Photoshop (Version 5, Adobe Systems, Europe, Edinburgh, UK) or Microsoft Powerpoint 
2000 (Microsoft Corporation, Seattle, USA) for labelling, or into Scion (Scion 
Corporation, USA) for counting and analysis o f in vitro cyst photographs.
Western blotting
Sigma Chemicals Company supplied 30% acrylamide, ammonium persulfate, aprotinin, 
bromophenol blue, glycerol, haematoxylin, phenylmethylsulphonyl fluoride (PMSF), 
Ponceau S, periodic acid Schiff, trizma base, sodium dodecyl lauryl sulphate (SDS), 
sodium orthovanadate and N,N,N’,N’ tetramethylethylenediamine (TEMED).
Enhanced Chemiluminescence Reagents (ECL), Hybond-P nitrocellulose membranes, 
RPN 800 molecular weight markers and spectrophotometer were from Amersham 
(Amersham Pharmacia, Little Chalfont, Bucks, UK), the Bicinchoninic acid (BCA) kit
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from Pierce (Rockford, Illinois, USA) and re-blot mild stripping solution from Chemicon 
International (Temecula, CA, USA). 3MM chromatography paper was supplied by 
Whatmann Ltd (Maidstone, Kent, UK), X-Ray film and saran wrap by Genetic Research 
Instrumentation (Braintree, Essex, UK). Mini-Protean II gel electrophoresis tanks, trans- 
blot SD semi-dry transfer cell and polyvinylidine difluoride membrane (PVDF) were 
purchased from Bio-Rad, supplied by Gibco BRL.
Antibodies
P2X7: T w o  antibodies against P2X 7 were used. Firstly ‘P2X7 antibody 1*, a polyclonal 
rabbit antibody (A PR-004; Alomone Laboratories, Jerusalem, Israel) raised against the 
20 carboxy-terminal amino acids (576-595; KIRKEFPKTQGQYSGFKYPY) o f rat P2X7 
[Collo et al., 1997;Surprenant et al., 1996]: this epitope is highly conserved between rat, 
mouse and humans and is not present in other P2X receptors, or in any other known 
protein. A second polyclonal rabbit antibody, ‘P2X7 antibody 2 ’, recognising amino acids 
555 to 569 (TWRFVSQDMADFAIL) [Groschel-Stewart et al., 1999a;Groschel-Stewart et 
al., 1999b;Lee et al., 2000] a gift from G. Bumstock (Autonomic Nervous Institute, UCL, 
UK) was also used for comparison. Stock antibody concentrations were 0.3 mg/ml.
PCNA: (Ab-1; Oncogene Science, Cambridge, Massachusetts, USA): mouse monoclonal 
antibody (IgG2) to the human DNA-polymerase 8 -associated protein that is expressed at 
high levels during S phase, and highly conserved across species [Bravo et al.,
1987;Suzuka et al., 1989]. Stock antibody concentration was 0.1 mg/ml.
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p-actin: (Sigma): mouse monoclonal (IgGl) to the N-terminal end o f p-actin, derived from 
the AC-15 hybridoma, produced by fusion o f mouse myeloma cells and splenocytes from 
an immunized mouse. P-actin is the most highly conserved cytoskeletal protein in 
eukaryotes, and is therefore frequently used as a housekeeping gene for western blotting.
Secondary biotinylated antibodies, including the ABC kit and secondary goat anti-rabbit 
horseradish peroxidase (HRP) were purchased from DAKO. Fluorescent secondary 
fluoroscein isothiocyanate (FITC)-conjugated antibodies raised against rabbit were 
purchased from Boehringer-Mannheim (Mannheim, Germany).
Reverse Transcription Polymerase Chain Reaction
Primers were based on those from published material, based on mouse cDNA sequences 
and synthesized by Sigma Genosys Biotechnologies (Europe) Limited (Pampisford, 
Cambridgeshire, UK):
P2X7, 5 ’ -  ATA TCC ACT TCC CCG GCC AC (sense primer corresponding to 
nucleotides (nt) 565 - 613) and 5’ - TCG GCA GTG ATG GGA CCA G - 3 ’ (antisense 
primer corresponding to nucleotides 801- 821) [Genbank accession number (GA) NM 
011027] [Mutini et al., 1999]. P2X4, 5’- GAG AAT GAC GCT GGT GTG CC -  3 ’ (sense 
nt 533 - 552) and 5’ -  TTG GTG AGT GTG CGT TGC TC -  3 ’ (antisense nt 869 - 888) 
[GA NM 011026]; P2X5, 5 ’ -  TCC ACC AAT CTC TAC TGC -  3 ’ (sense nt 822-841) 
and 5 ’ -  CCA GGT CAC AGA AGA AAG -  3’ (antisense nt 1071-1090) [GA NM
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033321]; P2X6> 5’ -  TAC GTA CTA ACA GAC GCA -  3 ’ and 5’ -  ATA TCA GGG TTC 
TTT GGG -  3 ’ based on published sequences [Dai et al., 2001].
Promega (Southampton, Hampshire, UK) provided pGEM DNA marker, reverse 
transcription system kit and Taq DNA polymerase. Sigma Chemical Company provided 
bromophenol blue, chloroform, diethylpyrocarbonate (DEPC), ethidium bromide, 
ethylenediaminetetraacetic acid (EDTA), glycerol, isopropanol, mineral oil, Tris-acetate 
and TRI-reagent. Gibco BRL supplied agarose and DNAse I (Amp Grade).
Tissue Culture equipment
Agar select, dispase, Dulbecco’s Modified Eagle Medium / F12 mix (DMEM/F12) and 
heat inactivated foetal calf serum (FCS) were supplied by Gibco BRL, and the following 
supplements supplied by Sigma Chemicals Company: insulin transferring selenium (ITS), 
dimethyl sulfoxide (DMSO), human recombinant epidermal growth factor (EGF), 
antibiotic solution, hydrocortisone and triiodothyronine (T3). Roche (Basel, Switzerland) 
provided collagenase A and DNAse I.
Nunc (Naperville, Illinois, USA) supplied 6 well plates and scalpels were purchased from 
Swann-Morton (Sheffield, UK).
Analysis of in vitro cyst cultures
Sigma Chemicals Company provided apyrase, ATP bioluminescent assay kit, FITC- 
Phalloidin, propidium iodide, adenosine triphosphate (ATP), benzoyl-benzoyl ATP
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(BzATP), oxidized ATP (oATP), uridine triphosphate (UTP). The caspase-3 activity assay 
kit and zVAD-fmk were supplied by Calbiochem (Nottingham, UK). Roche supplied the 
lactate dehydrogenase cytotoxicity detection system (Lewes, East Sussex, UK).
DT40 cell culture model
Chicken serum, Dulbecco’s modified Eagle’s medium (DMEM), foetal calf serum (FCS), 
glutamine and streptomycin were from Gibco (Life Technologies, Paisley, UK). Fura- 
2/AM and Pluronic F-127 were from Calbiochem (Nottingham, UK). Hanks’ balanced 
salts (HBSS), EGTA, ATP, BzATP and analogues, periodate oxidised ATP, and other 
chemicals were from Sigma (Dorset, UK). Anti-P2X7 antibody directed against the C- 
terminal 15 amino acids was from Alomone labs (Jerusalem, Israel). Promega 
(Southampton, Hampshire, UK) supplied Western Blue substrate.
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Methods
Animals
Protocols were approved by the Home Office. Normal C57BL/6J mice were maintained in 
our colony, cpk/cpk polycystic mice on a C57BL/6J background were generated by mating 
cpk/+ parents (Jackson Laboratories, Bar Harbor, Maine, USA). C57BL/6J metanephroi 
and kidneys were examined on embryonic day 11 (El 1; EO was the day o f the vaginal 
plug), E13, E16, E19, neonatally (within 24 hours o f birth) and at one, two, three and four 
weeks postnatally: this period spans the inception o f the organ, nephron generation (El4 
to one week postnatal), ending with early adulthood. Kidneys were collected from 
neonatal and one, two, three and four week postnatal cpk/cpk mice, and from 
phenotypically normal (i.e. +/+ and cpk/+) littermates: the cystic status o f organs was 
confirmed histologically, although cpk/cpk kidneys are grossly enlarged from two weeks 
postnatally [Woo et al., 1994]. At least three animals were examined at each age, for each 
group.
Microscopy
Light microscopy was performed using a Zeiss Axiophot microscope (Carl Zeiss, 
Oberkochen, Germany) using objective lenses o f magnification 5 x, 10 x, 20 x, 40 x and 
63 x oil immersion. Specimens were photographed using Fuji Super G 100 colour 
negative or digitally using an Olympus C-3030 camera (Olympus, Middlesex, UK).
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Confocal fluorescent microscopy was performed on a Leica Aristoplan microscope and 
confocal laser scanning system (Aristoplan-Leica, Heidleberg, Germany) with oil 
immersion objective lenses o f 16 x, 25 x, 40 x, 63 x and 100 x and software interpolation 
of intermediate magnifications. Images were saved as tagged image format (TIF) files and 
imported for labelling into Adobe Photoshop (version 5, Adobe Systems Europe, 
Edinburgh, UK) or Microsoft Powerpoint 2000 (Microsoft Corporation, Seattle, USA).
Immunohistochemistry 
Basic Principles
Immunohistochemistry is a well-established technique that allows detection o f protein 
epitopes in a tissue section using an antibody specific for the protein o f interest [Coons et 
al., 1955]. Tissues are first fixed to preserve morphology, dehydrated and then embedded 
in a wax block. Sections o f 3-6 pm are cut using a microtome and transferred to a glass 
slide. These are then rehydrated, pre-treated to increase penetration o f antibodies if  
required, blocked to minimize non-specific binding and then exposed to the primary 
antibody o f interest. Detection o f this antibody is then performed using secondary 
antibodies or other amplifying secondary detection techniques, such as the streptavidin- 
biotin peroxidase system. The distribution o f the protein is then visualized using light or 
fluorescent microscopy.
Antibodies used in immunohistochemistry are polyclonal or monoclonal. Polyclonal 
antibodies, usually generated in rabbits, but also other species, involves the recurrent
114
immunization o f animals with the antigen o f interest over several months. The antigen 
binds cell surface receptors on B-lymphocytes, resulting in proliferation o f the specific 
antigen-stimulated B-lymphocytes. This results in the secretion o f large amounts of  
antibody. Many different B-lymphocytes will be activated, by a variety o f antigenic 
determinants, giving rise to multiple clones o f B-lymphocytes, and the ‘polyclonal’ 
response.
Monoclonal antibodies are produced by the fusion o f activated B-lymphocytes to a 
myeloma B-lymphocyte, and hybrid cells cloned. These are immortalized and hence 
provide unlimited amounts o f identical antibody molecules. Rats or mice are generally 
used for this procedure.
Fixation, wax embedding and sectioning
Organs were fixed for between 1 and 24 hours, depending on size, in 4%  
paraformaldehyde and wax-embedded. Many samples were provided in this state by TM 
Johnson and PJD Winyard, and stored at room temperature. Tissue was sectioned at five 
pm, floated in a water bath at 45°C to remove creases and then transferred to poly-L- 
lysine-coated glass slides. Slides were dried at 37°C and stored at room temperature.
Pretreatment
Sections were dewaxed and rehydrated by sequential immersion for 5 minutes each in 
Histoclear twice, 100% ethanol twice and reducing ethanol concentrations o f 95%, 85%, 
70%, 50% and 30% and finally milliRo water for 5 minutes.
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Preliminary experiments showed that antibody penetration was improved by microwaving 
sections at 700W for 5 minutes in a solution o f citric acid (2.1g per litre o f milliRo water, 
adjusted to pH 6.0), a step reported to unmask antigens (Shi, Key & Kalra 1991). Slides 
were then cooled for 10 minutes, washed for 5 minutes in running tap water, rinsed twice 
in milliRo water and then washed in PBS twice for 5 minutes.
Blocking
The following steps were designed previously to reduce non-specific signals resulting 
from endogenous peroxidase activity and non-specific binding. For brightfield studies, 
endogenous peroxidase was quenched with 3% hydrogen peroxide for 20 minutes, washed 
twice in milliRo water and once in PBS for 5 minutes. Sections were then blocked in 10% 
foetal calf serum in PBS for 40 minutes at room temperature. All subsequent reagents used 
were diluted in blocking solution (10% FCS in PBS).
Primary antibodies
Optimal concentrations o f each specific antibody were determined by preliminary studies 
using serial dilutions on adjacent sections. After carefully wiping away excess blocking 
solution, 50 to 100 pi specific primary antibody solution was applied, each section 
covered with a plastic coverslip to ensure even distribution o f antibody and incubated at 
4°C overnight in a humid chamber. Either anti-P2X7 antibody was used at 1:50 (6  pg/ml), 
anti-PCNA at 1:50 (2 pg/ml). After incubation antibody was washed off by rinsing with 
PBS three times for 5 minutes.
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Detection systems
Light microscopy:
For light microscopy appropriate secondary antibodies were selected, for example anti­
rabbit secondary antibody was used to detect the rabbit anti-rat anti-P2X7 antibody, and 
anti-mouse was applied to detect the mouse monoclonal anti-PCNA antibody. A  
commercially available streptavidin-biotin peroxidase system (ABC kit; DAKO, High 
Wycombe, UK) was utilised for this detection step, followed by diaminobenzidine 
tetrahydrochloride (DAB) staining. Reagent C was first applied to sections at 1:400 
dilution for 30 minutes at room temperature in a humid chamber. This contains 
biotinylated secondary antibody that binds the unlabelled primary antibody bound to its 
target antigen, for example P2X7. Slides were washed 3 times in PBS and then treated 
with reagents A and B in the same way. Reagents A and B were mixed and diluted to 
1:100 and stored on ice for 30 minutes prior to use. This mixture forms the avidin-biotin 
peroxidase complex that amplifies the biotinylated signal. Peroxidase activity was then 
visualized as a brown colour generated with DAB. Reagents A and B were washed off 
with PBS 3 times and immersed in DAB (0.5 g/1 with 0.03% hydrogen peroxide). Slides 
were allowed to develop for 1 to 10 minutes depending on the colourimetric changes 
monitored either by eye or microscopically, each group o f sections for comparison being 
exposed for the same time period. They were then washed in running water, 
counterstained (see below), dehydrated through ascending alcohol concentrations to 
Histoclear and then air-dried. Slides were then mounted with DPEX and glass coverslips 
and stored at room temperature before being examined with a Zeiss Axiophot microscope
Fluorescent microscopy:
For immunofluorescent detection of P2X7, a similar protocol was followed, but hydrogen 
peroxide was omitted and primary antibody was detected by fluorescein isothiocyanate 
(FITC)-conjugated secondary antibody. This was applied to sections at 1:200 dilution, 
covered with a coverslip and incubated in the dark for one hour at room temperature. The 
slides were then washed 3 times in PBS and mounted with Citifluor™ (Chemical Labs, 
University o f Kent, Canterbury, UK). In most cases nuclei were stained with propidium 
iodide, a fluorescent dye that intercalates with nucleic acids and hence stains nuclei. 100 
jLxg/l propidium iodide with lOOpg/ml RNAse A (DNAse free) in PBS was applied for five 
minutes followed by washes with PBS. This technique was adapted from Coles et al. 
(1993) with minor modifications [Coles et al., 1993]. The edges o f the coverslip were 
sealed with nail varnish to prevent drying and slides stored at 4°C prior to fluorescent 
microscopy. Sections were viewed with an Aristoplan confocal laser scanning microscope 
(Leica, Heidelberg, Germany). Using appropriate wavelengths, FITC-bound P2X7 protein 
was detected as a green colour and propidium iodide-stained nuclei as a red colour. 
Apoptotic cells were identified by their small and fragmented bright pyknotic nuclei 
[Coles et al., 1993;Winyard et al., 1996a]: nucleated red blood cells also have bright 
nuclei but these are larger and regular in outline and therefore easily distinguished.
Negative Controls
Negative controls comprised pre-reaction o f primary antibody with immunising peptide or 
omission o f primary antibody.
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Counterstaining
Counterstaining was performed in order to define anatomy and histology and to identify 
specific cell types, by identification o f cell-specific epitopes. These reagents were all 
applied after dewaxing and rehydration as above.
Haematoxylin
Haematoxylin stains nuclei dark purple. Sections were dipped in 0.1% Harris’ 
haematoxylin for 90 seconds and rinsed in running water for 5 minutes, prior to 
dehydration and mounting as above.
Periodic acid Schiff (PAS)
Periodic acid Schiff (PAS) was used to stain proximal tubule brush borders and basement 
membranes red [Stoward et al., 1980]. These cellular components contain vicinal glycol 
groups; these or their amino alkylamino derivatives are oxidised by periodic acid to form 
dialdehydes. After reaction with Schiff s reagent (a mixture o f pararosaniline and sodium 
metabisulfite), a pararosaniline adduct is released, producing a pink stain. Periodic acid 
was applied after DAB for 5 minutes at room temperature and then washed off with 
several changes o f milliRo water. Schiff reagent was then applied for 15 minutes and 
washed off using running tap water for 5 minutes. Slides were air-dried and mounted as 
before.
Dolichos biflorous agglutinin (DBA)
The lectin DBA was used to detect the ureteric bud and its derivatives [Holthofer et al., 
1981] [Verani et al., 1989]. After dewaxing and rehydration, biotinylated DBA was 
applied at 1:100 for 30 minutes at room temperature. Slides were then washed 3 times in
PBS followed by reaction with streptavidin-peroxidase reagents (A and B) and DAB as 
before.
Proliferating cell nuclear antigen (PCNA)
Biotinylated antibody to human proliferating cell nuclear antigen (PCNA; 32552A, BD- 
Pharmingen, San Diego, USA), a surrogate marker o f mitosis [Bravo et al., 1987] was 
applied at a dilution o f  1:50 overnight at 4°C, followed by reaction with streptavidin- 
peroxidase and metal-enhanced DAB, resulting in positive blue nuclei.
Western blotting
The western blot technique uses specific antibodies to identify proteins within extracts of 
cells or tissues [Sambrook et al., 1989]. To summarize, proteins are extracted from tissues 
using a lysis buffer, quantified using a BCA protein assay kit, denatured and separated on 
sodium lauryl sulphate (SDS) -  polyacrilamide gels and then transferred onto a 
polyvinylidene difluoride (PVDF) membrane which can then be probed for specific 
antigen sites. Primary antibody raised against this epitope adheres to the protein o f interest 
and is visualized using either enzyme or conjugated secondary antibodies. Comparison 
with molecular markers determines the size o f the protein detected.
Protein extraction
In order to minimize degradation o f proteins, all samples o f tissue were snap frozen in 
liquid nitrogen or frozen and stored at -70°C. All subsequent steps in the extraction
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procedure are carried out on ice. Tissue is homogenized in lysis buffer, breaking up the 
cells and allowing solubilisation o f proteins. Lysis buffer contains protease inhibitors to 
prevent protein degradation. After extraction the sample is spun down to pellet all 
insoluble debris and the protein-containing supernatant stored [Sambrook et al., 1989]. 
Protein was extracted from E l9 C57BL/6J metanephroi, one week postnatal cpk/cpk 
kidneys, 3 week postnatal cpk/cpk kidneys and organs from phenotypically normal 
littermates. After careful thawing, samples were placed in ice-cold buffer (150 mM NaCl, 
50 mM Tris pH 8 , 1% Nonidet P40, 0.5% sodium deoxycholate, 1% sodium lauryl 
sulphate) containing proteinase inhibitors (30 ml/1 Aprotinin, 1 mM sodium 
orthovanadate, 0.1 g/1 Phenoxymethyl sulphoxide (PMSF)). Tissues were homogenized 
using initial cutting into small pieces with sterile scalpels, followed by repeated syringing 
through needles o f decreasing calibre. Homogenates were left to stand on ice for 30 
minutes to allow protein dissociation. They were then spun at 130 000 x g for 15 minutes 
at 4°C and the supernatant containing proteins aliquoted and stored at -70°C.
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Protein quantification
The Pierce BCA protein assay was used to quantify the total protein in the tissue lysates. 
This method combines the reduction o f  Cu2+ to Cu+ by protein in an alkaline medium (the 
Biuret reaction), with the highly sensitive and selective colorimetric detection o f the 
cuprous cation using a unique reagent containing BCA. The chelation o f 2 BCA molecules 
with one cuprous ion results in the formation o f a soluble purple coloured product, the 
absorbance o f which at 562 nm is linearly proportional to protein concentrations between 
20  and 2000  pg/ml.
The working reagent was prepared by mixing reagents A and B at a ratio o f 50:1. Samples 
for quantification were diluted as necessary in lysis buffer and then added to the assay 
mixture at a ratio o f 1:20. The mixtures were incubated at 37°C for 30 minutes, cooled to 
room temperature and then the absorbance at 562 nm recorded, versus assay mixture 
blank. To convert these readings to protein concentration, a standard curve was prepared 
using readings from the bovine serum albumin (BSA) standard provided, diluted from 
2000 down to 62.5 pg/ml, and creating a graph using Excel.
Polyacrilamide Gels
The SDS-polyacrilamide gels were prepared in Mini-Protean II gel apparatus (Gibco BRL, 
Paisley, UK) using two clean glass plates separated by 1.5 mm spacers. Resolving gel of 
required concentration was first poured between the glass plates. Concentration o f gel 
used was determined by the size o f protein being investigated: 8% was used for protein of
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5 0 -  100 kDa and 12.5% for 14 -  66 kDa, and was made up using milliRo water, variable 
concentration o f 30% acrylamide, 1.5 M Tris pH 8 .8 ,10%  SDS, 10% fresh ammonium 
persulfate and 1% N,N,N’,N’ tetramethylethylenediamine (TEMED). The latter two 
ingredients cause polymerization o f the acrylamide by the production o f free radicals and 
were therefore added last. After pouring the resolving gel, it was covered with a layer o f  
butan-l-ol to level the surface and prevent oxygen diffusion into the gel, which would 
inhibit acrylamide polymerization. Gels were allowed to set at room temperature, the 
butan-l-ol poured off and the surface washed with milliRo water and blotted dry using 
Whatmann 3 MM filter paper.
A 5% stacking gel was then poured onto the resolving gel, a high porosity gel that causes 
the proteins to stack at the gel interface, increasing protein resolution. Each 2 ml o f the 5% 
gel consisted of: 1.4 ml milliRo water, 0.33 ml acrylamide, 0.25 ml 1.0 M Tris pH 6 .8 , 
0.02 ml 10% ammonium persulfate and 2 pi TEMED. This was poured carefully onto the 
resolving gel up to the top o f the glass plates and a 10 well comb inserted, ensuring no air 
bubbles were trapped within the gel. Once this had set, the comb was removed and the gel 
placed in tris-glycine buffer (dilute 5 x stock: 25 mM Tris pH 8.3, 250 mM glycine, 0.1% 
SDS) in the running tank. The Laemmli discontinuous buffer system was used [Laemmli, 
1970] with part o f the buffer between the 2 gels and the remainder in the running tank.
Loading and running samples
The required amounts o f protein sample (20 - 40 pg) were mixed with equal volume o f 
sample buffer (1 ml glycerol, 0.5 ml p-mercaptoethanol, 3 ml 10% SDS, 1.25 ml Tris pH 
6.7 and 0.001 g bromophenol blue). This was then heated at 95°C for 5 minutes and
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quenched on ice, to reduce the proteins, and then equal quantities o f protein loaded. Care 
was taken to avoid cross contamination o f samples between wells. A rainbow protein 
marker was also loaded into one o f the lanes.
Proteins were run through the stacking gel at 40 volts until the bromophenol blue reached 
the gel interface, at which time voltage was increased to between 7 0 -1 0 0  volts. Samples 
were run until markers o f the appropriate size were visualized in the middle o f the gel.
Blotting
Electrophoresed proteins were transferred using a Mini-PROTEAN trans-blot cell (Gibco 
BRL) onto hybond-C pure nitrocellulose membranes (Amersham Life Science, 
Buckinghamshire, UK). After running the samples, the glass plates were gently prised 
apart and the gel placed straight into transfer buffer (48 mM Tris, 39 mM glycine, 0.037% 
SDS, 20% methanol) for 10 minutes. At the same time, one piece o f nitrocellulose 
membrane and 6 pieces o f Whatmann 3MM filter paper, cut to the exact size o f the gel, 
were soaked in transfer buffer. A semi-dry electroblotter was used to transfer proteins to 
the membrane. A sandwich of: 3 pieces filter paper, 1 membrane, gel and 3 pieces o f filter 
paper was assembled directly onto the anode and any air bubbles removed by rolling with 
a glass pipette. The cathode lid was then fitted and the proteins blotted at 12 volts for 40 - 
60 minutes, depending on % gel used. Transfer o f proteins was assessed using Ponceau S 
solution. Submerging the membrane in Ponceau S for 5 minutes followed by washing in 
milliRo water allows protein bands to be visualized as pink bands. The Ponceau S can be 
washed off with further rinses and does not interfere with immunological detection 
systems.
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Blocking, primary and secondary antibodies
As in immunohistochemistry, the remaining steps involve blocking o f  non-specific 
binding sites, application o f specific primary antibodies and subsequent use o f a 
conjugated secondary antibody / enzymatic detection system.
Blots were incubated overnight at 4°C in blocking solution (5% non-fat milk in PBS with 
0.1% Tween) and all subsequent steps were carried out in the same solution to reduce non­
specific background staining. Primary antibody was then applied at dilutions determined 
by preliminary studies: P2X7 was detected by applying anti- P2X7 antibody at 1:1000  at 
4°C for 1 hour, PCNA at 1:500, and p-actin at 1:12000. Membranes were washed 3 times 
in blocking solution at 4°C and then primaries detected using appropriate horseradish 
peroxidase conjugated secondary antibodies. Goat anti-rabbit horseradish-peroxidase 
conjugated secondary antibody was applied at 1:2000 for 30 minutes at room temperature 
to detect the rabbit anti-P2X7 antibody and the anti-p actin and anti-PCNA mouse 
antibodies detected using the commercially available EnVision mouse kit: 100 pi o f  
EnVision solution was diluted in 10 ml o f blocking solution and applied to the membrane 
for 30 minutes at room temperature.
Blots were then washed three times in PBS with 0.1% Tween-20 for thirty minutes and 
then in PBS twice for thirty minutes before bands were detected using 
chemiluminescence.
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Detection
Horseradish peroxidase signals were detected using enhanced chemiluminescence, more 
sensitive than colorimetric methods. After washing membranes thoroughly 3 times in PBS 
with 0.1% Tween, excess PBS was drained off and enhanced chemiluminescence (ECL) 
reaction mixture applied for 60 seconds. This was drained off, the membrane wrapped in 
Saran wrap, transferred immediately to an X-ray cassette and exposed to X-ray film under 
safe light conditions. Exposure times were varied, depending on signal intensity (10 
seconds -  1 hour). The sizes o f detected protein bands were determined by comparison to 
the reference markers.
Stripping blots
For some experiments blots were stripped o f the original primary antibody to allow re- 
probing with a different primary, for example P-actin for analysis o f relative expression 
levels. Blots were placed in antibody stripping solution for 5 -  15 minutes at room 
temperature according to manufacturers instructions, washed twice for 10 minutes in PBS 
and then blocked for one hour. The blot was then re-probed as described.
Semi-quantitative analysis o f protein bands
Semi-quantitative analysis o f expression levels was performed by comparing the signal 
density o f bands from tissue samples, analysed using Image J software (version 1.3, NIH,
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USA). To standardize these levels between several experiments all readings were 
expressed relative to levels o f the housekeeping gene p-actin in those samples.
Negative Controls
The following negative controls were used:
1) Omission o f primary antibody and substitution with blocking solution
2) Pre-reaction o f the primary antibody with an excess (2:1 weight/weight) o f  
immunizing peptide for one hour prior to probing the blot.
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Reverse Transcriptase Polymerase chain reaction (RT-PCR)
Basic Principles
Reverse transcription uses single stranded RNA as a template to produce complementary 
double stranded DNA (cDNA). This process requires a random eight base primer and is 
achieved using the retroviral enzyme reverse transcriptase. The cDNA produced can, in 
turn be amplified by the polymerase chain reaction (PCR).
PCR allows the selective amplification o f target DNA sequences. By designing 
oligonucleotide primers, one for each DNA strand, on either side o f the chosen target 
region, this can be amplified. Firstly, the double stranded DNA is denatured and the 
primers annealed to their complementary sequences on the single strands, hence 
synthesizing new complementary DNA strands. Secondly, successive repetition o f this 
process results in the specific exponential amplification o f the DNA region bounded by 
the primers.
Reverse transcription and PCR in combination provide a very powerful detection system 
that can be applied to small samples, such as suspension cultures o f cysts.
Precautionary Measures for RNA work
RNA is extremely vulnerable to degradation by RNAse enzymes, either in the sample
itself or in the processing environment. RNAses are found on human skin and it is
therefore o f importance to wear gloves throughout the following RNA experiments.
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RNAse free glassware and plasticware was also used throughout, and solutions were 
treated with 0.1% diethylpyrocarbonate (DEPC) at room temperature overnight and 
autoclaved, to inhibit RNAse production.
RNA Extraction
RNA was extracted from tissue and in vitro samples using TRI-reagent and 
homogenization, a method based on the guanidinium thiocyanate/phenol methodology of 
RNA extraction o f Chomczynski and Sacchi (1987) [Chomczynski and Sacchi, 1987]. 
TRI-reagent consists o f a mixture o f guanidine thiocyanate and phenol in a mono-phase 
solution that dissolves DNA, RNA and protein on lysis o f the tissue sample. The 
homogeniser was washed with DEPC treated water and 100% ethanol prior to use, and 
between samples to minimize contamination.
Samples o f kidney either fresh or previously snap-frozen in liquid nitrogen, were placed in 
1 ml TRI-reagent and in vitro sample pellets in smaller volume as necessary, and kept on 
ice during homogenization until sample were completely lysed. The samples were then 
left to stand for 15 minutes at room temperature to allow complete dissolution o f  
nucleoprotein complexes. 0.2 ml o f chloroform was added to each sample, per ml o f TRI- 
reagent and then samples were vortexed at high speed for 5 minutes and left to stand at 
room temperature for 15 minutes. The resulting mixture was centrifuged at 13 000 x g for 
35 minutes. This process separated the mixture into three phases: a red organic phase 
containing protein, the DNA-containing interphase and a colourless upper aqueous phase 
containing RNA. The aqueous phase was carefully transferred to a new tube and 0.5 ml 
isopropanol added per 1 ml TRI-reagent used initially. The sample was then vortexed,
allowed to stand at room temperature and centrifuged as before. The RNA is then 
precipitated in a pellet at the bottom o f the tube. The supernatant was carefully discarded 
and the RNA pellet washed by adding 70% ethanol. The sample was then vortexed and 
centrifuged at 13 000 x g for 10 minutes at 4°C, the ethanol removed and the pellet air- 
dried. The pellet was then dissolved in DEPC water (0.1% DEPC in distilled water, 
autoclaved) and stored at -70°C.
RNA was quantified by diluting to 1:500 in DEPC water and its absorbance value 
measured on a spectrophotometer at 260 nm, using nuclease-free water as a blank ([RNA] 
pg/ml = Absorbance at 260 nm x coefficient for RNA (40) x dilution factor). The quality 
o f the RNA was also assessed by running 1 pi samples with 1 pi loading buffer (50% 
glycerol, ImM EDTA pH 8.0, 0.25% bromophenol blue, 0.25% xylene cyarol FF) and 5 
pi DEPC water on a 1% agarose gel at 80 V for 45 minutes, as described below. Good 
quality RNA exhibits two clear bands representing 28S and 18S ribosomal RNA.
Removal o f contaminating genomic DNA
In order to remove DNA contamination o f the extracted RNA samples, each sample was 
treated with doxyribonuclease (DNAse), lpg  RNA was mixed with lp l DNAse I reaction 
buffer, lp l DNAse I (lU /p l Amp Grade) and 7 pi DEPC water and left to stand at room 
temperature for 10 minutes. The enzyme was inactivated by addition o f  lp l EDTA (25 
mM) and heating to 65°C for 10 minutes. The resultant RNA sample was then stored at - 
20°C.
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Reverse Transcription reaction
Firstly, a cDNA copy o f the total RNA extracted from kidneys or cyst cultures was 
synthesised using reverse transcriptase. For each sample a 20pl reaction mixture was set 
up in the order listed below. All ingredients were maintained at 4°C until use.
MgCl2 25 mM 4pl
Reverse transcription buffer 2 pi
dNTP mixture 2pl
Recombinant RNAsin inhibitor 0.5pl
AMV reverse transcriptase lp l
Oligo(dT) 15 Primer 1 pi
Substrate RNA 1 pg = volume x
DEPC water 9.5pl - x
For a negative control the reaction was performed in the absence o f the AMV enzyme, 
which was substituted with DEPC water. The mixture was incubated at 42°C for 15 
minutes, heated at 100°C for 5 minutes and then placed on ice for a further 5 minutes. This 
inactivated the enzyme, preventing it from binding the cDNA. Reverse transcription 
products were stored at -20°C prior to PCR amplification. 1 pi o f this product was used 
for the PCR reaction.
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Polymerase Chain Reaction
Primer sequences were chosen from previously published P2X studies. Taq DNA 
polymerase from the thermophilic bacterium Thermus aquaticus was used; its resistance to 
high temperatures avoids the need for replenishment during the PCR cycles and hence the 
reaction could be automated by placing the assembled reaction in a heating block with the 
chosen thermal cycling programme. For each PCR a reaction mixture was set up as 
follows:
Reverse transcription product lpl
DNTP mixture 0.5pl
Buffer 2.5pl
MgCl2 25 mM 3 pi
Primer (5’ and 3 ’) 0.5pl each
Taq polymerase 0.125pl
Sterile milliQ water 18pl
For each reaction, 25 pi mineral oil was added to prevent evaporation, and samples 
preheated to 95 °C for 1 minute prior to thermocycling. The PCR program was set up as 
follows, each including a number o f cycles consisting o f a denaturing phase, annealing 
phase and extension phase. For P2X7 primers 42 cycles were performed consisting of: 1 
minute o f denaturing at 94°C, 1 minute of annealing at 68°C and 1 minute o f extension at 
72°C. For other P2X primers 35 cycles o f 1 minute denaturing at 94°C, 1 minute annealing
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at 60°C and 1 minute extension at 72°C were used. Following this there was a 10 minute 
incubation at 72°C to allow products to complete elongation.
Agarose gel electrophoresis
Analysis o f PCR products was carried out using standard DNA electrophoresis. This 
technique is used to separate and visualize DNA fragments o f different sizes [Sambrook et 
al., 1989].
The agarose gel was prepared by dissolving agarose in TAE buffer (lOx TAE: 0.4M Tris- 
acetate, 0 .01M EDTA, pH 8.0) by microwaving, with the addition o f 50pl/l ethidium 
bromide as it cooled. Once cooled the agarose was poured into a casting tray, a comb 
inserted and left to set. Once ready to use, the comb was removed, the gel transferred to an 
electrophoresis tank and covered with TAE buffer.
lOpl each PCR reaction product, mixed with lp l loading buffer (50% glycerol, ImM 
EDTA pH 8.0, 0.25% bromophenol blue, 0.25% xylene cyarol FF), was loaded onto the 
1% agarose gel, and run at 100 Volts for approximately 45 minutes. The gel was 
visualised under ultra-violet light and photographed. The ultra-violet induced fluorescence 
is emitted by the ethidium bromide, which intercalates with the stacked base pairs o f DNA  
in the gel. The size o f the PCR product was determined by comparison with a DNA  
molecular weight marker, also mixed with loading buffer.
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In vitro studies of cyst development
In vitro studies were performed using 3 dimensional primary epithelial cell suspension 
cultures derived from cpk/cpk mice kidneys at 3 weeks o f age, and their phenotypically 
normal litter mates.
Epithelial cell isolation
The method employed for isolating epithelial cells aimed to dissociate kidneys from three 
week old cystic cpk/cpk mice, releasing single cells and small aggregates o f epithelial 
cells. The harvested kidneys were placed immediately into ice-cold L I5 medium with 
antibiotics (0.1 units/1 penicillin, 0.1 jng/1 streptomycin, 250 pg/1 amphoteracin B). All 
subsequent procedures were carried out in aseptic conditions, after first rinsing the organs 
with 70% ethanol.
The technique used to prepare suspension cultures o f cysts from the cpklcpk mouse was 
adapted from that o f Woo et al [Woo et al., 1994]. Prior to starting the dissociating 
procedure, the large cystic kidneys were punctured using sterile scalpels and the released 
‘cyst fluid’ was collected and immediately ‘snap’ frozen in and stored in liquid nitrogen 
for future analysis o f nucleotide content. The method utilized however, must inevitably 
lead to activation o f tissue ATP-hydrolysing enzymes in addition to release o f enzymes 
from damaged cells, making analysis o f results limited.
134
• • • 1  
In order to dissociate the tissue, firstly, each kidney was sliced into approximately 1mm
pieces using sterile scalpels, and placed immediately into 6ml o f DMEM:F12
supplemented with: 5% FCS, antibiotics as above, and 10 ng/ml EGF, 36 ng/ml
hydrocortisone, 4 pg/ml T3 and ITS cocktail (Insulin 10 pg/ml, Transferrin 5.5 pg/ml and
Selenium 5 ng/ml). This medium is widely used in renal epithelial cell culture [Detrisac et
al., 1984]. To this was added 1.4 mg/ml collagenase A, 2 mg/ml Dispase and 0.2 mg/ml
DNAse I, and the mixture incubated at 37°C for 40 minutes with frequent shaking. The
added enzymes disrupt cell adhesion and degrade released DNA, factors contributing to
cell clumping. Optimal conditions, including incubation time were determined by
preliminary experiments: under-digestion resulted in excess aggregates and few cysts
forming, whereas over-digestion also resulted in impaired cystogenesis and excess cell
death. After incubation the suspension includes a mixture o f single cells, cell aggregates,
tubule segments and some non-viable cells. The mixture was spun at 2000 x g for 5
minutes and the resultant cell pellet resuspended in 15 ml fresh supplemented DMEM:F12
(as above). After 3 minutes standing, to allow larger aggregates and tubules to settle to the
bottom o f the tube, the top 10 -  15 ml suspension o f single cells and small aggregates was
transferred to a fresh tube. Cell density and viability was assessed at this stage using a
tryphan blue ( 1:1 ratio with suspension volume) to label permeable dead cells blue, and
counting in a haemocytometer. Viable cell density o f initial preparations varied between
animals from 20 -  70 x 104 per ml, and all were standardized to a starting density o f 20 x
104 per ml.
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3D Cell culture
Cells were diluted in supplemented medium to a starting density o f 20 x 104 cells /ml and 
plated at 2 ml per well into 6 well plates pre-coated with 1% tissue culture grade agar. 
Suspensions were then incubated at 37°C in a moisture saturated incubator in 5% CO2 and 
air [Woo et al., 1994]. In most cases, sufficient cell suspension from each pair o f organs 
was produced to enable 12 wells from each animal, allowing a maximum o f 6 duplicate 
conditions to be examined in any single experiment. The required doses o f P2X7 agonist 
were added after plating. If the antagonist oATP was used, a 1 hour pre-incubation was 
necessary, and was carried out in suspension after initial dilution o f cells and followed by 
repeat spinning at 2000 rpm for 5 minutes and replacing supernatant with fresh medium. 
All control samples were treated in the same manner with the exclusion o f the antagonist.
Analysis o f cyst number and size
After 24 hours, cyst development was assessed by light microscopy and, after gently 
redispersing the aggregates and cysts, which tended to accumulate in the centre o f the 
well, 10 representative fields from each well were photographed for later analysis using an 
Olympus C-3030 (Olympus, Middlesex, UK) digital camera. Images were saved as TIFF 
files for later analysis: in each field photographed, the number o f cysts was counted, and 
measurements o f the 2 dimensional cross-sectional area made, both using Scion software 
(Scion Image, USA).
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Immunocytochemistry o f cysts formed in vitro
Immunocytochemistry was used to identify P2X7 protein in cells and cysts in culture, and 
also to visualize the morphology o f cytoskeleton and nuclei o f cells in the cysts and 
aggregates using fluorescent-conjugated Phalloidin and propidium iodide respectively. 
Phalloidin, a fungal toxin isolated from the poisonous mushroom Amanita phalloides is a 
specific ligand for F-actin, which upon binding stabilizes F-actin against 
depolymerization, hence causing severe toxicity particularly in liver and muscle cells 
[Lengsfeld et al., 1974]. The molecule binds very rapidly to F-actin and thus, phalloidin 
conjugated with a reactive form of fluorescein, fluorescein isothiocyanate (FITC), is a 
convenient molecular probe for F-actin. Propidium iodide is a widely used fluorescent 
stain for DNA in fixed cells [Coles et al., 1993], described above.
Techniques used for the detection o f antigens in cells in vitro are similar to those used in 
immunohistochemistry as described above. However, in the case o f 3D suspension 
cultures o f cysts, the processes o f staining and mounting cysts whilst ensuring the cysts 
retain their structural integrity raised technical difficulties, the cysts being prone to 
collapse and hence loss o f normal morphology. Several processes were utilized, after 
many preliminary experiments. In all cases the cysts and aggregates from the cultures after 
24 hour incubation time were fixed in 5% formalin, by adding equivalent volume o f 10% 
formalin to the contents o f the well. Cells were left in this solution for 15 minutes and then 
pelleted by spinning at 800 rpm for 15 minutes and washed in PBS. Samples were left in 
PBS at 4°C until processed. The use o f varying sucrose concentrations in the fixing 
process made no improvement to the maintenance o f cyst structural integrity.
137
In some experiments cysts were mounted on slides: cysts in PBS were seeded onto a 
chamber slide pre-coated with polylysine hyperbromide, and adhered by centrifuging the 
slide at 2000 rpm for 5 minutes in a microplate centrifuge. Adherent cells and cysts were 
then permeabilised using 0.1% triton X-100 for 5 minutes, followed by two very gentle 
washes with PBS, being careful not to disturb the adherent cells. 10% FCS in PBS was 
applied as a blocking step, for 45 minutes at room temperature. The samples were then 
treated with primary antibody, anti-P2X7 diluted to 1:50 in blocking solution, and 
incubated at 4°C overnight. Negative controls were carried out by omission o f primary 
antibody, or use o f antibody pre-adsorbed with excess (2 :1) immunizing peptide.
Slides were then gently washed three times with PBS and then detection o f primary 
antibody was undertaken using an FITC-conjugated anti-rabbit secondary at 1:100 dilution 
in blocking solution, for 45 minutes in the dark at room temperature. Secondary antibody 
was washed o ff using PBS three times, and the slides mounted with citifluor™ and a glass 
coverslip, fixed using nail varnish or glue for air-tight conditions. Slides were stored at 
4°C in the dark until analysis with a confocal Leica Aristoplan microscope.
For other experiments staining was carried out with the cysts in suspension. Use o f the 
technique as described above was limited by the tendency o f  larger cysts to roll to the 
edges o f the slide during centrifugation, and collapse or disintegrate completely. Although 
there was a greater loss o f cell numbers during repeat centrifugation required with the 
cysts in suspension, it was found that by limiting the speed o f centrifugation to 800 rpm 
for 15 minutes there was improved cyst integrity, required for demonstration o f  cyst 
morphology and the visual analysis o f nuclear morphology o f epithelial cells within the 
cyst and aggregates.
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Samples were fixed as above and permeabilised in 0.1 % triton X-100 in PBS for 5 -1 0  
minutes. After permeabilisation cyst were exposed to phalloidin-FITC (lpg/m l in PBS, 
stored at 500 x in DMSO) and propidium iodide (0.1pg/ml in PBS) for 30 minutes in the 
dark in rolling falcon tubes. This solution was washed o ff by adding a large volume of 
PBS, spinning slowly as above at 800 rpm for 15 minutes, re-suspending carefully in PBS 
and then spinning again to pellet the stained cells. Cysts were then placed on a slide, 
between two 0.15 mm coverslips and mounted with citifluor™ and another coverslip. 
Slides were stored in the dark at 4°C until analysis as above.
Assessment o f necrotic cell death in cpk/cpk cultures: measurement o f lactate 
dehydrogenase
Necrotic cell death is classically evaluated by quantification o f plasma membrane damage. 
Techniques used for this purpose include use o f uptake or exclusion o f vital dyes such as 
trypan blue and the measurement o f release o f cytoplasmic enzymes into the culture 
medium by damaged cells. The use o f dyes is not practical for large sample numbers and 
cannot account for dead cells which have already lysed at the time point being 
investigated and hence the measurement o f LDH was used in these experiments. LDH is a 
stable cytoplasmic enzyme present in all cells and released rapidly into supernatant on 
damage o f the cell membrane.
LDH measurements were made using a commercial kit (Roche) based on an enzymatic 
test: in the first step as LDH catalyses lactate to pyruvate, NAD+ is reduced to NADH/H+. 
In the second step the catalyst (diaphorase) transfers H/H+ from NADH/H+ to the 
tetrazolium salt INT that is reduced to formazan. The yellow formazan dye is water-
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soluble and shows a broad absorption maximum at 500 nm, whereas the INT shows no 
specific absorption at these wavelengths. Hence absorbance at 500 nm directly correlates 
to the amount o f LDH in the sample.
Culture supernatants were collected by spinning down cell suspensions at 2000 rpm for 5 
minutes. These samples were stored at -20°C before use. lOOpl o f  each supernatant was 
added to a 96-well microtiter plate and mixed with lOOpl assay mixture containing 
commercially supplied catalyst, diaphorase / NAD+ and dye. The plate was then incubated 
for 30 minutes at room temperature in the dark. Absorbance o f  samples at 490 nm was 
measured using an ELISA reader. Background control was read from well containing 
200jil assay mixture and duplicate measurements were made for each specimen. LDH 
release for each experimental condition was expressed as a % o f the maximum release 
induced by permeabilising cells with triton. An identical cell sample was incubated with 
1% triton for 10 minutes prior to centrifugation and harvesting o f supernatant.
Caspase-3 activity in cpk/cpk cultures
Caspase-3, a member o f the interleukin 1-0 converting enzyme (ICE) family o f cysteine 
proteases, is one o f the principal caspases found in apoptotic cells. It is derived from pro- 
caspase-3, which is cleaved, by upstream proteases such as caspase-6  and caspase-8 , to the 
17 and 12 kDa subunits comprising the active enzyme. Caspase-3 cellular activity was 
measured using commercially available assay kits, all using the ability o f the enzyme to 
cleave the colorimetric substrate Ac-DEVD-pNA (Calbiochem).
At specific time points, cpk cultures were removed from the 6 well plates and spun at 2000
rpm for 5 minutes. Pellets were rinsed with PBS and either snap frozen and stored at -
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70°C, or immediately lysed in lysis buffer: 50mM HEPES, 1 mM DTT, 0.1 mM EDTA, 
0.1% CHAPS, ph 7.4. Buffer was stored at -70°C and used chilled. After 10 minutes on 
ice, samples were centrifuged at 13000 rpm, 4°C for 10 minutes and the supernatant stored 
at -70°C or used immediately for caspase-3 activity measurement. Protein quantification 
was carried out using BCA kit as described previously, and approximately 50pg protein 
was used per lOOpl reaction. Assays were carried out in 96 well Vi volume microtiter 
plates. Assay buffer (lOOmM NaCl, 50mm HEPES, lOmM DTT, ImM EDTA, 10% 
glycerol, 0.1% CHAPS, pH 7.4) to make total volume o f each reaction 100 pi was added 
to the wells and, after equilibrating to assay temperature 37°C, 25pi cell extract or 15pi 
human recombinant caspase-3 was added to appropriate wells. 30 units caspase-3 were 
used as standard, where 1 unit is equivalent to the amount o f  enzyme that will release 1 
pmol ofpNitroanaline (pNA) from 200pM DEVD-pNA per minute at 30°C. In order to 
demonstrate the specificity o f the cleavage measured, caspase-3 inhibitor I (Ac-DEVD- 
CHO) was added at final concentration 0.1 pM to representative samples, and the mixture 
left to stand at 37°C for 10 minutes prior to addition o f substrate. 200pM caspase substrate 
I (Ac-DEVD-pNA) was added to all samples except buffer and sample blanks, to initiate 
the reaction, and absorbance at 405 nm read using a microtiter plate reader. Data was 
recorded every 1 5 - 3 0  minutes for up to 3 hours in order to calculate the rate o f change o f 
absorbance per minute. In all cases readings for sample blanks were taken, and as these 
demonstrated no slope, no adjustment was made to the readings from positive wells. The 
absorbance o f  50pM pNA standard, minus that o f the buffer blank was also measured and 
used to determine a conversion factor to calculate the activity o f each sample (expressed 
as pmol /?NA cleaved per minute at 37°C). Using data from the 30 unit caspase-3 standard
all data was converted to specific activity, caspase-3 units per pg protein per sample.
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ATP measurement in cpk cyst flu id
The concentration o f ATP present in cyst fluid was measured using a commercial 
bioluminescent assay kit. This utilizes the light-emitting firefly luciferase reaction. Firefly 
luciferase catalyzes the oxidation o f d-luciferin, consuming ATP and producing adenyl- 
luciferin (+ PPi). This reaction is reversible and equilibrium lies far towards adenyl- 
luciferin. In an essentially irreversible reaction, adenyl-luciferin in converted to 
oxyluciferin, with the release o f light; when ATP is the limiting reagent, the light emitted 
is proportional to the concentration o f ATP present.
For the bioluminescent assay, several precautions were taken to ensure reproducibility, 
low background and maximum sensitivity. Sterile, filtered water was used to reconstitute 
all reagents, all equipment was clean and free o f ATP or bacterial contamination and 
gloves were worn at all times.
The analysis o f human ADPKD cyst fluid ATP content has been investigated by others,
by using samples needle-aspirated from the large renal cysts [Wilson et al., 1999]. The
retrieval o f single cyst fluid from microscopic cpk mice cysts would be technically
difficult and produce volumes too small to anaylse using this technique. In this experiment
I collected cyst fluid at the time o f initial dissection o f the kidneys; a sterile scalpel was
used and the cystic kidney punctured a few times to release fluid. This was done with
minimum destruction o f surrounding tissue to reduce the release o f hydrolyzing
ectonucleotidases. Samples were snap frozen in small aliquots until analysis. Assay mix
solution (luciferase, luciferin, MgSC>4, DTT, EDTA, BSA and tricine buffer salts, stored
below 0°C in the dark), was prepared and allowed to stand at room temperature for
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approximately three minutes to allow hydrolysis o f  endogenous ATP and reduce 
background. The dilution o f assay mix suitable for the range o f ATP in cystic fluid was 
determined by preliminary studies. The amount o f background was determined by running 
a blank (sterile water) in each experiment.
To analyse the samples lOOpl was added to each well in the same plate; duplicate samples 
were used for each cystic kidney and in addition, a sample from each sample was treated 
with an ATP hydrolyzing enzyme, apyrase. This step was performed to prove the results 
were due to ATP-associated light emission rather than non-specific hydrolysis. Apyrase (5 
units/ml in dH20) was added to samples for 30 minutes prior to ATP assay. ATP standards 
were also used in the assay, concentrations o f 10*5 to 10' 12 M prepared by diluting stock in 
sterile water. lOOpl each standard was added to the 96-well plate, in duplicate and pre­
treated with apyrase as above. For the blank, lOOpl sterile water was used alone. All 
samples and blanks were added to wells o f an opaque 96-well plate, this being used to 
reduce cross-contamination o f light measurement. Samples were kept on ice prior to 
plating and the plate also kept on ice prior to reading. To begin the assay lOOpl assay mix 
was added to each well using automated pipette system, and the amount o f light emitted 
measured immediately using a luminometer. For each sample the average light emission 
from the duplicate wells was recorded and the blank value subtracted. This final value is 
proportional to the amount o f ATP in the sample or standard. Alternatively, actual ATP 
concentration was calculated by subtracting the value o f apyrase-treated samples from the 
average o f the duplicate result.
A calibration curve was drawn using the ATP standard results, and this used to convert the 
light emission results to ATP concentrations.
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Statistical Analysis
All data from in vitro cyst culture was analyzed using paired T-tests. Cyst numbers and 
cross-sectional area were also subjected to analysis using multi-level modeling (MlwiN 
1.10, UK), allowing the comparison o f all experiments taking into account large inter­
animal and intra-litter variation, in factoring for other variables such as agonist or 
antagonist doses and additional incubation times for different experimental protocols. The 
model was set up by Angie Wade, Department o f Statistics, Institute o f Child Health, 
London, UK.
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DT40 Cell System
Background
In this part o f my thesis I have used a novel cell system, the DT40 cell line (a gift from 
Jean-Marie Buerstedde, Basel Institute for Immunology). This is an avian pre-leukaemic B 
lymphocyte, which has grown in popularity over the last few years as a consequence of its 
remarkable genetic tractability [Winding and Berchtold, 2001]. A result o f its constant re­
arrangement o f native immunoglobulin elements is that the cell line shows an extremely 
high ratio o f targeted to random reinsertion into its genome, greater than 1:2 , higher than 
in any known mammalian system. Advantage o f this has been taken to study a range of  
cellular functions including B cell receptor signalling, but also properties common to all 
cells, for example calcium signalling, regulation o f  cell cycle, DNA repair and apoptotic 
pathways [Hawkins et al., 2002]. The lack o f Ca2+ influx in wild type DT40, in response 
to a panel o f nucleotides in preliminary experiments, suggested absence o f functional P2X 
or P2Y receptors, and cells did not express protein detected by the anti-rat P2X7 antibody. 
The DT40 was therefore be assumed to be a ‘null’ cell line, permitting study o f P2X7 in 
isolation from other P2 receptors, a useful feature in view o f the current lack o f specific 
agonists or antagonists for the group members. Formal exclusion o f native P2 receptor 
mRNA expression was not undertaken as no chicken P2 receptors had been cloned at the 
time o f this work.
My aim was to utilize the tractability o f the cell line to investigate the function o f the P2X7 
receptor, in particular its regulation and downstream signalling pathways.
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Cell Culture and Transfection and Selection
Transfection is the process by which a specific DNA sequence is introduced into the 
genome o f a selected cell type by non-viral methods, and is an ideal system for the 
detailed investigation o f genetic regulation and protein function within eukaryotic cells. 
The recent advances in the cloning o f plasmid DNA, enabling its manipulation and 
production in virtually unlimited amounts, has led to the development o f more efficient 
transfer o f nucleic acids into a broad range o f cultured mammalian cells. Electroporation 
is one such physical method, utilized in the generation o f the P2X7-expressing cell line 
described in this thesis and first reported in 1982 [Neumann et al., 1982], An electrical 
pulse is used to perturb the cell membrane, resulting in re-orientation o f the lipid bilayer 
and causing large hydrophilic pores to form, allowing the entry o f nucleic acids into the 
cell [Tsong, 1991].
DT40 cells were routinely cultured in Dulbecco’s Modified Eagle’s medium (DMEM)
supplemented with 10% foetal calf serum (FCS), penicillin (42 units/ml), streptomycin (42
pg/ml), glutamine (1.7 mM) and 1% chicken serum, at 40°C, 5% CO2 in humidified
incubators, at densities between 5 -  100 x 104 cell/ml. Cells were maintained in
logarithmic growth in 20 ml or 50 ml plastic culture bottles, and harvested for studies at
between 4 and 10 x 105 cells/ml. In view o f their rapid doubling time (approximately 10 -
12 hours), this necessitated spinning down and re-suspending at 15 -  20 x 104 cells per ml,
every one or two days. For storage, cells were frozen at 107 cells per ml in filter-sterilised
freezing medium (70% DMEM, 20% FCS, 10% DMSO), for 24 hours in a room
temperature Stratacooler-cryo (Stratagene) in a -80°C freezer prior to transfer to liquid
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nitrogen freezer. Cells defrosted showed high viability, around 90%, with normal 
replication rates within hours, in standard culture conditions. For all experiments, cell 
cultures were maintained for a maximum o f 4 weeks, and were then discarded and new 
cells defrosted.
The rat P2X7 cDNA construct (a generous gift o f Dr Gary Buell) in the mammalian
expression vector pcDNA3 was linearised at the Pvul site in the ampicillin resistance gene
and the linearised DNA was re-suspended in sterile water at a concentration o f 1 pg/pl for
use in transfection experiments. Transfection and selection o f stable clones was as
described elsewhere [Hawkins et al., 2002] and carried out by Professor S Moss. 107 cells
in logarithmic phase growth were washed once in PBS, and re-suspended in 400pl ice-
cold PBS with 25 pg linearized DNA in a pre-chilled 0.4-cm electroporation cuvette.
After standing for 10 minutes on ice, samples were electroporated (950 V, 25 pF, 00 Q),
left on ice for 5 minutes and diluted into 15 ml o f warm media, supplemented with 20%
conditioned medium. The latter was harvested previously from cells in log-phase growth
at 80 x 104/ml. A further x 4 dilution o f the electroporated cells was prepared and 0.5 ml
o f 1 x and 4 x mix plated into a 48 well, flat-bottomed tissue culture plate. The outer wells
were not used, but filled with PBS to reduce evaporation o f samples. After 24 hours, 0.5
ml o f selection drug was added (at 2x required concentration; neomycin 4mg/ml) to each
well. Plates were wrapped in damp tissue paper with a wick into a reservoir o f dilute
copper sulphate, to maintain sterility, in order to maintain 100% humidity and prevent
evaporation during incubation. This consisted o f an undisturbed 1 0 -1 4  day period, after
which time, loosely clumped colonies approximately 2 mm in diameter were pipetted up
with a 100 pi volume, and seeded into a 5 ml volume o f 20% conditioned medium
containing neomycin for a further 2 days undisturbed incubation. Surviving clones were
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then grown in logarithmic phase as described above. Each was assessed for the expression 
o f P2X7 receptors on a functional basis, with ATP-induced calcium influx and apparent 
apoptosis, and also using western blot.
Western blotting
Ten million cells were washed twice in ice-cold PBS (10 mM sodium phosphate pH 7.4, 
147 mM NaCl) and re-suspended in lOOjul SDS-PAGE sample buffer (0.125 M tris pH 
6 .8 , 10% v/v glycerol, 4% w/v SDS. 0.0001% bromophenol blue, 0.25 M DTT), in the 
presence o f  protease inhibitors (phenylmethylsulonyl fluoride (PMSF) 0.5mM and lpM  of 
each o f the small peptidase inhibitors, chymostatin, leupeptin and pepstatin), boiled and 
left to stand on ice for 10 minutes. After shearing using an fine gauge needle, these protein 
extracts were boiled for 5 minutes and loaded onto a 10% polyacrilamide gel; the 
concentration o f acrylamide was 10% in the resolving gel and 4% in the stacking gel. The 
quantities o f  protein in these sample was small and therefore, instead o f formal 
quantification, equal volumes o f 10pl, equivalent to a million cells o f each clone, was 
loaded per track o f the 10% gel. Pre-stained molecular weight markers were from Gibco. 
Proteins were run through the gel at 80 volts until the bromophenol blue reached the 
bottom, and transferred to PVDF membrane (Immobilon P, Millipore) using the Bio-Rad 
Electroblot Transfer Apparatus. Transfer was performed at 4°C in blotting buffer (39 mM 
glycine, 48 mM Tris, 20% methanol) at 12 volts.
Membranes were blocked in PBS with 0.1% Tween and 5% non-fat milk, overnight at
4°C, and incubated with primary antibody (1:1000) at room temperature for 1 hour.
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Membranes were then washed three times in block to remove unbound antibody, and 
incubated with secondary goat anti-rabbit IgG conjugated to alkaline phosphatase 
(1:10000). After washing again, three times with PBS/tween, membranes were developed 
using Western Blue substrate (a mix o f 5-bromo-4-chloro-3-indoyl-l-phosphate and nitro 
blue tetrazolium, Promega), which results in protein bands being visualised as a blue 
colour that can then be photographed.
Spectrofluorimetry
Fura-2 is a widely used UV-excitable fluorescent calcium indicator. Upon calcium 
binding, the fluorescent excitation maximum o f the indicator undergoes a blue shift from 
363 nm (Ca2+-free) to 335 nm (Ca2+-saturated), while the fluorescence emission maximum 
is relatively unchanged at ~510 nm. The indicator is typically excited at 340 nm and 380 
nm respectively and the ratio o f the fluorescent intensities corresponding to the two 
excitations is used in calculating the intracellular concentrations. At an excitation 
wavelength o f 340 nm, fura-2 fluorescence increases with increasing [Ca ] j ,  while the 
fluorescence at 380 nm decreases. Measurement o f calcium concentration using this 
ratiometric method avoids interference due to uneven dye distribution and photobleaching 
[Grynkiewicz et al., 1985].
These measurements, however, provide only indirect evidence for agonist-stimulated Ca2+ 
entry; an additional feature o f fura-2 , its susceptibility to fluorescence-quenching by 
manganese, can be exploited to demonstrate divalent cation entry directly. Manganese, on
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entering cells, binds fura-2 and quenches its fluorescence. Fluorescence at the isosbestic 
wavelength, 360 nm, in the presence o f 100 pM Mn2+ is measured, and quenching o f 
fluorescence shown graphically, or expressed as change in fluorescence per second in 
arbitrary units, with all values normalised to control values in the absence o f Mn2+.
For all following calcium measurements and manganese quench experiments, fura-2/AM 
is used. This is a membrane-permeant form of the fluorescent dye, and thus can be loaded 
into cells via incubation. Because o f the relatively low water solubility o f this AM ester, 
Pluronic F-127 a mild detergent, is often used as a dispersing agent to facilitate the 
loading. Fura-2/AM itself does not bind Ca2+, but it is readily hydrolyzed to Fura-2 by 
endogenous esterases once the dye has entered the cells.
All experiments were performed on stirred cell suspensions at 106 cells/ml at 40°C using 
an LS50 B fluorimeter (Perkin Elmer). Cells were suspended in Hank’s balanced salt 
solution (HBSS) supplemented with HEPES, sodium bicarbonate and contained (in mM): 
1.26 CaCl2, 0.81 M gS04, 5.4 KC1, 0.44 KH2P 0 4, 136.9 NaCl, 0.34 Na2H P04, 4.2 
NaHCC>3, 5.5 D-glucose and 10 HEPES. Three mM EGTA was added for calcium-free 
experiments and agonists and antagonists added as indicated.
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94-Cytosolic Calcium (Ca ) measurements
Measurements o f intracellular free calcium concentration ([Ca2+]i) were made using the
fluorescent indicator Fura-2. Ten million cells were loaded with 1.25pM Fura-2/AM and
0.0025% Pluronic F-127 (stocks combined in DMSO at 2000 x) in 4 ml growth medium at
40°C for 45 minute^. Cells were washed three times and re-suspended at 4°C in HBSS,
supplemented as above, to a final density o f  106 cells/ml and kept on ice in 2.5 ml aliquots
for up to 1 hour prior to fluorimetric analysis. After this time it was found that the fura-
2/AM began to leak out o f the cells, and cell viability fell. To analyse samples, cells were
pre-warmed to 40°C in a water bath; fluorescence o f the stirred cell suspension was then
measured ratiometrically by emission at 510 nm with excitation at 340 and 380 nm
respectively, using an LS 50 B fluorimeter with filter wheel attachment (Perkin Elmer).
The changes in cytosolic calcium concentrations were observed, including background
drift, in response to nucleotide agonists such as ATP and BzATP. For repeat studies in the
absence o f  extracellular calcium, chelation o f residual extracellular calcium was achieved
by addition o f 3 mM EGTA at the beginning o f fluorescence measurements. For
experiments in the presence o f antagonists, these were either added immediately before
the agonist, or in the case o f oATP, cells were pre-incubated with antagonist, which was
removed prior to Fura-2/AM loading. Timeline ratiometric fluorescence readings were
saved in Excel format (Microsoft, USA) for later analysis and graphic representation.
Background drift o f fluorescence signal was seen in most experiments, due to extrusion o f
the indicator by an anion transporter [Thomas and Delaville, 1991], and this could be
corrected by subtraction o f typical linear drift traces obtained in separated experiments, if
necessary. Results are displayed as arbitrary ratio units that correspond to intracellular
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calcium. Conversion to estimated free calcium was not performed in these experiments: it 
is considered that such estimation would be inaccurate, and in population studies where 
only some cells may respond, calcium rises would be inevitably underestimated. However, 
ratio data can be used to compare responses o f cell populations to different conditions. 
Data is shown as representative traces o f experiments from one clone on three or more 
different occasions, or as the average o f three such studies (± SE).
Manganese quench
DT40 cells were loaded with Fura-2/AM, washed three times and re-suspended in 
supplemented HBSS, as above. Suspensions o f cells at 106 cells/ml were pre-warmed to 
40°C; stirred samples were then excited at the dye’s isosbestic wavelength o f  360nm and 
emission monitored at 5 lOnm. Antagonists and agonists were added from stock solutions 
to the desired concentrations at 50 seconds and 150 seconds after the addition o f lOOpM 
manganese (Mn2+) respectively. Again, a background drift o f fluorescence downwards in 
the presence o f  Mn2+ alone, presumably due to dye extrusion, is seen. Traces from 
individual experiments were standardized to a value o f fluorescence as 1.0 , the starting 
fluorescence reading after addition o f Mn2+, and data is shown as the average readings 
from the same P2X7-expressing clone on three different occasions (± SE). The rate o f  
change o f fluorescence in response to agonist was proportional to the rate o f cation influx. 
In order to make quantitative comparisons between the effects o f different antagonists, 
using Excel, for each experiment cation influx rate was calculated as the difference
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between the slope on the trace prior to agonist addition, and that immediately after agonist 
addition. In this way, the baseline drift was corrected for in each case.
Ethidium bromide influx
The P2X7 receptor is known to function as a permeabilising ‘pore’ in many cell types, the 
size being dependent on cell-type, with a maximum o f 900 Daltons (Da). Ethidium 
bromide is frequently used to assess entry via pores; it is 314 Da in size, and after entry 
into a cell, on chelation with nucleic acids, emits fluorescence that can be measured using 
spectrofluorimetry. This increase in fluorescence is proportional to ethidium bromide 
entry and hence the presence o f pores, and for standardization, can be expressed as a 
percentage o f the total fluorescence after digitonin-induced cell permeabilisation.
To assess ethidium bromide influx, cells were washed three times in HBSS, warmed to 
40°C and placed in a cuvette at 106 cells/ml. Twenty-five pM ethidium bromide was 
added and fluorescence recorded as a function o f time: cells were excited at 302nm and 
emission monitored at 560nm. Fluorescence values were corrected for background 
fluorescence, a small concentration-dependent quenching o f fluorescence by BzATP and 
expressed as a percentage o f the maximum value obtained following complete 
permeabilisation o f the cells with lOpM digitonin. Data is shown as representative traces 
o f experiments from one clone on three or more different occasions, or as the average o f 
three such studies (± SE).
153
Fluorescence-Activated Cell Sorter (FACS) analysis of nuclei
Cells undergoing apoptosis exhibit many pathognomonic morphological features, 
including condensation o f the nucleus. In this method, after induction o f apoptosis with 
various agonists, the cells were stained with propidium iodide that fluoresces on chelation 
with DNA. Propidium iodide is therefore potentially highly carcinogenic and handled with 
appropriate precautions including glasses, gloves and protective clothing. The sorting o f  
these stained nuclei for size, using fluorescence-activated cell sorting (FACS) allows an 
estimation o f the proportion o f cells exhibiting pyknotic, small nuclei, assumed to 
represent cells undergoing apoptotic cell death [Takata et al., 1995]. This is not a direct 
measure o f  rates o f  apoptosis, but provides a useful indirect estimation o f cells undergoing 
nuclear condensation suggestive o f apoptosis. Direct methods such as TUNEL were not 
performed in this study
Cells were harvested between 40 and 100 x 104/ml for viability assays, as it was found that
greater density induced high baseline rates o f apoptotic death, particularly in P2X7-
expressing clones. Cells were re-suspended in fresh medium to final density 40 x 104/ml,
placed in 200ul aliquots in round-bottomed 96 well plates and P2X7 agonists added. Each
condition was replicated at least three times with wild type DT40, P2X7-expressing and
vector only-transfected cell lines. Plates were incubated for specified time periods at 40°C
in 5% CO2 incubator. At the end o f the experimental period, cells were spun down at 1400
rpm for 5 minutes on balanced swing-out plate rotors. Medium was discarded by a single
sharp shake o f the plate and each pellet was then fixed with 200pl filtered hypotonic DNA
staining solution (50 pg/ml propidium iodide, 0.1% triton X-100, 0.1% sodium citrate)
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using a multi-channel pipette. Samples were pipetted up and down once to mix, 
transferred to 50 x 6 mm FACS analysis tubes (Sterilin) racked in an identical labeled 96- 
well plate and stored at 4°C until FACS sorting o f nuclei using Becton Dickinson 
FACSCalibur equipment. Data was analyzed using CellQuest software as set out by the 
manufacturers, or using WinMDI (WinMDI version 2.8). No forward or side scatter 
thresholds were used, but fragments with FL2-H intensity below the lower limit o f the 
‘apoptotic’ gate, and doublets were excluded and the remaining data displayed as in the 
figure (Fig. 8). The percentage o f apoptotic nuclei was taken as the sub-2n population as a 
percentage o f  all gated nuclei. Data is shown as the mean (± SE) for three or more 
experiments. Background levels o f apoptosis (2 -  10 %  for 24 hour experiments) were 
measured for each experiment and subtracted using Excel.
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Apoptotic
FL2-H
Figure 8 . FACs sorting o f propidium iodide -  stained DT40 nuclei.
A typical analysis o f DT40 nuclei, stained with propidium iodide, after 
cells were exposed to BzATP for 24 hours. The sub-2n population of 
nuclei, taken as shrunken ‘pyknotic’ nuclei o f cells undergoing apoptotic 
death, are gated as shown, and presented as a percentage of all nuclei 
(after arbitrary exclusion of small fragments of nucleic acids).
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Chapter 5. Results - P2X7 protein expression in mouse 
nephrogenesis
Prior to my investigation o f P2X7 expression in kidney development in this thesis, there 
was little published describing P2X7 expression in the normal kidney. Initial studies o f the 
receptor had revealed mRNA in the whole human kidney [Rassendren et al., 1997], and 
our group and others described functional expression o f P2X7 in rat glomerular mesangial 
cells in vitro, in response to inflammatory stimulation [Harada et al., 2000;Schulze-Lohoff 
et al., 1998] with very low levels o f protein immunoreactivity found in the normal adult 
rat kidney, compared with, for example adult brain. In this study, I systematically 
examined the spatial and temporal expression o f P2X7 in the normal rodent, using tissue 
from the C57BL/6J mouse. As well as providing a normal animal in which it is possible to 
examine multiple time points in a number o f animals, the predominance o f cell turnover in 
nephrogenesis is well documented in this model. The expanding data on the role o f P2X7 
in induction o f cell turn over, in particular apoptosis, make this receptor an interesting 
target molecule to study in kidney development.
Validation of the P2X7 antibody
The scarcity o f descriptive studies o f P2X7 expression in the urinary tract at this time was,
in part, due to the lack o f reliable antibodies to the receptor protein. In order to verify the
reactivity o f the Alomone antibody (as described in Materials) used in my studies, I
carried out several preliminary studies: Firstly, the polyclonal rabbit anti-rat P2X7 receptor
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antibody detected an approximately 70 kDa band in both normal embryonic and postnatal 
kidneys o f the C57BL/6J mouse, and in the cpk/cpk mouse model o f ARPKD using 
western blot analysis o f whole kidney protein extracts. Figure 9 shows a representative 
immunoblot o f P2X7 in embryonic day 19 (E l9) metanephroi (A), 1 week postnatally (B) 
and the same age in the cpk/cpk kidney (C). The 70 kDa protein band was detected 
reproducibly at all time points, the experiment repeated using protein extracted from at 
least three different animals. The specificity o f this result was supported by the negative 
control experiment in which the primary antibody was pre-reacted with excess (2:1 weight 
: weight) immunizing peptide, provided by the supplier (Alomone, Jerusalem, Israel): no 
such band was seen in any sample after pre-adsorption o f the antibody as described, or 
after omission o f the primary antibody. Secondly, using E l 8 mouse samples, P2X7 
immunoreactivity localised to the epidermis o f the skin (Fig. 10A), a site known to 
express high levels o f P2X7 protein in the rat [Groschel-Stewart et al., 1999a]. The signal 
from the P2X 7 primary antibody was detected using a biotin-streptavidin system 
ultimately bound by diaminobenzidine (DAB) hence giving a dark brown positive signal. 
All sections described in the thesis were counterstained with haematoxylin to provide a 
purple nuclear counterstain. In this case, as in western blot studies, no signal was detected 
after pre-reacting the antibody with excess immunising peptide (Fig. 10B). Although the 
antibody used in this thesis has been used successfully in other models, many o f the recent 
studies used an alternative antibody (Roche, as described in Materials). I carried out a 
comparison o f the two antibodies using 3 week old cpk/cpk kidneys, results, shown in the 
next chapter, being similar (Fig. 20). All subsequent experiments described in this thesis 
thus use the antibody supplied by Alomone (Israel).
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Figure 9. W estern blot P2X7 protein detection in normal and cystic 
mouse kidney
A representative result from three experiments, using polyclonal rabbit 
anti-rat P2X7 antibody. A major band at approximately 70 kDa was 
detected in C57BL/6J embryonic (E l9) metanephroi (lane A), 1 week 
postnatal phenotypically normal kidneys (+/+ or cpk/+ ) (lane B) and 1 
week littermate cpk/cpk kidneys (lane C). No band was seen after pre­
reacting the antibody with excess (2:1) immunizing peptide (data not 
shown).
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Figure 10. P2X7 immunolocalisation in murine skin squamous  
epithelium
Sections of neonatal (El 8) C57BL/6J mouse probed with P2X7 antibody 
(Alomone) as described in the Methods, visualised with diaminobenzidine 
(DAB) as a brown colour, and counterstained with haematoxylin. A. P2X7 
was immunolocalised to epidermis of the skin, as previously described in 
the rat, using alternative commercially available antibodies. B. Pre­
reaction of the antibody with excess immunizing peptide as a negative 
control revealed no signal, as did omission of primary antibody (data not 
shown). Bar is 40 pm.
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Histological P2X7 immunolocalisation in the early metanephros
Sections o f kidneys from embryos o f different ages were examined; embryonic ages are 
defined as the number o f days after vaginal plug o f the female, for example E ll  being 
eleven days post vaginal plug. In early nephrogenesis, as described in Figure 3, there is 
extension o f the ureteric bud from the Wolffian duct and then branching in the renal 
mesenchyme, the latter undergoing condensation or aggregation around the ureteric bud 
tips, polarisation into vesicles and comma-shaped bodies and the eventual formation o f the 
nephrons. The ureteric bud arborises to form the branching system o f the collecting 
system o f the urinary tract; collecting ducts, renal pelvis, ureter and trigone o f the urinary 
bladder. This process begins at around El 1 in the mouse kidney, which is equivalent to 
approximately five weeks gestation in human embryogenesis [Kaufman, 1992].
In my systematic investigation o f P2X7 expression in normal mouse kidney development,
I used El 1 as the first experimental stage. At E l 1 in the C57BL/6J mouse there was 
virtually no immunoreactivity above background, in either ureteric bud tip or the 
associated intermediate mesenchyme (Fig. 11A). However at E l3, P2X7 immunoreactivity 
was present and localised most prominently to subsets o f  the mesenchymal cells that are 
undergoing condensation around the ureteric bud tips, the condensing mesenchyme (Fig.
1 IB). In contrast, little P2X7 signal was seen in either the ureteric bud tips or the early 
renal vesicles developing from the polarising and differentiating condensing mesenchyme. 
Figure 11C shows a similar E13 sample with ureteric bud and condensing mesenchyme, 
probed with pre-adsorbed primary antibody as a negative control: no signal was seen in
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the condensing mesenchyme, supporting the specificity o f P2X7 protein 
immunolocalisation in the condensing mesenchyme at this stage o f renal development. All 
figures show a representative slide from several sections using at least three animals.
P2X7 immunolocalisation at E l6
By E16 in the mouse, the ureteric bud has undergone multiple rounds o f branching to form 
the early collecting ducts and urinary collecting system, and the first layers o f primitive 
glomeruli have formed. Despite P2X7 expression in the condensing mesenchyme at earlier 
stages, in keeping with its apparent down-regulation in the early polarising vesicles, I 
detected no P2X7 immunoreactivity in the S-shaped bodies (primitive glomeruli) in the 
outer cortex (Fig. 12 A) or more mature glomeruli seen in the deeper cortex at E16 (Fig. 
12B); these contained forming capillary loops around a ‘mesangial’ core. In contrast,
P2X7 protein at this stage immunolocalised to the tubules with location consistent with 
distal tubules and collecting ducts, derivatives o f the ureteric bud and often situated 
adjacent to glomeruli, in both superficial and deep cortex (Fig. 12). Proximal tubules did 
not express P2X7 (Fig.l2B); the faint signal seen in some proximal tubules is caused by 
high levels o f endogenous peroxidase activity in this segment.
P2X7 immunolocalisation in the adult kidney
Several later fetal stages were studied, between E l6 and 4 weeks postnatally, at which the
animal has reached adult maturity. At all stages examined, E l8 , neonatal, 1 week and 4
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weeks o f age, a similar pattern o f P2X7 expression was seen, with P2X7 restricted to 
derivatives o f the ureteric bud i.e. the collecting ducts in the kidney. For brevity, only 
sections o f kidney from a 4 week old mouse are shown in figure 13, with P2X7 
immunoreactivity seen in a subset o f cortical tubules (Fig. 13 A) again adjacent to P2X7- 
negative glomeruli, and likely to be distal tubules or collecting ducts. In these epithelia, 
protein appeared to be localised to the apical part o f the cells. In the medulla o f the adult 
mouse kidney, P2X7 was detected in the collecting ducts (Fig. 13B).
P2X7 expression in the lower urinary tract
P2X7 expression has been demonstrated recently in both ureter and urinary bladder o f the 
adult rat [Lee et al., 2000], but prior to this study there was no published data on receptor 
expression in the developing lower urinary tract. The ureter is formed from the lower 
ureteric bud stalk, and in early organogenesis is surrounded by condensing mesenchyme 
that will form the surrounding muscle layer. At E l3, as in the early metanephros described 
above, P2X7 was immunolocalised to the dense collar o f condensing mesenchyme 
surrounding the ureteric bud stalk (Fig. 14A). At later stages, e.g. day one postnatally (Fig. 
14B), P2X7 expression had strikingly shifted, in terms o f  cell lineage, to the ureteric 
urothelium, and was absent from surrounding tissues including the smooth muscle layer. 
This shift between cell types from the early condensing mesenchyme, later to the ureteric 
bud derivatives, paralleled what I described in the kidney itself e.g. a shift from the 
mesenchymal component to ureteric bud derivatives.
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The mouse urinary bladder first appears as a discrete entity at E l4, when it forms from the 
cloaca-derived urogenital sinus. P2X7 expression has been documented previously in the 
adult rat bladder [Lee et al., 2000]: in this thesis I found similar staining pattern in the 
embryonic and postnatal bladder o f the CD1 mouse. Histological sections were treated as 
for the kidney sections, counterstained with haematoxylin and probed with the anti-P2X7 
antibody. From El 5, P2X7 immunolocalised to the urothelium o f the urinary bladder. 
Figure 15 shows representative sections from E l8 (Fig. 15A) and day one postnatally 
(Fig. 15C), in both cases P2X7 protein expression limited to the urothelium. Negative 
control was performed using antibody pre-adsorbed with immunising peptide (Fig. 15B).
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Figure 11. P2X7 immunolocalisation in C57BL/6J mouse nephrogenesis
All sections were counterstained with haematoxylin, and A  and B probed with 
the P2X7 antibody as described in Methods. A. At E l 1, no 
immunohistochemical P2X7 signal was detected above background (data not 
shown), in either ureteric bud (ub) or mesenchyme (m). B. At E l3, significant 
P2X7 immunoreactivity was not detected in the branching ureteric bud tips (ub), 
but was detected in condensing mesenchyme (cm), with down-regulation in 
primitive nephron vesicles (v). C. No signal was detected after pre-reacting the 
primary antibody with excess immunizing peptide (E l3). Bar is 40 pm.
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Figure 11. P2X7 immunolocalisation in C57BL/6J mouse nephrogenesis
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Figure 12. P2X7 immunolocalisation in C57BL/6J mouse 
nephrogenesis: E16
Sections were counterstained with haematoxylin. A. At E l6 P2X7 
immunolocalised to ureteric bud branches / collecting ducts in the 
superficial cortex, but not the adjacent S-shape bodies (s). B. Similarly, 
in deep cortex, P2X7 immunolocalised to collecting ducts, whereas 
primitive glomeruli (g) and proximal tubules (pt) did not express P2X7. 
Bar is 40 pm.
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Figure 13. P2X7 immunolocalisation in the mature C57BL/6J 
mouse kidney
Sections were counterstained with haematoxylin. A. Four weeks 
postnatally P2X7 protein was detected in a subset o f cortical tubules, 
probably distal convoluted tubules or collecting ducts, but not the 
adjacent glomeruli. B. P2X7 immunolocalized to medullary tubules. 
Bar is 40 pm.
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Figure 14. P2X7 immunolocalisation in C57BL/6J mouse 
ureteric development
Sections were counterstained with haematoxylin. A. At E l3 
P2X7 immunolocalised to condensing mesenchyme (cm) around 
the ureter (u). B. Neonatally (day one after birth), P2X7 was 
detected in urothelium (—>) of the mature ureter with an apparent 
apical distribution. Bar is 40 pm.
Figure 15. P2X7 immunolcalisation in bladder development in 
the CD1 mouse
Sections were counterstained with haematoxylin. Samples o f  the 
developing urinary tract o f  the CD1 mouse were probed with the 
P2X7 antibody. A  and C. At E l8 (A) and after birth (C) P2X7 
immunolocalised to the urothelium o f  the maturing mouse 
bladder. In postnatal sections, P2X7 also immunolocalised to cells, 
apparently ‘myofibroblasts’ in the lamina propria layer (—») (C).
B. No signal was seen (E l8) using antibody pre-reacted with 
excess immunising peptide. Bar is 40 pm for all frames.
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Figure 15. P2X7 immunolocalisation in urinary bladder 
development in the CD1 mouse
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Identification o f apoptotic nuclei in the early metanephros
Apoptotic cells demonstrate typical, condensed ‘pyknotic’ nuclei, and in this study were 
observed occasionally, within the condensing mesenchyme. This is demonstrated in 
Figure 16A, a section o f El 3 metanephros probed with the P2X7 antibody and 
counterstained with haematoxylin. The latter stains nuclei purple, the dense, small purple 
nuclei in this group o f  cells o f the condensing mesenchyme, suggestive o f cells 
undergoing programmed cell death. An alternative way o f staining nuclei in order to 
assess their morphology more closely, and in order to compare their distribution with the 
cellular expression o f P2X7, is to use propidium iodide (PI). Pi-stained nuclei exhibit red 
fluorescence when viewed by confocal microscopy using wavelength 543 nm [Coles et al., 
1993] (Fig. 16B), and were localised to the condensing mesenchyme at E l3, a region 
known to undergo extensive cell turnover at this stage o f kidney development [Welham et 
al., 2002]. The concurrent use o f FITC-labelled secondary antibody to visualise P2X7 
immunoreactivity, at 488 nm, provided a green fluorescent marker o f P2X7 
immunoreactivity (Fig. 16C), and when viewing the merged images from the two 
fluorescent wavelengths, the pyknotic ‘apoptotic’ nuclei can be seen within the P2X7- 
expressing condensing mesenchyme (Fig. 16D). The metanephric mesenchyme is a 
common site for apoptotic cell death in embryogenesis [Welham et al., 2002], however, 
only a small percentage (<1%) o f the P2X7-positive cells appeared at the final stages of 
apoptosis in these sections, and it is known that such cells may be cleared very quickly. 
More sensitive methods for identifying cells at earlier stages o f  the apoptotic process, such
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as electron microscopy or TUNEL, would be required to make an accurate quantitative 
analysis o f cell death in this cell population.
Identification of proliferation in the early metanephros
Proliferating cells were identified using an antibody recognising proliferating cell nuclear 
antigen (PCNA), positive staining appearing as a blue colour. PCNA is a human DNA- 
polymerase delta associated protein is expressed at high levels during S phase (Bravo et al 
1987). PCNA immunoreactivity was detected in numerous cells o f the condensing 
mesenchyme, whereas few cells in the surrounding loose mesenchyme, ureteric bud tips or 
vesicles were positive (Fig. 17A). When used together with the P2X7 detection system as 
described previously, most cells o f the condensing mesenchyme at E13 appeared positive 
for both P2X7- and PCNA immunoreactivity (Fig. 17B). A positive control for PCNA 
expression was not performed in this study, but would be useful to support a positive 
result in this condition. However, there are previous studies showing PCNA immuno­
reactivity in the condensing mesenchyme at this stage in murine nephrogenesis [Winyard 
et al., 1996a]. Furthermore, studies have demonstrated an 100-fold increase in cell 
numbers o f this lineage, in equivalent stages o f rat kidney development (El 3) [Welham et 
al., 2002], the latter explaining the relatively large numbers o f cells expressing 
proliferation markers at this critical stage in forming precursors o f the renal vesicles.
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Figure 16. Localisation of P2X7 immunostaining and pyknotic nuclei in 
C57BL/6J E13 metanephros
A. In E l3 metanephros several cell nuclei, counterstained with haematoxylin, 
demonstrated the morphological appearance o f  apoptotic cell death. Some o f  these 
cells were immuno-positive for P2X7 (4-). B-D. Confocal scanning 
photomicrographs o f  sections from a normal C57BL/6J mouse embryonic day 13 
metanephros stained with propidium iodide (PI) and P2X7 primary antibody 
detected using an FITC-conjugated secondary antibody. B. The PI wavelength 
revealed 3 pyknotic nuclei with morphological appearance o f  cells undergoing 
apoptosis (-») within the condensing mesenchyme (cm). C. The FITC wavelength 
shows expression o f  P2X7 restricted to the condensing mesenchyme, with little 
expression in the ureteric bud branch epithelia (ub). D. The merged image shows 
Pi-stained nuclei in red and FITC-labelled P2X7 immuno-positivity in green, the 
apoptotic nuclei detected within the P2X7-expressing condensing mesenchyme. Bar 
is 20 pm in A  and D.
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Figure 16. Localisation of P2X7 immunostaining and pyknotic nuclei 
in C57BL/6J E13 metanephros
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Figure 17. Cell proliferation within the condensing mesenchyme of  
C57BL/6J mouse kidney
Sections o f El 3 metanephros probed PCNA antibody revealed a positive 
blue nuclear signal in proliferating cells (->) (A & B). A. Counterstaining 
with P2X7 antibody (a brown positive signal) shows numerous cells in the 
mesenchymal condensates (cm) expressed both proteins. Few cells in the 
loose mesenchyme (lm), ureteric bud tip (ub) or vesicle (v) were immuno- 
positive for PCNA. Note that these sections were not counterstained with 
haematoxylin. Bar is 20 pm.
Summary
The systematic examination o f P2X7 expression in normal mouse nephrogenesis in my 
thesis revealed an interesting spatial and temporal pattern, seen in both the kidney itself 
and the lower urinary tract.
• Metanephric P2X7 receptor expression was first seen at E l3, restricted to a subset 
o f mesenchymal cells undergoing aggregation around branching ureteric bud tips. 
The latter structures did not express receptor protein at this stage using this 
immunohistochemical methodology.
• From El 6 throughout the remainder o f kidney formation until adulthood P2X7 
protein was detected in derivatives o f the ureteric bud; distal tubules, collecting 
ducts, renal pelvis, ureter and urinary bladder urothelium.
• P2X7 expression was down regulated in metanephric mesenchymal cells once 
condensation had begun, with formation o f the polarised vesicles. The more 
mature structures derived from the condensing mesenchyme, i.e. glomeruli and 
more proximal tubules, did not express P2X7 in normal mice.
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• It was difficult, using the standard immunohistochemical techniques used in this 
work, to determine exact cellular localisation o f the protein, although studies of  
more mature tissue, and the lower urinary tract were at times consistent with 
immunolocalisation to the apical, or luminal part o f the epithelia.
• Both proliferation and apoptosis were demonstrated in subsets o f cells o f  the 
condensing metanephric mesenchyme at E l3, also positive for P2X7 
immunoreactivity, and these observations are consistent with possible roles for the 
receptor in modulation o f cell turn over in early nephrogenesis.
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Chapter 6. Results - P2X7 expression in the cpk/cpk mouse 
model of autosomal recessive polycystic kidney disease
The initial investigation o f P2X7 expression in ARPKD was undertaken using the cpk/cpk 
C57BL/6J mouse, a model with a very similar renal phenotype to the human form o f the 
disease. The genotypes o f the two forms o f the condition are not the same, human ARPKD 
caused by a mutation o f the PKHD1 gene encoding fibrocystin [Onuchic et al., 2002;Ward 
et al., 2002] and the cpk/cpk mouse, a mutation o f the cpk gene, encoding cystin [Hou et 
al., 2002]. In understanding the human condition, it would be preferable to investigate the 
same gene mutation in an animal model. The mouse homologue o f the human mutation 
has now been described [Nagasawa et al., 2002], but neither the PKHD1 gene nor this 
mouse homologue were published at the time I undertook this study. Both human ARPKD 
and the cpk/cpk mouse exhibit early proximal and collecting duct dilatation and cyst 
formation [Nakanishi et al., 2000;Verani et al., 1989], with the progressive disease 
comprising o f collecting duct cysts with loss o f functional renal tissue i.e. atrophy of 
glomeruli and non-cystic tubules [Kissane, 1990]. The animal model is useful for such 
descriptive work, in which several animals can be studied at specific time points 
throughout disease progression. Affected homozygous mice develop multiple large 
collecting duct cysts and die, reproducibly, o f most likely, uraemia by four weeks o f age, 
thus allowing the study o f disease progression. Littermates with normal phenotype, i.e. 
+/+  or +/cpk were used as normal controls: these were not distinguished by genotyping in 
this study, but to date there is no data to suggest that +/cpk mice or humans carrying a
179
single PKHD1 mutation have abnormal kidneys. At three weeks o f age, shown in Figure 
18, the kidneys from cpk/cpk mice are grossly enlarged, approximately five times larger 
by length, than those o f a normal littermate, shown for comparison.
I demonstrated the progressive development and expansion o f collecting duct cysts in this 
model using DBA-staining o f collecting duct derivatives at various stages. Figure 19 
shows low power views o f kidney sections stained with this lectin, giving a brown signal 
using a peroxidase-based detection system. Phenotypically normal littermate and affected 
neonatal kidneys are shown: in the normal mouse neonatal kidney, maturing collecting 
ducts can be seen in the cortex and medulla (Fig. 19A), whereas the affected animals at 
this age already exhibit mild dilatation o f the collecting ducts especially at the border o f  
the cortex and medulla (Fig. 19B). At this early stage, several cysts are proximal in origin 
and hence DBA-negative. At one week o f age, proximal cysts (i.e. DBA-negative) can still 
be seen, but there is expansion o f the collecting duct cysts (Fig. 19C), which by three 
weeks o f age dominate the terminal stages o f disease, with loss o f normal renal 
architecture (Fig. 19D).
As discussed in the previous chapter, the immunoreactivity o f two different antibodies was 
compared using cystic tissue from a 3 week old cpk/cpk kidney, both antibodies giving 
similar patterns o f reactivity, P2X7 expression localising to the epithelium o f normal- 
calibre and cystic collecting ducts (Fig. 20). In all cases, the Figures show representative 
sections o f several processed, examining at least three animals.
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Figure 18. Gross appearance of murine autosomal recessive 
polycystic kidneys (cpk/cpk)
Kidneys removed from 3 week old cpk/cpk homozygous affected mice 
were grossly enlarged, compared to kidneys from a phenotypically 
normal littermate (+/cpk or +/+), shown above for comparison. Bar is 
approximately 500 pm.
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Figure 19. Dolichos biflorus labelling o f collecting duct dilatation and cyst 
formation in the cpk/cpk mouse
Low magnification ( x 5 ) views of neonatal kidneys from phenotypically normal 
littermates (A) and cpk/cpk mice (B) There was clearer cortico-medullary (c-m) 
differentiation in the phenotypically normal kidney (+/cpk or +/+), and the 
appearance of small cysts, several proximal tubule (PT) in origin (DBA-negative, x) 
in the affected kidney. C. At one week o f age collecting duct dilatation is more 
prominent, especially in the outer medullary region, with PT cyst remaining in the 
cortex (x). D: By three weeks of age, cysts are mainly o f collecting duct origin, 
with progressive loss of cortico-medullary differentiation and loss o f functional 
renal tissue. Bar is 240 pm.
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Figure 20. Comparison of two anti-P2X7 antibodies.
Sections of 3 week old cpk/cpk cystic kidney, counterstained with 
haematoxylin. Immunoreactivity of two anti-rat P2X7 antibodies was 
compared at 1:50 dilution on similar sections. The resulting 
localisation of immunoreactivity to the collecting duct cyst 
epithelium using the Alomone antibody (A) was similar to that with 
the Roche antibody (B) and was therefore used throughout the thesis. 
Bar is 40 pm.
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P2X7 immunolocalisation in neonatal cpk/cpk kidneys
In all Figures depicting P2X7 immunoreactivity in cpk/cpk polycystic kidney disease 
progression, the low power, DBA-stained section from the corresponding age is shown for 
orientation (neonatal: Fig. 21 A). The occurrence o f both proximal and collecting duct 
cysts in the neonatal stage o f the disease was investigated further using different markers 
of the two types o f tubule. Periodic acid Schiff (PAS) labels the proximal tubular brush 
border pink, and in the neonatal cpk/cpk kidney several dilated PAS-positive tubules were 
detected (Fig. 2 IB). Sections B, C and D in Figure 21 were also probed with anti-P2X7, 
with no signal above background noted in the PAS-positive proximal tubule cysts. On the 
other hand, P2X7 immunolocalised to the PAS-negative, normal-calibre collecting ducts, 
and also to collecting duct cysts (Fig. 21C). The sections shown in Figures 21D and 21E 
are adjacent sections: Figure 2 ID was reacted with P2X7 antibody and PAS and shows 
small and large collecting duct cysts expressing P2X7, and a normal proximal tubule and 
proximal cyst exhibiting no significant P2X7 immunoreactivity. The collecting duct origin 
of the large and small cysts is shown using DBA-staining o f the adjacent section (Fig.
2 IE).
P2X7 immunolocalisation in cpk/cpk kidneys at one week of age
Figure 22A shows low power histology o f DBA-positive collecting duct cysts in the
cpk/cpk mouse kidney at one week o f age. In the superficial cortex at this age there is
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residual functional tissue, with relatively normal glomeruli. P2X7 expression was not seen 
in the glomeruli, but subsets o f epithelial cells o f both normal collecting ducts and cysts at 
this stage expressed P2X7 (Fig. 22B). P2X7 was also immunolocalised to the dilating 
collecting ducts in the medulla (Fig. 22C), and the larger, expanding cysts (Fig. 22E). No 
immunoreactivity was seen after pre-reacting the antibody with immunising peptide (Fig. 
22D).
P2X7 immunolocalisation in cpk/cpk kidneys at three weeks of age
+
Again, the DBA-stained section o f three week old cpk/cpk kidney is shown to demonstrate 
the predominance o f  DBA-positive collecting duct cysts (Fig. 23 A). At this pre-terminal 
stage, there was little remaining normal renal tissue between cysts. P2X7 was 
immunolocalised to many o f the epithelial cells o f the different sized cysts (Fig. 23 B & 
C), with no expression in the interstitial areas between cysts. There were few proximal 
tubule-derived cysts present at this stage, and these did not express P2X7. The negative 
control experiment on a similar section is shown for comparison, with no 
immunoreactivity (Fig. 23D).
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Figure 21. P2X7 receptor immunohistochemistry in neonantal cpk/cpk 
kidneys
A ll sections were counterstained with haematoxylin, A  and E with DBA and B, 
C and D with PAS. A. Neonatal cpk/cpk kidney stained with DBA as in Figure 
11. B. In the neonatal cpk/cpk kidney proximal tubules, with pink PAS-positive 
brush borders (PAS-positive) did not express P2X7, whereas in C, P2X7 (—> ) 
immunolocalised to collecting duct cysts as well as normal calibre collecting 
ducts, with no PAS-positive brush borders (PAS-negative). P2X7 was not seen 
in maturing glomeruli (C). D and E are adjacent sections o f  neonatal cpk/cpk 
kidney shown at higher power. D. P2X7 (->) immunolocalised to epithelial cells 
o f  PAS-negative collecting duct (cd) cysts, defined by DBA labelling in E. 
Normal calibre and dilated proximal tubules (pt) do not express P2X7. Bar is 
240 pm in A, 40 pm in B and C, and 20 pm in D and E.
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Figure 21. P2X7 receptor immunohistochemistry in neonantal cpk/cpk kidneys
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Figure 22. P2X7 receptor immunohistochemistry in 1 w eek old cpk/cpk  
mouse kidneys
A ll sections were counterstained with haematoxylin. A. Low power 
photomicrograph o f  DBA-stained 1 week old cpk/cpk kidney as in figure 11.
B. P2X7 (-* ) was expressed in normal calibre and dilating collecting ducts in 
the outer cortex, and was absent in maturing glomeruli and proximal tubules.
C. Dilated collecting ducts in the medulla also expressed P2X7, as did large 
and medium sized cysts (E). D. Negative control was performed using 
antibody pre-reacted with excess immunising peptide. Bar is 240 pm in A  and 
40 pm in all others.
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Figure 22. P2X7 receptor immunohistochemistry in 1 week old cpk/cpk 
mouse kidneys
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Figure 23. P2X7 receptor immunohistochemistry in mature cpk/cpk kidneys.
All sections were counterstained with haematoxylin. A. 3 week old cpk/cpk kidney 
stained with DBA as in figure 11 to demonstrate predominance o f collecting duct 
cysts in the late stages of disease progression. B and C. P2X7 is expressed in medium­
sized and large collecting ducts cysts in the 3 week old cpk/cpk mouse kidneys. Note 
that staining is present in epithelial cells of the cysts but absent in the interstitium 
between cysts. D. Negative control was performed using antibody pre-reacted with 
excess immunising peptide. Bar is 240 pm in A and 40 pm in others.
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Epithelial cells within the cpk/cpk cyst lumen
My documentation o f P2X7 expression in the cpk/cpk kidney cyst was not restricted to the 
intact epithelium. In approximately five percent o f cysts, epithelial cells appeared to be 
undergoing cell turnover, with ‘hillocks’ o f cells protruding into the cyst lumen, and also 
cells appearing to slough off into the lumen. The latter is suggestive o f either reduced 
adhesion or viability, both features o f the proximal tubular epithelial cells shed during 
acute tubular necrosis [Racusen, 1995]. Figure 24 shows examples o f these luminal cells: 
cells apparently sloughing off the epithelium and into the lumen demonstrate positive 
P2X7-immunoreactivity (Fig. 24A), as do those apparently proliferating to form a 
protrusion o f cells into the lumen (Fig. 24B). Due to the low frequency o f such findings, 
there were no luminal cells o f interest in the sections probed with PI and PCNA to assess 
apoptotic and proliferative status further.
Apoptotic cells in the three week old cpk/cpk kidney
Using a combined staining protocol as described in the previous chapter, pyknotic
apoptotic nuclei were identified using propidium iodide, and P2X7 immunoreactivity was
visualised using an FITC-labelled secondary antibody. In tissue from a three week old
cpk/cpk kidney apoptotic nuclei were detected in the interstitium between cysts (Fig.
25A), rather than in the cyst epithelia, the population that expresses P2X7 (Fig. 25B). The
dissociation between the occurrence o f pyknotic, presumed apoptotic nuclei, and
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expression o f P2X7 was more clearly seen in the merged image at high power (Fig. 25C), 
in which nuclei were stained red and P2X7-expressing cells bright green.
Proliferation in the three week old cpk/cpk kidney
Detection o f proliferating cells using an antibody raised against proliferating cell nuclear 
antigen (PCNA), revealed very few proliferating cells at three weeks o f age. Double 
staining with P2X7 antibody confirmed the expression o f receptor protein in many 
epithelial cells o f renal cysts with no immunoreactivity within the interstitium: no cells 
were found to be positive for both P2X7 and PCNA in the sections examined (data not 
shown). A positive control for PCNA expression would be required to support this 
negative finding.
P2X5 immunolocalisation in the cpk/cpk kidney
The expression o f another member o f the P2X family was briefly explored. P2Xs is often 
expressed in close proximity to P2X7, for example in stratified squamous epithelia such as 
the skin, where the receptors are present in different layers o f the epidermis and where in 
vitro studies have implied specific functional roles: P2Xs appears to mediate early 
differentiation o f keratinocytes, and P2X7 mediates keratinisation, cell death and 
exfoliation [Groschel-Stewart et al., 1999a] [Greig et al., 2003].
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In sections o f cystic kidney from the 3 week old cpk/cpk mouse, P2Xs immunoreactivity 
was detected in epithelial cells o f different sized cysts (Fig. 26A & B). The negative 
controls for these experiments (not shown) were carried out by omission o f primary 
antibody as immunising peptide was not available, and thus interpretation o f the 
specificity o f low levels o f signal above background were difficult. Counterstaining with 
DBA and PAS to determine tubular origin was not included in these preliminary studies, 
but the positive P2Xs immunoreactivity in the majority o f cysts would be consistent with 
expression in the collecting duct cysts.
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Figure 24. Epithelial cells within cpk/cpk cyst lumen
High power light microscopy of sections of 3 week old cpk/cpk kidney, 
counterstained with haematoxylin. A. Cells which may be undergoing 
apoptosis, expressing P2X7 (—») appear to slough off into lumen, and in 
B, may be undergoing proliferation. Bar is 20 pm.
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Figure 25. Localisation of P2X7 immunoreactivity and pyknotic nuclei in 3 
week old cpk/cpk kidney by confocal microscopy
Sections from a 3 week old cpk/cpk kidney were stained with propidium iodide 
and P2X7 primary antibody detected using an FITC-conjugated secondary 
antibody. A. The PI wavelength revealed 2 pyknotic nuclei with 
morphological appearance o f  cells undergoing apoptosis (-» ) within the 
interstitium B. The FITC wavelength shows expression o f  P2X7 restricted to 
the epithelium itself, absent in the interstitium. C. The merged image shows 
Pi-stained nuclei in red and FITC-labelled P2X7 immuno-positivity in green. 
Bar is 20 pm in C.
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Figure 25. Localisation of P2X7 immunoreactivity and pyknotic nuclei 
in 3 week old cpk/cpk kidney by confocal microscopy
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Figure 26. P2X5 immunohistochemistry in 3 week cpk/cpk kidney
Sections were counterstained with haematoxylin. P2X5 receptor 
expression was detected in collecting duct (cd) cyst epithelium, in 
medium and large cysts (A and B) in the kidneys of mature cpk/cpk 
mice at 3 weeks of age. Bar is 40 pm.
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Summary
The main finding o f this study was that, in progression o f  this polycystic mouse model, as 
in the development o f the normal mouse kidney, P2X7 was detected in the epithelia o f the 
collecting ducts.
• In the cpk/cpk mouse, P2X7 was localised to both normal collecting ducts in the 
earlier stages o f disease, and later the dilating and eventually grossly cystic 
collecting duct structures.
• Receptor protein was expressed throughout the time course o f disease progression, 
from neonatal, early cystogenesis, through to the pre-terminal state.
•  Apoptosis in this model, as assessed by detection o f Pi-positive, pyknotic nuclei, 
was restricted to the interstitial compartment between cysts, where no P2X7 
immunoreactivity was seen, whereas the epithelia were positive for P2X7 
immunoreactivity in the majority o f cysts.
• Preliminary investigation also detected P2X5 protein, another member o f the P2X 
family, in the cyst epithelium of this model.
198
Chapter 7. Results - P2X7 expression in human kidneys: normal 
and cystic
In order to extend my findings humans, I performed a limited study in which I examined 
the developmental expression o f P2X7 in human samples, including two normal and five 
cystic kidneys. Tissue was provided by Dr PJD Winyard at the Institute o f  Child Health, 
London, and in all cases shown was taken from mid-gestation (approximately 20 weeks) 
fetal terminations.
In the normal fetal kidney, a low level o f P2X7 immunoreactivity was found: at low power 
a faint P2X7 signal was detected, mainly localised to the medulla o f the kidney (not 
shown). At higher power some maturing tubular segments were seen to express P2X7 (Fig. 
27A). Negative control was depicted at both magnifications, using antibody pre-reacted 
with excess immunising peptide; no signal was seen in these studies (Fig. 27B). These 
results were confirmed in one further sample o f mid-gestation kidney.
Tissue from three ARPKD kidneys from approximately 20 week gestation, was probed 
with the same technique, and revealed a pattern o f  expression similar to that o f  the murine 
model o f the disease {cpk/cpk). Mid-gestation ARPKD kidneys contain cystic collecting 
ducts throughout cortex and medulla. Cysts in both regions were found to express P2X7, 
shown at low power (Fig. 28A) compared with the negative control (Fig. 28B). At higher 
power P2X7 was found to immunolocalise to the cystic epithelium o f dilating collecting 
ducts and cysts o f different sizes (Figs. 28C & E), but was not expressed in maturing
199
glomeruli or proximal tubules. Negative control processing o f adjacent sections is shown 
in each case using pre-reacted primary antibody (Figs. 28D & F).
Cysts are found in a wide range o f renal disorders, and in this study I immunolocalised 
P2X7 to the cyst epithelium o f cysts from kidneys with renal dysplasia. Two such samples 
were available, representative sections from a mid-gestation kidney shown in Figure 29. 
Dysplastic tubules and the epithelium o f large cysts, all expressed P2X7 and low levels o f  
immunoreactivity were also found within the collar o f fibromuscular tissue surrounding 
the cysts and in loose cells between these structures. No signals were seen in the negative 
controls (Figs. 29B & D) carried out without primary antibody.
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Negative control
Figure 27. P2X7 immunolocalisation in normal foetal human kidney
Sections were counterstained with haematoxylin. A. P2X7 immunoreactivity 
was seen in some maturing tubules ( i) , probably collecting ducts. B shows 
the negative control a performed with primary antibody pre-reacted with 
excess immunizing peptide. Bar is 10 pm.
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Figure 28. P2X7 immunolocalisation in foetal human ARPKD
Sections were counterstained with haematoxylin. Samples from mid-gestation 
human kidneys were probed with P2X7 antibody. A. At low power widespread 
expression is seen in dilating collecting ducts and cysts in cortex and medulla. 
High power photomicrographs revealed specific P2X7 immunolocalisation in 
the epithelia o f  collecting duct cysts (cy) in superficial (C) and deeper cortex 
(E), and no such signal in maturing glomeruli (g). B, D and F were probed with 
antibody pre-reacted with excess immunizing peptide. Bar is 5 pm in A  and B  
and 40 pm in C - D
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Figure 28. P2X7 immunolocalisation in mid-gestation human ARPKD
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Figure 29. P2X7 immunolocalisation in human dysplastic kidney cysts
Sections were counterstained with haematoxylin. A and C. Small and large 
cysts (cy) in mid-gestation dysplastic kidneys expressed P2X7 protein. Lower 
level immuno-reactivity was seen in surrounding fibromuscular collarettes (fc) 
and loosely arranged cells (1). B and D show similar sections with primary 
antibody omitted. Bar is 20 pm.
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Summary
• P2X7 was detected in the normal fetal human kidney, mainly in medullary tubules.
• P2X7 immunoreactivity was detected in the collecting duct cysts in human 
ARPKD, with similar distribution to that described in the cpk/cpk murine model o f  
the disease.
•  P2X7 also immunolocalised to abnormal tubules and cysts found in human 
dysplastic kidneys.
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Chapter 8. Results - Investigation of the role of P2X7 in 
cystogenesis in vitro
Having described the expression o f the P2X7 receptor protein in mouse and human forms 
of ARPKD, I next used an in vitro technique to investigate its possible functional role in 
the formation o f cysts. The dissociation and culture o f kidneys o f three week old cpk/cpk 
mice provides the starting material for a 3D system o f cell aggregation, lumen formation 
and cyst growth, and allows detailed monitoring o f pharmacological effects on the number 
and size o f cysts forming, as well as facilitating the investigation o f biological 
mechanisms mediating these effects.
3D suspension cyst culture
Dissociated tissue from three week old cpk/cpk mice, when grown in suspension culture
on agar-plated wells, formed cysts as previously described [Woo et al., 1994]. The initial
suspensions from ‘normal’ littermates (i.e. + /+  or +/cpk) (Fig. 30A), or cpk/cpk mice (Fig.
30C), contained cells, single or in small aggregates, short tubular segments but no visible
intact cysts. Photomicrographs taken after 24 hours, demonstrated that in the normal
controls, appearance was not significantly altered, with a few larger aggregates and rare
formation o f small cysts (Fig. 30B). In samples prepared from the cystic kidneys o f three
week old cpk/cpk mice, cystic structures were noted within the first few hours and mean
numbers and sizes assessed at the 24 hour end point used in these experiments. These
preparations contained cysts o f varying size, from approximately 10 to 100 microns in
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diameter (Fig. 30D). In a high power photomicrograph o f a group o f cysts, the individual 
epithelial cells stretched to form cyst walls could be visualised (Fig. 30E). This Figure 
also demonstrates the common association o f a number o f cysts o f variable size, with a 
central aggregate.
P2X7 expression in 3D cyst cultures
Firstly, expression o f the P2X7 receptor in the cpk/cpk mouse kidney, described earlier in 
vivo, was confirmed at the mRNA level using RT-PCR. Total RNA extracted from the 
kidneys o f 3 week old cpk/cpk mice, normal littermates and from the cpk/cpk 3D 
suspension cultures after 24 hours was converted into cDNA and amplified using primers 
validated by Mutini et al [Mutini et al., 1999], amplifying a 230 base pair region o f  the 
receptor sequence. mRNA from murine brain, known to express P2X7 [Surprenant et al., 
1996], was used as a positive control (data not shown). A  PCR product o f the correct size 
was demonstrated using cDNA from normal and cystic whole kidneys (Fig. 31 lanes 1 and 
3 respectively), as well as the 24 hour suspension cyst cultures (Fig. 31 lane 5). In all 
cases the reaction was repeated with omission o f reverse transcriptase (lanes 2 ,4  and 6) 
and also substituting the cDNA with distilled water (lane 7). This result was representative 
o f RT-PCR carried out using cDNA extracted from three animals or in vitro experiments, 
but was not quantitative.
Determination o f the precise site o f P2X7 protein expression within these multicellular 
cyst suspensions, using immunocytochemistry was technically difficult.
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Immunocytochemistry was attempted using various modifications o f fixing and mounting 
procedures as discussed previously: cysts were fixed in varying sucrose concentrations, 
mounted on slides coated with poly-L-lysine or processed entirely in suspension, and 
finally cryosections o f culture pellet frozen in OCT were attempted. As the latter was 
associated with freeze-fracture artefact, a result o f cyst fluid content, the best results were 
obtained completing all immunocytochemical steps in suspension. In this case, however, 
as with the use o f slides, the sequential centrifugation o f samples, either to adhere cysts to 
slides, or in order to perform antibody staining, resulted in a significant loss o f  cysts, and 
the collapse and loss o f structural integrity o f the larger cysts. One caveat here is that the 
remaining processed cysts are only a ‘surviving’ subset o f  all the material in the whole 
suspension culture.
An example o f the P2X7 immunoreactivity o f aggregates and small cysts is shown in 
Figure 32. Samples probed with the polyclonal anti-P2X7 antibody used to detect P2X7 
immunoreactivity in the whole organ, demonstrated P2X7-immunoreactivity, as assessed 
by a FITC-conjugated secondary antibody, in both cysts and aggregates (Fig. 32A). The 
fluorescent signal was much reduced following pre-incubation o f  the primary antibody 
with immunising peptide (Fig. 32B). These images were taken using the x 20 confocal 
objective, and further amplified using associated software, producing some loss o f  
resolution and pixelation o f the image. Higher power microscopy, for better definition o f  
the sub-cellular localisation o f P2X7 protein in these experiments was not possible in view  
o f the technical difficulty encountered as above. Cysts processed in suspension and 
mounted, even with fixed coverslips, tended to move when viewed with the shorter 
working distance, higher power lenses.
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ATP levels in fluid from cystic cpk/cpk kidneys
Previous studies have demonstrated measurable levels o f nucleotides such as ATP, within 
fluid extracted from the lumen o f the large cysts found in human ADPKD [Wilson et al., 
1999]. The presence o f nucleotides within the cysts o f murine models o f polycystic kidney 
disease has not been described, although higher levels o f ATP can be measured in 
conditioned media from monolayers o f cyst epithelial cells, than from normal cortical 
epithelial cell monolayers [Schwiebert et al., 2001]. Hence, I sought the presence o f ATP 
in ‘cyst fluid’ in the cpk/cpk mouse kidney. The size o f these cysts made it impossible to 
sample the fluid o f individual cysts, without destruction o f surrounding tissues using 
facilities available at the time: I collected the fluid that oozed from the cut surface on 
initial, sterile puncture o f the 3 week old cystic kidneys. The unavoidable damage o f tissue 
during this process will lead to release o f some cellular ATP, but also hydrolysing 
ATPases, which were not inhibited in this study, and hence the quantitative results may 
not be an accurate reflection o f levels within the intact cysts.
Using the bioluminescence assay as described in the methods, luminescence readings were
made in duplicate for ten animals. As a ‘blank’ in each case, fluid was pre-treated with
apyrase, an ATP hydrolysing enzyme: the difference in luminescence between these two
readings was then converted into ATP concentration using the calibration curve. ATP
standards were analysed in the same way as fluid samples and a calibration curve
produced on a logarithmic-logarithmic scale using Excel. The concentration o f  ATP in
cyst fluid extracted from cystic kidneys is shown in Figure 33: in one sample this was
below the range o f sensitivity o f this assay, designed to detect levels down to 10"12 M, but
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the remaining 9 samples all contained detectable levels in the nanomolar range, between 
0.3 and 15.0 nM (Fig. 33). Variation in readings may be due to differences in the 
extraction and storage o f fluid samples: immediate freezing o f fluid may reduce the 
hydrolysis o f ATP by hydrolysing enzymes, whereas repeat freeze-thawing reduced ATP 
levels.
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Figure 30. Light microscopy of cpk/cpk cysts growing in 3 dimensional 
suspension culture
Three week old cpk/cpk kidneys, and those from phenotypically normal 
littermates (+ /+  or cpk/+) were dissociated as described in text. A  & C. 
Dissociated phenotypically normal kidneys (A) and cpk/cpk kidneys (C) in 
suspension contain single cells, small aggregates and short tubule segments, 
with no cysts at time zero. B. The culture from phenotypically normal kidneys 
demonstrated little morphological change after 24 hours, with larger 
aggregates and occasional cysts. D. Representative field from a cpk/cpk 
culture, demonstrating larger cell aggregates and multiple cysts after 24 hours. 
E. At higher power individual epithelial cells comprising the cyst wall can be 
seen, and the central aggregate associated with 5 separate cysts. Bar is 200 pm  
in A  - D, and 100 pm in E.
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Figure 30. Light microscopy of cpk/cpk cysts growing in 3 dimensional 
suspension culture
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Figure 31. Expression of P2X7 in phenotypically normal kidneys and 
cpk/cpk kidneys in vivo and in vitro as detected by RT-PCR
cDNA was prepared from total RNA extracted from kidneys or suspension 
cultures, and RT-PCR performed with (lanes 1, 3, 5 and 7) or without (lanes 2, 
4, 6) reverse transcriptase. In lane 7 cDNA was substituted with water. Lanes 1 
and 2 contained cDNA from a phenotypically normal 3 week old kidneys, lanes 
3 and 4, cDNA from 3 week old cpk/cpk kidney and lanes 5 and 6, cDNA from 
cpk/cpk suspension cultures after 24 hours. A 230 base pair (bp) PCR product 
was detected using total RNA from normal littermate (+/+ or +/cpk) (lane 1) 
and cystic cpk/cpk 3 week old kidneys (lane 3 ), and RNA from 24 hour cpk/cpk 
suspension cultures (lane 5). Lane 8 is a 123 bp marker lane (lowest band 
showing 123 bp). The result shown was similar in three experiments performed 
with different samples from the same experimental conditions.
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Figure 32. P2X7 immunofluorescence o f cpk/cpk cysts growing in 3D 
suspension culture
Three week old cpk/cpk kidneys dissociated as described in text. A. Both large 
cellular aggregates (Ag) and cysts (Cy) demonstrated positive P2X7 
immunofluorescence, using confocal microscopy to visualise FITC-bound 
secondary to the P2X7 antibody. Images were taken with a x 20 objective, then 
magnified using confocal software. B. Pre-reaction o f the antibody with excess 
immunising peptide reduced the signal significantly. Bar is 70 pm.
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Figure 33. ATP concentration in cpk/cpk kidney cyst fluid
ATP concentration o f fluid harvested from 3 week old cpk/cpk kidneys was 
measured using a bioluminescent assay. Serial dilutions o f ATP from 10"4 M 
was used to produce a standard curve as shown on this logarithmic- 
logarithmic scale. O f the ten samples analysed, ATP content o f one fell 
below the sensitivity o f this assay (10'l2M), the remaining 9 falling between 
0.3 and 15.0 nM. Dotted lines represent average o f duplicate luminescent 
readings, corrected for background after hydrolysis with apyrase, for each of 
ten samples.
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Effects of a P2X7 agonist on cyst growth in vitro
Having established the expression o f P2X7 in the cysts grown in suspension culture, and 
the fact that ATP was apparently present in cyst fluid in vivo, the next aim o f my study 
was to investigate the potential role o f the receptor in the development o f these cysts using 
the in vitro model. The dissociation o f each pair o f 3 week old kidneys provided sufficient 
dissociated tissue, plated at a starting density o f 20 -  30 x 104 cells per ml, for up to 12 
wells for each experiment. Each experiment included duplicate conditions, all conditions 
tested in each animal, hence enabling paired analyses o f both mean cyst numbers and 
cross-sectional area per field photographed in each condition.
Cyst numbers and size were found to vary between animals, between littermates, and also 
between groups o f experiments. The fact that the differing conditions in any experiment 
were tested on each individual animal enabled paired data to be analysed. In addition to 
paired t-tests, statistical analysis o f these results using multilevel modelling (ML WiN 
1.10) o f all experiments together was used, enabling analysis o f the results o f experiments 
with several variables, for example doses o f agonist or antagonist, and allowing for inter­
animal variation.
BzATP is a non-hydrolysable analogue o f ATP, more potent at the P2X7 receptor than 
ATP or other nucleotides, with lesser effects at other P2X receptors, and is therefore often 
used to discern specific P2X7 affects [North and Surprenant, 2000]. The exposure of 
cultures from cystic mice, to doses o f BzATP between 0 and 200 pM resulted in a
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significant reduction in the numbers o f cysts formed at 24 hours. Higher doses were not 
used, because in preliminary studies they tended to cause non-specific reduction in cell 
viability. Use o f paired t-tests initially, demonstrated the significance o f this BzATP- 
induced reduction in cyst number at 24 hours. Analysis o f all experiments together, using 
multilevel modelling o f logged data, confirmed a significant reduction o f cyst numbers in 
response to 24 hour exposure to increasing doses o f  BzATP: on average, cyst numbers fell 
exponentially by 0.38 % for each 1 pM rise in BzATP (p < 0.0001, 95% confidence 
interval (Cl): 0.25 -  0.40 % fall). Hence, exposure to 100 pM BzATP gave a mean 
reduction in cyst number, o f 32.2 %. Figure 34 shows mean changes in cyst numbers in 
individual experiments represented as lines (Fig. 34A), the log-transformed data, as used 
in the multilevel model statistical analysis, shown in Figure 34B.
The same software (Scion, USA) was used to analyse the cross-sectional area o f cysts, 
taken as a marker o f cyst size. There was no significant difference in mean cyst size with 
increasing doses o f BzATP (p = 0.072), the mean cyst size for individual animals 
represented as separate points in Figure 35.
Effects of a P2X7 inhibitor agonist on BzATP-induced reduction in cyst 
numbers
In order to support the role o f P2X7 in the BzATP-induced reduction in cyst numbers after 
24 hours, I repeated the exposure o f cultures from cystic mice to high doses o f the P2X7 
agonist, with or without prior incubation for 1 hour with 100 pM oxidised ATP (oATP),
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an inhibitor o f  the P2X7 receptor [Murgia et al., 1993]. This group o f experiments 
included one hour pre-incubation after cpk/cpk kidney dissociation, and prior to plating 
suspensions into wells, all under standard culture conditions. Using the multilevel model 
o f statistical analysis, these data can be compared to the previous set o f experiments. The 
mean cyst numbers in this set o f experiments were on average 105 % higher than in the 
earlier dose response studies (p = 0.0028, 95% Cl: 28 -  228 %), possibly due in part to the 
lag time between dissociation and plating with agonists. Oxidised ATP is toxic to various 
cell types if  applied for long time periods [Craighead et al., 2001], and was therefore 
applied for one hour and washed off prior to plating.
Oxidised ATP itself did not significantly reduce the average cyst number in these 
experiments, starting counts falling by 9 % (p = 0.42, 95 % Cl: - 30 % - + 15 %). 
However, with oATP, reduction in cyst number induced by BzATP was ameliorated: 
Figure 36A shows mean cyst numbers in each condition (n = 4), expressed as percentage 
of the number present after 24 hours in control conditions, i.e. without BzATP or oATP. 
Using paired t-tests to analyse these experiments, there was a significant reduction o f cyst 
number in response to lOOpM BzATP (40 %, p = 0.01, 95 % Cl 18 -  62 %) and 200 pM 
BzATP (52 %, p = 0.033, 95 % Cl 8 -  97 %), in the absence o f oATP. The effect o f the 
BzATP after pre-incubation with the inhibitor oATP was reduced: 100 pM BzATP did not 
cause a statistically significant change in cyst number (8 % reduction, p = 0.14) whereas 
200 pM BzATP caused a significant, but smaller reduction in cyst number (19 %, p = 
0.047, 95 % Cl 4 -  37 %) than when applied without oATP.
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Additional analysis o f the data using multilevel modelling o f log-transformed data, 
confirmed the significance o f this effect, data expressed as the exponential change in cyst 
number per dose change. After pre-treatment with 100 pM oATP, the BzATP-induced 
reduction o f cyst numbers after 24 hours was significantly decreased, by 0.11% per pM 
increase in BzATP (p = 0.00074, 95 % Cl: -0.05 % - + 0.27 %), compared with the cyst 
number reduction seen after BzATP treatment alone (0.38% per pM increase in BzATP; p 
< 0.0001, 95% Cl: 0.25 -  0.40%). Logged data is shown in Figure 36B and C, 
experiments with BzATP shown as lines (Fig. 36B), and the same animal experiments pre­
treated with oATP shown as dotted lines (Fig. 36C). This significant decrease in the 
BzATP-induced reduction in cyst numbers using oATP is supportive o f the role o f P2X7 
in this effect.
Comparison of effects of BzATP on cyst growth with effects of ATP or UTP
The use o f BzATP as a potent agonist o f the P2X7 receptor and additional studies in which 
the biological effect o f BzATP was blocked partially by oATP, provide support for a role 
o f P2X7 in cyst development, although it is possible that other P2 receptors may in part 
mediate the response. Although other groups have found evidence for expression o f P2Yi 
and P2Y2 mRNA in the cpk/cpk mouse using specific primers, their investigation o f P2X 
expression, based on the use o f degenerate primers, suggested P2X3 and P2X4 mRNA 
expression only [Schwiebert et al., 2001]. In preliminary studies, I have identified mRNA 
expression o f P2X4 and P2X5 in addition to P2X7 in the cpk/cpk in vitro system using RT- 
PCR (data not shown).
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In order to investigate whether the BzATP-induced reduction in cyst numbers involves the 
activity o f other P2 receptors, I compared the effect o f  100 pM BzATP on cyst growth, to 
the effects o f the same doses o f other nucleotides. There are to date no specific agonists or 
antagonists o f the P2 receptors, and therefore the profile o f nucleotide responses is often 
used to determine which receptor has predominant functional effect [Khakh et al., 
2001;North and Surprenant, 2000]. P2X7 responds to nucleotides with the following 
potency profile: BzATP »  ATP >2-MeSATP > ATPyS »  ADP, with no response to 
UTP, a P2Y agonist [Surprenant et al., 1996]. BzATP may induce other P2X receptor 
responses, but a greater affect o f this agonist than ATP is suggestive o f P2X7 activity. ATP 
activates all purinergic receptors with variable potency, whereas UTP induces P2Y effects 
[Khakh et al., 2001].
Using paired t-tests, cyst numbers after 24 hour treatment with 100 pM ATP or UTP, were 
compared with the result with 100 pM BzATP. In this set o f experiments (n = 6 ), there 
was an average 44 % reduction in cyst numbers after exposure to 100 pM BzATP (p = 
0.0008, 95 % Cl 28 -  60 %). 100 pM ATP did cause a significant reduction in cyst 
numbers (17 %, p = 0.0025, 95 % Cl 9 -  25 %), but this was also significantly smaller 
than the response to equimolar BzATP (p = 0.0006). 100 pM UTP, a P2Y agonist, had no 
significant effect on cyst number (p = 0.06). Raw data is shown in Figure 37A, individual 
points representing mean values for an individual animal, overall mean shown as a 
horizontal line.
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Analysis o f the cross-sectional area o f cysts grown in the presence o f different agonists are 
shown in Figure 37B, cyst area being unaffected by these nucleotides. Using paired t-tests 
to analyse this data, ATP and UTP had no significant effect on cyst size (ATP; p = 0.61, 
UTP; p = 0.53). 100 pM BzATP appeared to cause a small reduction in cyst size in this 
small number o f experiments (14 %, p = 0.033, 95 % Cl 2- 27 %) but re-analysis using 
multilevel modelling, to compare all experiments performed, did not confirm a significant 
effect (p = 0.072). In both graphs the dots represent the mean result for an individual 
animal with different agonists, a line representing the overall mean for that treatment.
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Figure 34. Effects o f increasing doses o f BzATP on cyst number in vitro
Suspension cyst cultures prepared from dissociated 3 week old cpk/cpk 
kidneys were incubated for 24 hours with a range of BzATP concentrations, 
and mean cyst number per photographed field, calculated using Scion 
software. A. Cyst number fell significantly with increasing doses o f BzATP 
( 0.38% per 1 pM BzATP, p < 0.0001), using multilevel modelling o f logged 
data (B). Each line represents mean data for suspension cultures from a single 
animal.
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Figure 35. Lack o f effect of increasing doses of BzATP on cyst size in vitro
Suspension cyst cultures prepared from dissociated 3 week old cpk/cpk kidneys 
were incubated for 24 hours with a range of BzATP concentrations and cyst 
cross-sectional area measured for each counted cyst, using Scion software. 
Mean cyst size, as assessed by cross-sectional area was not affected by BzATP 
(p = 0.072).
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Figure 36. Oxidised ATP reduces effect of BzATP on cyst growth in vitro
Suspension cultures prepared from dissociated 3 week old cpk/cpk kidneys were 
incubated for 24 hours with 0 ,100  or 200 pM BzATP, with or without 100 pM  
oATP. A. Mean cyst number per photographed field in each condition is shown, as 
a percentage o f  the control i.e. mean cyst numbers in the absence o f  either BzATP 
or oATP, and statistical analysis using paired t-tests. Black bars represent 
experiments without oATP and dotted bars those with oATP (n = 4). Exposure to 
BzATP alone caused significant reduction in cyst numbers, as previously (100 pM: 
40.2 %, *p = 0.01; 200 pM: 52.3 %, *p = 0.03). Pre-treatment with oATP caused a 
non-significant reduction in cyst numbers (15.8 %  p =  0.22). There was no 
significant change in cyst numbers in response to 100 pM BzATP after pre­
incubation with oATP (8.0 %, p = 0.14), and the response to 200 pM BzATP after 
oATP pre-treatment, reduction in cyst number was smaller than with 200 pM  
BzATP alone (18.6 %, *p = 0.047). B. Data was also analysed using the multilevel 
model o f  logged data, shown here as individual experiments. Full lines represent 
log results o f  experiments without oATP, and C. dotted lines represent experiments 
in which cultures were pre-incubated for one hour with oATP. The BzATP-induced 
reduction in cyst number was significantly smaller after treatment with oATP (0.27 
% versus 0.38% per pM increase in BzATP, p = 0.00074), supporting an inhibition 
o f  a P2X7 receptor-mediated effect.
224
A 1coo
»*-o
d
a>-Q
E
(0>»o
p =  0 . 0 1
*  p  =  0 . 0 3
*  p <  0 . 0 5
I
100 
BzATP (^M)
200
B
2
<D«=
k.5
3  1
L _
©-O
E
CO
a
O)O
100 200 0 100 200
Figure 36. Oxidised ATP reduces effect o f BzATP on cyst growth in vitro
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Figure 37. Comparison of effect of different nucleotides on cysts in vitro
Suspension cyst cultures prepared from dissociated 3 week old cpk/cpk 
kidneys were incubated with 100 pM BzATP, ATP or UTP. Mean cyst 
number and cross-sectional area after 24 hours were assessed per 
photographed field for each agonist and compared using paired t-tests. A. 
100 pM BzATP significantly reduced cyst number (44 %, **p = 0.0008). 
Exposure to 100 pM ATP caused a statistically significant reduction in cyst 
number (17 %, *p = 0.0025), which was significantly less than the BzATP 
effect (p =  0.0006). 100 pM UTP had no significant effect on cyst number 
(p =  0.06). B. None o f the nucleotides had a significant effect on cyst cross- 
sectional area (BzATP; p = 0.072, ATP; p = 0.61, UTP; p = 0.53). Dots 
represent individual animal means, with overall means shown as a line.
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Figure 37. Comparison o f different nucleotides on cysts in vitro
227
Assessment o f cell proliferation and death in cpk/cpk cyst cultures
Since P2X7 induces apoptosis and proliferation in many cell types [Baricordi et al., 
1999;Chiozzi et al., 1996;Coutinho-Silva et al., 1999;Ferrari et al., 1997a;Harada et al., 
2000;Schulze-Lohoff et al., 1998], I investigated whether changes in cell turnover might 
explain the BzATP-induced reduction in cyst growth in this 3D suspension system. I 
aimed to assess which, if  any cells in the suspension culture system, undergo cell turnover 
in control and treated conditions, and also to perform quantitative analysis o f markers o f  
proliferation or cell death in these experiments. Visualisation o f  specific cell types 
undergoing death in these 3D suspension cultures was limited by the difficulty in fixing 
and staining samples. I was therefore not able to perform systematic or quantitative 
analysis o f apoptotic markers in these samples. The biochemical assessment o f  
proliferation and cell death was performed on the tissue centrifuged at the end o f the 
incubation period, and therefore represents changes in the whole culture population, not 
exclusively the cystic structures.
As an initial assessment o f the effect o f BzATP on cell turnover, I counted the number o f
viable cells present after 24 hours with or without 100 pM BzATP. In all experiments, the
starting density for each condition was the 20 x 104 per ml. At the end o f the incubation
period, aliquots o f the suspension cultures were taken from control and experimental
wells, and samples trypsinised until single cells could be counted using a haemocytometer.
There was no significant difference (p = 0.79) between the mean density o f  cells in
cultures exposed to 100 pM BzATP, compared with controls (22 x 104 / ml (± 1) versus
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22 x 104 / ml (± 1), analysing 5 experiments performed on the offspring o f 2 litters on the 
same experimental day (Table 4), using paired t-test.
Visualisation of apoptosis in cpk/cpk cyst cultures
Although apoptosis is well-documented in the cpk/cpk mouse in vivo [Ali et al., 
2000;Winyard et al., 1996a], mostly in the interstitium, as described in this study, it has 
not been shown in the in vitro model. Ideally, visualisation o f dying cells using markers of 
apoptosis, would be undertaken using fixed samples o f the in vitro material, thereby 
facilitating quantitative assessment o f apoptosis in these experiments. Limitation o f  
immunocytochemistry described earlier, precluded such quantitative analysis. However, 
staining using propidium iodide to visualise nuclei and FITC-phalloidin to label the F- 
actin o f the cytoskeleton, allowed assessment o f cells with an apoptotic phenotype. 
Pyknotic, small dense nuclei, suggestive o f cells undergoing apoptotic cell death were 
visualised frequently within the cell aggregates, but rarely within the epithelial cystic 
structures (Fig. 38). In the future, with improved methods o f  immunocytochemical 
processing, levels o f apoptosis, for example using TUNEL, would be assessed in 
individual cell types.
Biochemical assessment of cell death in cpk/cpk cyst cultures
The following biochemical methods were all carried out on extracts o f protein or culture
medium taken from the whole culture population. The measurements therefore represent
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an integrated result derived from all cell types within the suspension culture. Analysis was 
performed on extracts from identical conditions, in 5 -  9 experiments. Each therefore had 
an intrinsic control and paired data was analysed using students’ t-tests.
Analysis o f necrotic cell death was based on LDH levels in the culture medium after 24 
hours: LDH is released as cells undergo necrosis and subsequent lysis, releasing cytosolic 
enzymes. The amount present in medium depends in part on the cell density, and to 
standardise between experiments, each value was expressed as the percentage o f the total 
amount o f LDH released after permeabilising the same suspension volume with triton X- 
100 for 15 minutes. Levels o f LDH released in all conditions were high (39 -  45 %), 
probably reflecting the significant amount o f cellular damage occurring during the 
harvesting and dissociation procedure. There was, however, no significant difference 
between the LDH release after exposure to 100 pM BzATP for 24 hours (46 % (± 4)) (p = 
0.55), or BzATP after pre-treatment with 100 pM oATP (39 %  (± 4)) (p = 0.94), 
compared with controls (42 % (± 4)) (Table 4).
Quantitative analysis o f apoptosis was undertaken by measuring caspase-3 activity within 
protein extracts from suspensions harvested at 24 hours. Activation o f this enzyme has 
been documented in P2X7-mediated apoptotic cell death in other cell types [Ferrari et al., 
1999a;Humphreys et al., 2000;Solini et al., 2000;Wen et al., 2003]. Initial attempts to 
identify the inactive or active, cleaved forms o f this enzyme using western blot were 
unsuccessful, possibly due to the small amounts o f  protein available for investigation, and 
low levels o f enzyme present, and I therefore used a colorimetric activity assay. Activity 
of the enzyme in protein extracted from control and treated suspension cultures after 24
230
hours was measured using the assay kit described in the methods, utilising the ability o f  
the enzyme to cleave the colorimetric substrate Ac-DEVD-pNA. Data was collected as the 
changes in optical density at 405 nm with time, over 3 hours, the rate o f change in OD 
being proportional to pNA cleavage and hence enzyme activity. Examples o f data from a 
representative cpk/cpk culture, and from 30 units o f the human recombinant caspase-3 are 
shown (Fig. 39 A & B), with the equation and R2 value o f  the line o f best fit as shown. In 
all cases tested, including those shown, the addition o f 200 pM Ac-DEVD-CHO, a 
caspase inhibitor, prior to addition o f substrate resulted in dramatic reduction o f the 
activity measured, demonstrating the specificity o f this assay (Fig. 39).
The activity o f caspase-3 in protein extracts form control conditions was 0.30 (+/- 0.07) 
units per pg. There was no significant difference in activity levels after treatment with 100 
pM BzATP for 24 hours (0.63 (± 0.22) units per pg) (p = 0.08) despite the increased 
trend, or after treatment with 100 pM BzATP in the presence o f 100 pM oATP (0.33 (± 
0.07) units per pg) (p = 0.26), (Table 4). Results are the mean o f nine experiments (± SE).
Inhibition of caspase in cpk/cpk cyst cultures
Although I could not demonstrate a significant change in caspase-3 activity in response to 
BzATP, it is possible that caspase-3 independent apoptosis may be induced. Further study 
of the importance o f other members o f the caspase family in the BzATP-mediated 
reduction in cyst development was undertaken using a non-specific inhibitor o f  this family 
o f enzymes. zVAD-fmk is a cell permeable, irreversible pan-caspase inhibitor, functioning
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by the blockade o f processing o f caspase 3 to its active form [Zhu et al., 1995]. The effect 
o f 100 pM BzATP on the number o f cysts after 24 hours was measured as above, samples 
being treated, in addition, with 100 pM zVAD-fmk. The drug vehicle, DMSO, was used 
in equal volumes in all conditions tested, and did not alone affect cyst growth at this dose 
(data not shown). The reduction in cyst numbers caused by BzATP was not significantly 
affected by the use o f zVAD-fmk, as shown in Figure 40. Full lines represent logged data 
of experiments performed without zVAD-fmk (Fig. 40A) and dotted lines, experiments 
prepared from the same animals, pre-treated with zVAD-fmk (Fig. 40B). Statistical 
analysis o f the data using multilevel modelling, in order to compare these experiments to 
the whole group o f experiments, revealed no significant difference between cyst reduction 
without, or with zVAD-fmk (mean change in exponential fall: 0.14% per pM increase 
BzATP, p = 0.42, 95% Cl: - 0.49 to + 0.20%). I did not confirm the inhibition o f caspase 
activity after treatment with zVAD-fink in this experimental protocol, but would perform 
this in future experiments. However, a relatively high dose o f the inhibitor was used.
Biochemical assessment of proliferation in cpk/cpk cyst cultures
The role o f proliferation in BzATP-induced reduction o f cyst numbers in the cpk/cpk in 
vitro system was investigated by measuring changes in the proliferating cell nuclear 
antigen (PCNA). This human DNA-polymerase 8 associated protein is expressed at high 
levels during S phase [Bravo et al., 1987]. Protein was extracted from control wells and 
those exposed to 100 pM BzATP for 24 hours with or without 100 pM oATP as described 
in other experiments. Western blot using the anti-human PCNA antibody was performed
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for five different experiments, the density o f the protein band then standardised against the 
‘housekeeper’ protein P-actin (Fig. 41 A). Mean relative density o f the PCNA band 
detected, versus p-actin for each condition is shown as a bar chart (Fig. 4 IB), data 
expressed as a percentage o f the expression under control conditions, i.e. without added 
BzATP or oATP. The mean level o f PCNA: p-actin expression, as measured using 
densitometry, was not significantly different between control (taken as 100%) and cultures 
exposed to 100 pM BzATP (122 % (± 47) (p = 0.58), or those exposed to both 100 pM 
BzATP and oATP (89 % (± 23) (p = 0.41) (Table 4).
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Figure 38. Apoptotic nuclei in aggregates o f cpk/cpk cells growing in 3 
dimensional suspension culture
Three week old cpk/cpk kidneys dissociated as described in text.
Propidium iodide-stained, dense red pyknotic nuclei, with morphological 
appearance o f apoptotic death, are seen within cell aggregates (-») but 
rarely within cyst epithelia. Counterstaining with green fluorescent FITC- 
phalloidin shows cytoskeletal F-actin, for visualization of cystic structures. 
Bar is 50 pm.
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Figure 39. Caspase-3 activity in a representative cpk/cpk culture and human 
recombinant caspase-3 standard
Caspase-3 activity in protein extracted from cpk/cpk cultures after the 24 hour 
incubation was measured using colorimetric cleavage o f  Ac-DEVD-pNA. 
Increasing optical density o f  cleaved pN A  at 405 nm with time is proportional to 
the rate o f  substrate cleavage, and thus caspase-3 activity levels. A. 
Representative trendline o f  OD with time in a cpk/cpk culture extract is shown as 
a full line, and the same sample treated with caspase-3 inhibitor, Ac-DEVD-CHO  
(200 pM), shown as a dotted line. The R2 value and equation o f  the line o f  best 
fit is shown, from which enzyme activity is extrapolated. Measurable increases in 
OD with time were inhibited by the specific caspase-3 inhibitor. B. 
Representative readings from 30 units o f  recombinant human caspase-3 shown as 
a full line, with the ability to inhibit this activity with 200 pM Ac-DEVD-CHO  
shown in the dotted line.
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Figure 39. Caspase-3 activity in a representative cpk/cpk culture and 
human recombinant caspase-3 standard
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Figure 40. Effect o f zVAD-fmk on BzATP-induced cyst reduction
cpk/cpk suspension cultures, prepared as in other experiments were exposed 
to 100 pM BzATP for 24 hours, with or without pre-incubation with 100 
pM zVAD-fmk to inhibit caspase activity. The effects on cyst number in 
each case, in three individual animal experiments, are shown as lines A. Full 
lines represent experiments in the absence of inhibitor, and B. dotted lines 
represent results after inhibition of caspases with zVAD-fmk. There was no 
significant alteration of BzATP-related cyst reduction after zVAD-fmk 
treatment (p = 0.42).
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Figure 41. Western blot detection of PCNA protein in cpk/cpk suspension cultures
Protein extracts from tissue pellets harvested after 24 hours in culture were probed for 
PCNA (32 kDa) and then the housekeeping protein P-actin (40 kDa). A. A blot 
showing three separate experiments ( 1 - 3 )  exposed to the following conditions, a: 
control (i.e. 0 pM BzATP added), b: treatment with 100 pM BzATP alone, and c: 100 
pM BzATP after incubation with 100 pM oATP (c). B. Mean relative density o f the 
PCNA signal from five experiments, corrected for p-actin to control for protein load, 
and expressed as a fraction of the control expression, is shown as a bar chart (+ SE). 
There was no statistical difference in PCNA expression in these experiments (p = 
0.58).
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OpM BzATP 100 pM BzATP
100 pM BzATP 
100 pM oATP
Viable cell number 
( x  104 /  ml)
22 (± 1.1) 22 (±1 .1)
LDH released 
(%  o f  maximal)
42 (± 4) 45 (± 2 ) 39 (± 4)
Caspase-3 activity 
(units per pg protein)
0.29 (± 0.07) 0.63 (± 0.22) 0.33 (± 0.07)
PCNA expression 
(% o f  control)
100 122 (± 47) 89 (± 23)
Table 4. M arkers o f cell proliferation and death in cpk/cpk  cyst cultures
Tissue and media were harvested from 3D cpk/cpk suspension cultures after 24 
hours, treated either under control conditions i.e. 0 pM BzATP added, with 100 pM 
BzATP alone, or 100 pM BzATP after pre-treatment with 100 pM inhibitor oATP. 
Results are represented as the mean (±SE). Viable cell number, counted using a 
haemocytometer, were no different at 24 hours (n =  5, p = 0.79). LDH levels in 
culture medium at 24 hours, expressed as %  o f  maximal released by permeabilising 
cells with triton X-100, were high in all cases but not significantly different (n = 5, 
p =  0.55). Caspase-3 activity per pg protein was not significantly increased (p =  
0.081), despite a trend upwards (n = 9). Treatment with BzATP did not 
significantly alter proliferation rates, as assessed by western blot for PCNA, 
standardised against p-actin and expressed as % o f  control (n = 5, p = 0.58).
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Summary
Using 3D suspension culture o f cysts from 3 week old cpk/cpk mouse kidneys, I found 
that
• Tissue from the cpk/cpk kidneys cultured in suspension for 24 hours express P2X7 
mRNA and protein.
• ATP was detected in fluid harvested from the cpk/cpk kidneys.
•  Exposure to BzATP, a potent P2X7 agonist, caused a significant reduction in 
numbers o f cysts after 24 hours, which was partially blocked by the inhibitor 
oATP.
• The same dose o f ATP caused a smaller reduction in cyst numbers, and UTP did 
not cause a reduction, suggesting that other P2X or P2Y receptors do not play a 
major role in the BzATP-induced reduction in cyst number.
•  BzATP did not affect mean cyst cross-sectional area, suggesting no major effect on 
trans-epithelial fluid shift into the cyst lumen.
• Apoptotic appearing nuclei were detected in cell aggregates in suspension cultures, 
but not in the cyst epithelia.
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• Overall cell numbers, counted after 24 hours, and proliferation, as assessed by 
PCNA western blot, were not significantly affected by treatment o f suspension 
cultures with 100 pM BzATP.
• Necrosis rate, as assessed by LDH release into media was not affected by exposure 
to 100 pM BzATP.
• Caspase-3 activity in protein extracts o f cpk/cpk cultures, showed an increased 
trend after treatment with 100 pM BzATP, which did not reach statistical 
significance. In addition, the pan-caspase inhibitor, zVAD-fmk made no difference 
to the BzATP-induced reduction in cyst numbers, suggesting that caspase- 
dependent apoptosis was not an important mediator o f this effect.
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Chapter 9. Results -  Investigation of P2X7 receptor function 
using stable transfection into DT40 cells
Stable transfection of the DT40 cell line
The clones used in my thesis were transfected prior to my work by Professor S Moss. A 
number o f stable clones were produced by a single transfection experiment, using the 
electroporation method as described. The rat P2X7 cDNA inserted was a gift from Dr Gary 
Buell.
Clones were selected initially by neomycin (G418) resistance and subsequently confirmed 
by their responses to ATP. During the course o f the studies described in this thesis, the 
DT40 cells, both wild-type and transfected became increasingly unreliable for use in 
physiological experiments, with wide fluctuation seen in both baseline calcium handling 
and apoptosis rates. Several factors were proposed as mediators o f this decline in baseline 
characteristics o f the cells, for example changes in storage techniques and altering sources 
of fetal calf and chicken serum. The latter made it difficult to perform a further round o f  
transfection to produce healthier clones for the completion o f these studies.
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Expression o f P2X7 protein in transfected DT40 clones
Following selection o f clones, expression o f P2X7 protein by these cell lines was 
confirmed using western blot. A representative membrane is shown, the bands visualised 
using western blue substrate as described in the methods (Fig. 42). A major band o f  
approximately 75 kDa was revealed in the P2X7-transfected clone (lane 2) but was absent 
in both wild-type and vector-only transfected lines (lanes 1 and 3 respectively).
Calcium signalling in P2X7- transfected DT40 clones
The first demonstration o f functional expression o f the P2X7 receptor in the transfected 
clones was the stimulation o f calcium influx into the cells in response to nucleotide 
agonists. Intracellular free calcium was measured ratiometrically using the fura 2/AM as 
described in the Methods. The wild-type DT40 population, when exposed to high 
concentrations o f ATP or the potent P2X7-ligand, BzATP, showed no response in terms of 
calcium levels (Fig. 43). This supports the hypothesis that this cell line does not express 
functional P2X or P2Y receptors. The trace from a representative wild-type experiment is 
shown, with a typical baseline drift (due to slow leak o f the fluorophore): a small fall in 
the fluorescence ratio was seen on addition o f BzATP to non-responding clones in all 
experiments. Treatment o f a P2X7-positive clone with BzATP resulted in a rapid and
sustained rise in intracellular calcium, at doses from 25 pM, with maximal effect at 200 
pM. A typical trace o f the response to 50 pM is shown (Fig. 43). The ratiometric data 
acquired in this assessment o f calcium flux cannot reliably be converted to absolute 
calcium concentrations, and data here is used to demonstrate the presence o f functional 
receptor.
The rise in intracellular calcium demonstrated above was shown to be the result o f rapid 
calcium influx from the extracellular medium, rather than mobilisation o f intracellular 
stores. Chelation o f extracellular calcium in the medium prior to the addition o f nucleotide 
agonists, using 3 mM EGTA, caused an initial drop in fluorescence ratio, as calcium was 
bound to the EGTA, and subsequently abolished the response o f the clone to 50 pM 
BzATP (Fig. 44A). The reproducibility o f these findings was high, the mean and standard 
error o f three such experiments on different occasions shown in Figure 44B. These 
findings demonstrate that the total calcium rise seen in response to BzATP in this cell line 
is a result o f influx across the cell membrane.
Antagonist profile of P2X7- transfected DT40 clones
There is no specific antagonist o f the rat P2X7 receptor to date, and the susceptibility of 
the P2X7 receptor to different antagonists varies between species. The demonstration of 
the ability to block calcium responses in this system is also restricted by the interference 
o f many drugs with the fura 2/AM -  dependent ratiometric measurements. I have used
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oxidised ATP (oATP), a commonly used but not specific, competitive inhibitor o f the 
receptor.
Pre-incubation o f the receptor with oATP for up to an hour is required to allow the 
molecule to bind the receptor: it is thought to allosterically modulate the receptor, hence 
inhibiting ATP or BzATP binding. Treatment o f the transfected clone with 100 pM oATP 
for 1 hour, and replacement with inhibitor-free experimental buffer prior to exposure to 
100 pM BzATP, caused a large reduction in calcium influx seen in response to the agonist 
(Fig. 45). More accurate analysis o f cation influx can be undertaken using the manganese 
quench technique: manganese causes a quench o f fura-2 fluorescence, and hence the fall 
in fluorescence at the isosbestic wavelength is directly proportional to the rate o f  entry of 
manganese into the cell via the non-selective P2X7 cation channel. Data acquired in this 
way can be used to compare more accurately, the effect o f antagonists on initial cation 
influx rate through the channel in response to agonist. The rate o f cation influx in these 
studies was determined by analysis o f the rate o f fall o f fluorescence, or slope o f the time­
line shown in figure 46 (A & B), and is expressed in arbitrary units. The baseline drift, or 
quench was subtracted from each study, using the gradient o f the line prior to addition o f 
the agonist. Pre-incubation o f the clone with 100 pM oATP (green line) caused a 
reduction in gradient seen in response to 100 pM BzATP (red line), and almost no cation 
influx was seen after treatment with 300 pM oATP (light blue line) (Fig. 46A). Data 
represents the mean and standard error o f 3 experiments in each case. The analysis o f  
reduction in slope, or cation influx rate is shown as a bar chart (Fig. 46C): the response to 
100 pM BzATP is shown in lane 1, and the same agonist response after pre-treatment with 
100 pM oATP in lane 2, and 300 pM oATP in lane 3. Oxidised ATP caused a significant
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reduction in cation influx rate in response to 100 pM BzATP; 86.1 % at 100 pM and 96.9 
% at 300 pM (Fig. 46C).
A similar experiment was performed comparing the response to 100 pM BzATP with and 
without the P2X7 antagonist calmidazolium. A reduction in cation influx was seen after 
addition o f  400 nm calmidazolium prior to agonist, the mean o f three experiments shown 
(Fig. 46B), and this is shown graphically in Figure 46C. Calmidazolium caused 
approximately 68.2 % reduction in initial cation influx rate in response to 100 pM BzATP.
Pore activity of P2X7 receptor in transfected DT40 clones
In addition to the cation channel properties o f the receptor in this expression system, I 
investigated the ability o f the P2X7 receptor to form a membrane pore. This physical 
property o f the P2X7 receptor is not fully understood and appears to be dependent on cell 
type and species. Membrane permeabilising pores have been described in many cell types, 
admitting molecules up to 900 Da in the most extreme cases. The entry o f a smaller 
molecule, ethidium bromide (314 Da), has been used in this thesis, utilising the 
fluorescence changes o f the molecule on entry into cells and subsequent nucleic acid 
binding. Fluorescence measurements against time were recorded, the baseline situation 
revealing a small upward trend in fluorescence, presumably as cellular nucleic acids come 
into contact with ethidium bromide, as cells are damaged or die. Representative traces are 
shown in Figure 47A. The addition o f 100 pM BzATP to the wild-type DT40 caused a 
small quenching o f fluorescence, but no change in the change o f fluorescence with time;
there was no evidence o f ethidium bromide entry across the cell membrane (Fig. 47A). All 
data is presented as the fraction o f the total ethidium bromide fluorescence o f the cell 
population after permeabilsation with digitonin, therefore allowing for any differences in 
cell numbers between experiments. The P2X7-expressing clone, when stimulated with 100 
pM BzATP, demonstrated a small increase in fluorescence with time (approximately 5 -  
10 % o f total in 300 seconds) (Fig. 47A), and the reduction o f this response by pre­
incubating cells with 100 pM oATP supports the role o f P2X7 in this, albeit small 
response (Fig. 47 A). Reproducibility o f these findings was dependent on ‘healthy’ clones, 
background increase in fluorescence dominating the traces if  cells exhibited poor viability. 
The response o f the P2X7-expressing clone to a higher dose o f  BzATP (200 pM) was not 
significantly greater than the effect o f 100 pM, data shown as the mean o f three 
experiment with standard error (Fig. 47B).
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Figure 42. Western blot P2X7 protein detection in transfected DT40 clone
A representative result from three experiments, using polyclonal rabbit anti-rat 
P2X7 antibody. A major 75 kDa band was detected in a P2X7 - transfected clone 
(lane 2), but was absent in both wild-type (lane 1) and vector-only transfected clone 
(lane 3). Pre-stained molecular weight markers are shown in lane M for 
comparison, bands visualised by reaction with western blue substrate as described 
in methods.
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Figure 43. Intracellular calcium measurements in DT40 cells in 
response to BzATP
Intracellular free calcium of populations o f wild-type and P2X7- 
expressing DT40 cells, prepared as described in methods, was measured 
ratiometrically with Fura 2/AM in the presence of extracellular calcium. 
Baseline drift is shown in blue, response o f a P2X7-expressing clone to 
50 pM BzATP (>I ) added at 100 seconds in red and the lack of response 
o f wild-type cells shown in green. Note a small reduction in fura 2 
fluorescence in the wild-type DT40, a consequence of BzATP-related 
quenching.
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Figure 44. Calcium measurements in P2X7-expressing DT40 in the 
absence of extracellular calcium
A: A representative trace of changes in intracellular calcium with time, 
measured ratiometrically with fura-2 as described. Baseline drift is shown 
in blue, and response to 50 pm BzATP added at 100 seconds, in red. 
Chelation of extracellular calcium by addition of 3 mM EGTA at 50 
seconds abolishes the rise in intracellular calcium in response to 50 pM 
BzATP. B: Mean o f 3 experiments on different occasions (± SE) shows the 
reproducibility of the findings, the response to 50 pM BzATP with (red) 
and without (green) extracellular calcium.
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Figure 45. Effect of oxidised ATP on intracellular calcium  
measurements in response to BzATP in P2X7-transfected DT40
A representative trace of ratiometric fiira-2 fluorescence changes with 
time, in response to 100 pM BzATP (red), with baseline drift in blue. 
Pre-incubation with oATP for 1 hour, and resuspension in buffer prior 
to measurements of response to 100 mM BzATP, reduces increase in 
intracellular calcium (green).
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Figure 46. M anganese quench demonstration o f cation influx into P2X t~ 
expressing DT40 cells
Populations o f  P2X7-expressing DT40, loaded with fura 2/AM as described.
A: Fluorescence changes were measured, the addition o f  M n’-1' (4<) causing an 
immediate quenching o f  fluorescence o f  any remaining extracellular Fura 2. 
Changes in the rate o f  fall o f  fluorescence with time in response to 100 pM BzATP 
(4<) at 220 seconds, are proportional to the rate o f  cation entry and further M n^- 
dependent quench o f  fluorescence. Baseline drift is shown in blue, response to 100 
pM BzATP alone in red, and the experiment repeated after 1 hour pre-incubation 
with 100 pM (grey) or 300 pM oATP (light blue) . B: The effect o f  400 nm 
calmidazolium (green) added prior to 100 pM BzATP is shown, with baseline and 
response to 100 pM BzATP alone shown as above. Data is standardised to represent 
starting fluorescence, after Mn*4- addition as 1.0 and points represent the mean (± 
SE) o f  3 experiments. C: Change in rate o f  quench o f  fura 2/AM from baseline, 
proportional to cation influx, expressed as arbitrary units for each agonist/agonist 
combination (1: red -1 0 0  pM BzATP alone, 2: green -  100 pM BzATP after 100 
pM oATP, 3: light blue -1 0 0  pM BzATP after 300 pM oATP, 4: grey -  100 pM  
BzATP after 400 nm calmidazolium). Bars represent mean o f  3 experiments (± SE).
252
Figure 46. Manganese quench demonstration of cation influx 
into P2X7-expressing DT40 cells
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Figure 47. Ethidium bromide influx into PlXy-expressing DT40 cells
Increase in fluorescence o f  DT40 cells (as described in methods), after 
equilibration in 25 pM ethidium bromide at 40°C. A: Representative traces o f  
increase in fluorescence with time in P2X7-expressing DT40 in response to 
100 pM BzATP (red) and after treatment with 100 pM oATP (green) as 
described. Baseline drift is shown in blue, and trace from wild-type cells in 
light blue; note small fluorescence quench in response to BzATP itself. B: 
Points represent mean o f  3 experiments carried out on different occasions. 
Blue line shows baseline drift, and response to 100 pM BzATP shown in red 
and 200 pM BzATP in dark blue. Agonists cause a small increase in 
fluorescence, shown as a fraction o f  the maximum induced by digitonin, 
proportional to entry into the cell via a membrane pore, and subsequent 
chelation with intracellular nucleic acids. Data represents the mean o f  3 
experiments, bars show SE.
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Apoptosis o f P2X7 - transfected DT40 clones
The induction o f apoptosis by the P2X7 receptor was initially assessed visually, in 
selection o f the transfected clones. It was noted that the transfected clones underwent high 
rates o f cell death when exposed to BzATP. Wild-type cells exposed to high doses o f ATP 
or BzATP (up to 200 pM) did not undergo cell death: healthy DT40 cells viewed under 
phase contrast exhibit a uniform spherical morphology, and cell death rates are very low if  
cell density is maintained below 10 x 105 per ml. Their appearance at the start o f  
experiments was identical to that 24 hours later (Fig. 48 A & B), and there was no visual 
effect o f high doses o f BzATP (Fig. 48C: 100 pM, 40D: 200 pM) applied for 24 hours. 
The phenotype o f apoptotic DT40 is shown in the positive control experiment, in which 
cells were exposed to 100 nM staurosporin (Fig. 48E).
The P2X7-transfected clones had the same appearance as wild-type DT40 when 
maintained at equivalent density (Fig. 48A). After 24 hours in control experimental 
conditions there was small percentage o f cells with apparent apoptotic phenotype (Fig. 
40B) particularly if  the cells reached densities in excess o f  105 per ml. The effect o f 24 
hour incubation with 100 or 200 pM BzATP was an increase in the proportion o f  cells 
undergoing cell death (Fig. 48 C & D). The positive control experiment, in which 
apoptosis was triggered by 100 nM staurosporin is shown for comparison (Fig. 48E)
In order to quantify the apoptotic response to P2X7 agonists I examined the percentage of  
apoptotic nuclei in populations o f cells cultured in different conditions. Cells were
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permeabilised and the nuclei stained with PI as described in the methods section. Samples 
processed in this way were analysed using flow cytometry, the condensed pyknotic nuclei 
being gated and measured as a percentage o f total nuclei assessed. A typical histogram 
demonstrating the FL2-H intensity o f nuclei within a stimulated population is shown in 
Figure 8: particulates falling below the chosen ‘apoptotic’ gate (less than 10% the size of 
the 2n peak) were excluded and the sub-2n, or sub-Go/Gi population recorded as a 
fraction o f total nuclei. Wild-type DT40 demonstrated very low levels o f apoptosis (< 
2%), whereas the background rates found in the transfected clones were variable and 
closely dependent on the stringency o f culture conditions in the days preceding apoptosis 
experiments. Background levels up to 10% were accepted and subtracted from total 
apoptotic rates.
Despite many attempts to quantify the apoptotic response to P2X7 agonists, the data
presented in my thesis is limited: the DT40 became unreliable in culture, with variable
background rates o f cell death. Preliminary experiments to assess the doses o f  BzATP
required to induce apoptotic nuclear condensation revealed that doses less than 50 pM did
not induce apoptosis, whereas > 200 pM caused a degree o f apoptosis in all clones
including healthy wild-type, by 7 hours (data not shown). In addition, the percentage o f
nuclei undergoing apoptosis reached a peak between 6 and 10 hours. For these reasons,
the percentage apoptosis rate 7 hours after addition o f 100 pM BzATP to DT40 clones
was measured. Each o f the wild-type, two vector-transfected clones and four P2X7
expressing clones were investigated on three separate occasions. There was no significant
difference in mean apoptotic rates between wild-type and vector-only transfected controls,
in response to 100 pM BzATP. All P2X7 -  expressing DT40 clones exhibited increased
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apoptosis above baseline, compared with the wild-type DT40 (Fig. 49) when exposed to 
100 pM BzATP for 7 hours (mean increases between 6.2 -  16.7%) (Fig. 49). In three 
clones (C4, C9, C l 1) the apoptotic response reached statistical significance, using un­
paired t-tests (C4: p = 0.04, C9: p = 0.04, C l 1: p = 0.01), compared with wild-type. The 
remaining clone (CIO) exhibited the highest apoptotic response, but also a large variation 
between experiments, hence data failing to reach statistical significance (p = 0.08). 
Staurosporin, an apoptotic agent, was used as positive control, significant apoptosis 
induced by 100 nM in all clones (mean increases at 7 hours: wild-type 18.8%, vector- 
transfected 27.4% and P2X7-expressing clones 24.6%, data not shown). Baseline apoptotic 
rates varied between experiments, but were not significant between clones in this 
experiment (Fig. 49), as only assays o f clones with a baseline less than 10% were accepted 
for further analysis.
Attempts to manipulate the apoptotic response o f the transfected clones were dependent 
on the maintenance o f  healthy cells; further data is therefore limited and insufficient for 
statistical analysis. The effect o f 100 pM BzATP on two o f the P2X7 expressing clones 
was investigated after blocking the receptor with 100 pM oxidised ATP. The experiment 
was carried out in triplicate, and apoptosis rates expressed as means for each condition. 
The percentage o f  apoptotic nuclei in both clones, was reduced by pre-treating the cells 
with oATP, the P2X7 antagonist (Fig. 50).
The relatively high intrinsic apoptotic rates o f these cells at the time o f these assays, 
particularly the P2X7-expressing clones, suggested that these clones may be more 
susceptible to changes in culture conditions. I found the P2X7-expressing cells highly 
sensitive to overcrowding, with high levels o f apoptosis seen if  densities exceeded 100 x 
104 per ml, a level at which wild-type DT40 remained healthy. It is possible that
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‘unhealthy’ DT40 release increased amounts o f ATP and other nucleotides into the 
medium, stimulating ‘background’ P2X7-induced death, or de-sensitising the membrane 
receptors. To assess this further it will be interesting firstly, to measure ATP released into 
conditioned media, and secondly, investigate the effect o f using hydrolysing enzymes to 
reduce concentrations o f these extracellular nucleotides, on baseline viability and 
subsequent response to P2X7 agonists
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Figure 48. Light microscopy of wild-type and PlX-T-expressing DT40 
after 24 hour exposure to BzATP
DT40 cells were grown in logarithmic growth in medium supplemented as 
listed in methods. Cells were visualised by phase contrast light microscopy at 
time 0 (A) and again after 24 hours, incubated in the presence o f  B: no 
agonist, C: 100 pM BzATP, D: 200 pM BzATP or E: 100 nm staurosporin as 
a positive control apoptotic inducer. Wild-type DT40 responded only to 
staurosporin, cells demonstrating the phenotypic changes o f  apoptosis. The 
P2X7-expressing clone demonstrates apoptotic response to 100 and 200 pM  
o f  BzATP and stauropsorin. Note the background level o f  cell death in the 
untreated P2X7-trsansfected clone.
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Figure 48. Light microscopy of wild-type and P2X7-expressing DT40 
after 24 hour exposure to BzATP
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Vector-tra nsfected P2X7-transfected
Figure 49. BzATP induces apoptotic cell death in P2X7-expressing DT40
DT40 clones were exposed to 100 pM BzATP for 7 hours in standard culture 
conditions as described in methods. The percentage of cells with small 
pyknotic nuclei, stained with propidium iodide, were assessed using FACS 
analysis and expressed as the increase above baseline apoptotic rate in that 
clone. Baseline rates of apoptosis in the absence o f BzATP are shown in 
hatched bars, and were not significantly different between clones in these 
assays. Bars represent the mean o f three experiments (+ SE) for wild-type 
DT40 (grey), 2 vector-only transfected clones (white) and four P2X7- 
transfected clones (black). There is a significant induction of apoptosis in 
P2X7-expressing clones (* p < 0.05 using unpaired t-test).
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Figure 50. BzATP- induced apoptotic cell death in P2X7-expressing DT40 
is reduced by oxidised ATP
Two P2X7-expressing DT40 clones were exposed to 100 pM BzATP for 7 
hours in standard culture conditions as described in methods. The percentage 
of cells with small pyknotic nuclei, stained with propidium iodide, were 
assessed using FACS analysis and expressed as the increase above baseline 
apoptotic rate in that clone. Bars represent the mean of three experiments (+ 
SE) using two P2X7 positive clones: apoptosis induced by 100 pM BzATP 
(black) is reduced by pre-incubation with 100 pM oATP (striped).
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Summary and Collaborative Data
In order to study the signalling functions o f the P2X7 receptor in more detail, I used an 
expression system: rat P2X7 cDNA was transfected into the DT40 cell line.
•  I demonstrated successful transfection and expression o f the P2X7 cDNA into the 
DT40 cell line: P2X7 protein was expressed, as determined by western blot.
•  P2X7 activation in transfected DT40 cells induced a rapid, sustained rise in 
intracellular calcium, as a result o f cation influx.
• Oxidised ATP and calmidazolium, two known inhibitors o f the receptor, partially 
blocked calcium influx.
• The small increase in ethidium bromide fluorescence o f these cells in response to 
BzATP may be due to the presence o f a pore, although the low levels described 
suggest a small degree o f coupling o f the receptor to pore formation in this cell 
line.
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• BzATP induced increased rates o f apoptotic cell death o f P2X7-expressing cells, as 
assessed by quantitative analysis o f nuclear shrinkage, although these levels were 
modest at the doses used.
In view o f the difficulties encountered during these assays, I was unable to proceed with 
further investigation o f the signalling pathways o f the P2X7 receptor using the DT40 cell 
line. However, studies performed by collaborators have confirmed the P2X7-induced 
apoptosis in the transfected DT40. Work performed by Hitoshi Harada’s group in Japan, 
demonstrated concentration-dependent BzATP-induced cell death in P2X7-transfeced 
DT40, that was inhibited by oxidised ATP (oATP) and magnesium chloride (Fig. 51). 
They demonstrated the induction o f apoptotic cell death by TUNEL-labelling, 
phosphatidyl serine exposure and DNA laddering, and also documented the activation of  
caspase-3 (Fig. 52) [Hillman et al., 2003]. Caspase-3 activation was inhibited by oATP, 
but intriguingly the blockade o f caspase-3 using z-VAD-fmk, a pan-caspase inhibitor, did 
not affect the overall reduction in cell viability induced by BzATP [Hillman et al., 2003].
With the characterisation o f new, stable clones, the DT40 will provide a useful tool for the 
study o f the mechanisms by which P2X7 induces its wide range o f biological functions, 
and further our understanding o f the role o f caspases in P2X7-mediated cell death.
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Figure 51. Effect of P2X7 receptor activation on cell viability in transfected DT40 cells. 
(A) Concentration-response curve for the decrease in cell viability produced by ATP (o) 
and Bz-ATP (•) measured after 24 hr incubation with the agonist. (B) Transfected cells 
were incubated with 100 pM Bz-ATP for indicated times, then washed with Bz-ATP-ffee 
medium and cell viability measured 24 hr after Bz-ATP exposure. (C) Cells were pre­
treated with 300 pM oxidised ATP (oATP) or 5 mM MgCb for 1 hr, exposed to 100 pM 
Bz-ATP for 3 hr, and then washed with Bz-ATP-free medium. Cell viability was 
measured 24 hr after Bz-ATP treatment and in time matched untreated cells (□). Bars 
represent the mean±SD from three experiments. An asterisk (*) significantly different 
PO .01. Cell viability was determined by succinate-tetrazolium reductase activity.
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Figure 52. Involvement of caspase activation in P2X7-mediated cell death
(A) Caspase-3-(like) activity by Bz-ATP in transfected DT40 cells. Cells were treated 
with Bz-ATP 100 pM (□) or 200 pM (■) for the indicated times. (B) Cells were pre­
treated with oATP 200 pM for 3 hr, washed with oATP-free medium and then treated with 
or without Bz-ATP for 12 hr. Columns represent the mean±SEM from three experiments. 
(C) Inhibition of Bz-ATP-induced exposure of phosphatidylserine (using annexin-V- 
FLUOS staining kit) on the outside of cell membrane by Z-VAD-fmk. Cells were pre­
treated with or without 60 pM Z-VAD-fmk for 1 hr and then treated with (■) or without 
(□) Bz-ATP 100 pM for 6 hr. (D) Cells were pre-treated with 60 pM Z-VAD-fmk for 1 hr 
and then treated with Bz-ATP 100 pM for 6 hr. Oligonucleosomal DNA was extracted 
and electrophoresed on agarose gel containing ethidium bromide. Fragmented DNA was 
visualised under ultraviolet light. Lane 1: DNA size marker (X I74 DNA/Zfadll digest), 
lane 2: untreated cells, lane 3: Bz-ATP, lane 4: Z-VAD-fmk and Bz-ATP. (E) Cells were 
pre-treated with Z-VAD-fmk 100 pM for 1 hr and then treated with Bz-ATP 100 pM for 
3 hr. After 3 hr cells were washed with Z-VAD-fmk-free and Bz-ATP-free medium, and 
cell viability assessed 24 hr after agonist application, using MTT assay. An asterisk (*) 
significantly different PO .01 [Hillman et al., 2003].
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Chapter 10. Discussion
Recent data suggests that the P2X7 receptor is expressed in many tissues outside the 
immune and nervous systems, often in cells o f epithelial lineage. The original studies o f  
cloned human P2X7 documented a low level o f mRNA expression in the adult kidney 
compared with, for example brain [Rassendren et al., 1997] but, other than its up- 
regulation in mesangial cells in vitro, little was known o f the expression o f the receptor 
protein in the normal kidney. In this study I have demonstrated the temporal and spatial 
expression patterns o f the P2X7 receptor in the kidney and lower urinary tract, both during 
normal development and in the pathological progression o f cystic kidneys.
Normal kidney development
P2X7 receptor protein was detected by Western blot in kidneys at all stages examined, 
ranging between E l6 and maturity, four weeks postnatally. By immunohistochemistry, 
P2X7 was not seen at El 1 o f the developing kidney, but was detected at E l 3, at that stage 
restricted to a subset o f the mesenchymal cells aggregating around the branching ureteric 
bud tips, themselves immuno-negative for P2X7. Interestingly, these mesenchymal cells 
undergo aggregation and subsequent polarisation and lumen formation, to produce the 
structural precursors o f the mature glomerulus. However, by El 6 , P2X7 was down 
regulated in these polarised vesicles, and was not seen in the S-shaped bodies, mature 
glomerulus or the proximal tubule segments o f the mouse. By this stage there was a shift 
in expression o f P2X7, to the ureteric bud and its branches. Derivatives o f these structures,
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i.e. the collecting ducts, renal pelvis, ureter and urinary bladder urothelium, all expressed 
P2X7 in the adult mouse. Although some sections examined, particularly the mature tissue 
and the lower urinary tract, were suggestive o f apical or luminal expression o f the receptor 
protein, identification o f the precise sub-cellular localisation o f the receptor was limited 
with the immunohistochemical techniques employed in this thesis. An apical distribution 
would support a functional role o f the receptor, perhaps in solute transport in the mature 
renal tract, but further examination using confocal or electron microscopy is required to 
determine both the cell types expressing the receptor and the precise cellular location o f  
the protein.
In addition to its potential roles in transmembrane ion and solute fluxes, I hypothesized 
that the ability o f  P2X7 to modulate cell turnover may be important in kidney 
development. To examine this I assessed proliferation and apoptosis: markers o f both were 
identified in subsets o f the condensing metanephric mesenchyme at E l 3, also immuno- 
positive for P2X7. This finding is consistent with a possible role for P2X7-mediated 
modulation o f cell-tumover in early nephrogenesis. However, functional studies are 
required to understand the biological importance o f the receptor in this complex process, 
such as examining the effect o f BzATP on the growth o f metanephric organ cultures, and 
assessing the E l3 mesenchyme and overall glomerular numbers in the developing kidney 
o f the P2X7 null mutant mouse.
An alternative possibility is that P2X7 may be involved in cell aggregation and subsequent 
morphological changes o f lumen, or tube formation, either directly, or via interaction with 
other molecules known to be important in nephrogenesis. The complex interactions 
between the many families o f molecules important in orchestrating and effecting 
development o f  the kidney are still being unraveled, and further investigation o f potential
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interactions between the P2X7 ATP receptor and other key molecules may reveal 
mechanisms by which this molecule functions during nephrogenesis. In certain cell types, 
P2X7 forms a membrane signalling complex with various other molecules [Kim et al., 
2001b] implicated both in its multiple downstream signalling pathways but also in 
rearrangements o f the cytoskeleton; one o f these is the extracellular matrix protein laminin 
a3, a component o f laminin-5, which binds integrins a 3 p i, a6p4 and a 6 p l, previously 
implicated in nephrogenesis, [Kim et al., 2001a] [Zent et al., 2001]. As well as providing a 
potential role for P2X7 in normal kidney development, P2X7-mediated modulation o f  
lumen formation might also be important in the abnormal form o f lumen and tube 
formation seen in polycystic kidney diseases, as discussed later.
The roles o f P2X7 in the adult kidney must also be considered, and may be discrete from 
any potential lumen-mediating function in nephrogenesis. There is little known o f the 
physiological roles o f the P2X receptors in the adult nephron, despite increasing 
knowledge o f the profile and function o f P2Y expression along the nephron [Bailey et al., 
2000;Deetjen et al., 2000]. Studies o f P2X7 function in other epithelial structures have 
been carried out: receptors on the luminal surface o f the rat submandibular gland ducts 
respond to BzATP with an increase in calcium influx [Lee et al., 1997]. In the 
investigation o f nucleotide signalling along the adult mouse collecting duct, however, 
neither apical nor basolateral BzATP (IOOjiM) elicited an increase o f intracellular 
calcium, suggesting the absence o f functional P2X7 receptors in the isolated perfused 
mouse collecting duct [Deetjen et al., 2000]. It may be that the exact age o f the animals is 
important; in this thesis kidneys o f animals up to four weeks o f age were examined, and it 
is possible that the receptor may be down regulated, or inactive later in adult life. The
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exact cellular localisation o f the receptor was also not clearly defined in the current study: 
immunohistochemistry was suggestive o f apical membrane expression but in some cases 
an intracellular pattern was also seen. This will be important in determining the functional 
importance o f P2X7 in the adult nephron, as will information regarding potential 
trafficking o f receptor molecules into the membrane from intracellular sites.
In conclusion, I have demonstrated the expression o f P2X7 protein in all stages o f mouse 
kidney development from E l3 to the adult stage at 4 weeks postnatally, initially in the 
condensing mesenchyme in early nephrogenesis but subsequently in the ureteric bud 
derivatives. Further studies are required to elucidate the precise sub-cellular location o f the 
protein and to determine the functional importance o f the receptor in these sites.
Polycystic kidney disease
In addition to demonstrating P2X7 expression in the mesenchyme and ureteric bud 
lineages in the normal mouse kidney, I also localised P2X7 protein to the collecting duct 
cysts o f the cpk/cpk mouse model o f ARPKD. Epithelial cells o f the collecting duct cysts, 
but not the cysts derived from proximal tubules expressed receptor protein. This was seen 
at all stages o f the disease, from early collecting duct dilatation in the neonate, to the 
gross, progressive expansion o f cysts in the terminal stages. This pattern o f expression was 
also found in human ARPKD, with P2X7 receptor protein expressed in the epithelium of 
dilating collecting ducts and cysts o f kidneys from 20-week old foetuses.
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My initial hypothesis suggested that the functional importance o f P2X7 in the kidney was 
via its ability to induce apoptotic cell death, a feature o f normal kidney development 
[Welham et al., 2002] and indeed the development and progression o f polycystic kidney 
disease [Ali et al., 2000;Winyard et al., 1996a;Woo, 1995]. As previously demonstrated in 
this model [Winyard et al., 1996a] apoptosis was detected in cells o f the interstitial 
compartment between cysts, but not in the P2X7-expressing cyst epithelium itself. This 
does not support a major role for P2X7-mediated cell death in the pathogenesis o f 
ARPKD. There are, however many limitations to the use o f histological associations to 
determine possible functional roles o f receptors. In this study I examined a single time 
point in the dynamic process o f  cyst formation and progression, and although apoptosis 
and P2X7 expression were not related spatially at the end-stage o f disease, it is possible 
that P2X7-mediated cell death may occur at other stages o f disease, for example at the 
initial inception o f lumen formation or tubule dilatation.
In order to investigate the potential functional role o f this signalling system in the 
pathogenesis o f ARPKD in more detail, it is necessary to identify the active ligand in this 
model, in addition to expression o f the receptor. Although ATP is released from 
monolayers o f cells derived from the cpk/cpk mouse kidney [Schwiebert et al., 2001], the 
concentrations o f nucleotides present within cyst lumen and thus able to ligate epithelial 
receptors in vivo is not known. The same group have identified concentrations up to 
approximately 10 pM in the fluid o f human ADPKD cysts [Wilson et al., 1999], and in 
this thesis I used a bioluminescent assay to detect ATP in the fluid extracted from cpk/cpk 
kidneys. Fluid was collected after initial puncture o f the three week old cystic kidneys and 
snap frozen for later analysis. Low nanomolar concentrations o f ATP were detected in this
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fluid, although the absolute levels present in the cyst fluid itself are difficult to interpret. 
This method did not involve inhibition o f the ecto-ATPases present in these specimens, 
which may catalyse degradation o f nucleotides after release from the kidney, but may 
have also caused release o f ATP itself from tissues damaged by the puncture procedure.
Schwiebert’s group demonstrated o f high concentrations o f ATP and its metabolites in 
cyst fluid o f human ADPKD cysts [Wilson et al., 1999] and also the increased levels o f  
ATP in conditioned media from cultured epithelial cells derived from these kidneys and 
animal models such as the cpk/cpk mouse as compared with cortical epithelial cells from 
normal kidneys [Schwiebert et al., 2001]. They then suggested that nucleotides released by 
the epithelial lining o f a cyst may become ‘trapped’ within the lumen for longer than in a 
normal tubule with urine flow, and hence be available to activate membrane P2 receptors. 
They hypothesised that ATP and other nucleotides induce flux o f ions and solute across 
the membrane into the cyst lumen, hence causing a rapid expansion in cyst size. It is likely 
that a range o f P2X and P2Y receptors are functionally expressed in renal cysts, and that 
they mediate diverse events important in cyst development and progression. Studies 
profiling purinergic receptor expression in different cystic models prior to this thesis, 
including the cpk/cpk mouse, did not detect P2X7, although this was carried out in vitro 
using methodology based on the detection o f mRNA using degenerate primers 
[Schwiebert et al., 2001]. I have demonstrated P2X7 expression in the cyst epithelia of 
cpk/cpk mouse cysts in vivo and also demonstrated the presence o f P2X 5 receptor protein, 
often detected in a similar distribution to P2X7 [Groschel-Stewart et al., 1999a].
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In order to investigate the potential functional importance o f  P2X7 receptor itself in the 
pathogenesis o f polycystic kidney disease I used an in vitro model derived from 3 week 
old cpk/cpk polycystic mice. Dissociated cystic kidney cultured in 3 dimensional 
suspension preparations, forms cystic structures a few hours after dissociation. This 
method was adapted from that previously characterised by Woo et al [Woo et al., 1994]: 
the appearance o f single cells, aggregates o f cells and cysts is reminiscent o f the paradigm 
of lumen, or cyst formation as described earlier, and thus this system can be considered 
useful in the investigation o f both the early events in lumen initiation and progression, or 
cyst expansion.
In addition to the confirmation o f P2X7 mRNA and protein expression by cpk/cpk cysts, 
the major finding o f this set o f experiments was that the P2X7 agonist BzATP caused a 
reduction in cyst numbers after 24 hours. The greater potency o f this nucleotide versus 
ATP itself is consistent with a P2X7-mediated effect, BzATP being between 10 and 30 
times more potent than ATP at this receptor. However, BzATP is not selective for P2X7 
and may activate other P2X receptors such as P2Xi and P2X3 [Bianchi et al., 1999;Evans 
et al., 1995;Khakh et al., 2001], at least in human cells. Reports o f binding between 
BzATP and bovine serum albumin (BSA) resulting in reduced agonist potency, may also 
affect the investigation o f P2X7 function in this in vitro system, utilising serum-containing 
culture medium [Michel et al., 2001].
The use o f the generic P2X7 antagonist oxidised ATP (oATP) [Murgia et al., 1993] 
partially blocked the cyst reduction induced by BzATP, again supportive o f  a role for the 
P2X7 receptor, although there are also reports o f oATP blocking currents at P2Xi and 
P2X2 receptors in human and rat [Evans et al., 1995]. Other antagonists are difficult to use
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in cell culture, due to toxicity with prolonged exposure, or are not effective at the mouse 
receptor [North, 2002]. An alternative strategy would be to demonstrate reduced receptor 
effect by increasing extracellular cation concentrations, for example calcium, zinc, 
magnesium or copper, which may be useful in single cell studies, but this was not 
undertaken in this study o f cyst culture. Finally, there was no effect o f UTP, a P2Y 
agonist, on the numbers o f cysts forming in vitro in this study, excluding a confounding 
P2Y effect. This is important in view o f recent reports o f inhibition o f the P2Y4 receptor 
by BzATP (Wildman et al, 14 554A 2003, JASN).
In view o f the pharmacological difficulties in examining single receptor function in this 
system, it is important to determine the receptor profile o f the cystic epithelium. In my 
study, preliminary RT-PCR did not detect P2Xi, P2X2, P2X3 or P2X6, but did detect P2X4 
and P2X5, the latter also shown to be expressed as protein by cyst epithelia, using 
immunofluorescent methods in this thesis. Another group investigating ATP-purinergic 
receptor signalling in PKD models in vitro, used specific primers designed to amplify P2Y 
sequences, but identification o f P2X mRNA was undertaken using degenerate primers 
[Schwiebert et al., 2001]. In the cpk/cpk mouse they found P2Yi and P2Y2 mRNA: 
sequencing analysis o f the degenerate P2X PCR products revealed P2X2, P2X3 and P2X4, 
although confirmation o f translation into protein was not performed in this model. Of note, 
P2X7 sequences were identified in human mixed renal epithelial cultures, but not in 
primary cultures o f  ADPKD cysts, wild-type B6 mouse kidneys or the cpk/cpk mouse 
kidneys as stated. The disparity o f expression patterns found, between these findings and 
my own, may be in part due to their use o f degenerate primers, but also their use of 
monolayers compared with suspension cultures in this thesis.
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Interestingly, despite the apparent lack of P2X7 sequences in mRNA derived from human 
ADPKD cysts, but presence o f P2X4 and P2Xs, monolayers o f the cells did respond to a 
cocktail o f P2X agonists: a,p-methylene-ATP and BzATP together increased cytosolic 
calcium, and apical application o f 10 pM BzATP alone stimulated a transient increase in 
short-circuit current [Schwiebert et al., 2001]. The effect o f a relatively low dose o f 
BzATP would support functional activity o f P2X7, although not detected using degenerate 
primers in this particular study.
Having documented P2X7 mRNA and protein expression in the cpk/cpk mouse kidney as 
well as the primary suspension cultures, and shown a BzATP-induced reduction in the 
cyst numbers in the latter, I next attempted to determine a mechanism by which BzATP, 
acting via the P2X7 receptor might affect cysts in culture. As discussed previously, cyst 
progression, or expansion, may be enhanced by nucleotides via ion and solute fluxes into 
the cyst lumen [Wilson et al., 1999]. Although my study did not investigate ion 
movements directly, an indirect measure o f net flux into the lumen was taken as the mean 
size o f the cysts present, measured as cross-sectional area o f cysts counted. There was no 
significant effect o f BzATP on mean cyst size, perhaps excluding a major effect o f this 
agonist on transepithelial fluxes into the cyst lumen. There was also no effect in response 
to ATP or UTP in a small number o f studies performed, also excluding other P2X or P2Y 
mediated effects on cyst size.
Early interest in the P2X7 receptor was fuelled by its diverse range o f downstream events, 
particularly its function as a modulator o f cell turnover, and I hypothesised that P2X7 may 
mediate cell death in the kidney. In this thesis I demonstrated both in vivo and in vitro,
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that P2X7 was expressed in cystic epithelium, but that paradoxically there is little 
apoptosis in the cyst epithelium once these structures are established. Using 
immunofluoresence, phenotypically apoptotic nuclei were detected in the interstitium 
between cysts in vivo, a region with little P2X7 expression, and were only seen in the cell 
aggregates in culture and not within the cysts themselves. It should be noted however, that 
in established cysts in vivo, apoptotic nuclei were detected in cells appearing to slough off 
the epithelium into the cyst lumen, and it is therefore possible that these cells are rapidly 
lost from the viable epithelium, explaining why they are rarely seen in this site. It is also 
possible that apoptosis may be important at the earlier stages o f cyst formation, as tubules 
become ectatic, as a means by which excess luminal cells are removed, enabling tube or 
lumen expansion.
Investigation o f the importance o f P2X7-induced apoptosis in the in vitro model o f cyst 
development was carried out using samples from the 24 hour end-point, which may not be 
an accurate reflection o f early events in cyst development in vitro. Two methods were 
used to determine the relative importance o f apoptosis in this model, and in the BzATP- 
mediated effects. Firstly, activity o f caspase-3, a cysteine protease activated by P2X7, was 
not significantly different between control cultures and those treated with 100 pM BzATP, 
with or without the inhibitor oATP. The reduction in cyst numbers mediated by BzATP is 
not associated with an increase in caspase-3 activity. However it should be noted that 
measurement o f caspase activity after 24 hours may not reveal an up-regulation o f  
activity, the likely peak occurring between 6 and 10 hours after initial exposure to the 
agonist, and these measurements should be repeated at earlier time points. However, the 
use o f a pan-caspase inhibitor, zVAD-fmk, applied prior to the addition o f BzATP, did not
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alter this effect. Taken together, these preliminary studies do not support a major role for 
P2X7-mediated apoptosis in the reduction o f cysts forming in vitro, at least caspase- 
dependent apoptosis.
I also excluded an effect on necrotic cell death as measured using lactate dehydrogenase 
release. Overall numbers o f viable cells after 24 hours were not affected by BzATP, and 
there was no difference in proliferation rates as assessed by PCNA expression. The latter 
is not a sensitive means o f quantifying proliferation rates, but earlier studies have shown 
that inhibitors o f DNA, RNA and protein synthesis do not prevent cyst formation in this 
model, suggesting that cell proliferation is not required for cystogenesis, at least in vitro 
[Woo et al., 1994]. Thus, in this in vitro model o f formation o f cpk/cpk cysts, the BzATP- 
induced reduction in cyst numbers does not appear to involve modulation o f cell turnover. 
As there was also no significant effect on cyst size in this study, excluding a major effect 
on fluid and solute shifts, P2X7 must be functioning either via as yet undefined 
mechanisms, or may be important at the very early stages o f lumen formation that are 
independent o f cell turnover (Fig. 53). For example, P2X7 may be important in initial cell 
aggregation or the transduction o f signals o f lumen expansion.
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Figure 53. Potential site of P2X7 action during lumen or cyst initiation
The absence o f  effect o f  BzATP on either cyst size or markers o f  cell 
proliferation and apoptosis, exclude a role for P2X7 in the modulation o f  cyst 
growth via solute and fluid flux, or cell turnover respectively. P2X7 may 
therefore be causing an effect on the numbers o f  cysts forming in vitro via 
actions at an earlier stage in lumen formation, for example, on cell aggregation 
or initiation o f  lumen formation. These putative sites o f  action are highlighted 
by the blue arrows.
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Figure 53. Potential site of P2X7 action during lumen or cyst initiation
This study has identified a novel signalling pathway that appears to mediate a reduction in 
cyst numbers developing in the cpk/cpk cyst culture model. Further work is essential to 
determine which other P2 receptors are expressed in this model, and to explore potential 
mechanisms by which P2X7 may be acting in this system. Interestingly, a recent 
publication has identified a polymorphism in the C57BL mouse, the background strain o f  
the cpk/cpk mouse that appears to result in abnormal P2X7 function. The polymorphism 
was found in the putative death domain o f the C-terminus causing a single amino acid 
change from proline to leucine at position 451 and lymphocytes from these mice 
demonstrate reduced pore formation and phosphatidyl serine exposure, in response to 
P2X7 agonists, compared with cells from the BALB/c mouse and four other wild-type 
strains examined [Adriouch et al., 2002]. Interestingly the only mouse P2X7 sequence 
listed in the databases (NM_011027) also carries this leucine residue at position 451, 
whereas the rat and human sequences show sequence alignment with the BALB/c mouse 
i.e., proline at 451. Sequence analysis o f P2X7 in the cpk/cpk mouse is required to 
determine whether this polymorphism occurs in this domain, as it does in the background 
strain. The presence o f a mutation causing disruption o f the putative death domain may 
suggest an alternative mechanism by which P2X7 agonists modulate cyst formation in the 
cp£-derived in vitro model, also supported by the findings o f this thesis, in which no 
significant increase in apoptosis was demonstrated in cyst cultures exposed to P2X7 
agonists. It is also possible that modulation o f the P2X7 receptor may have a greater effect 
on cyst formation in culture derived from cpk/cpk mice raised on a different background 
without this polymorphism.
Study o f P2X7 function in a novel cell line
The ability o f the P2X7 receptor to induce apoptosis, and the investigation o f its 
importance in the kidney was the main focus o f this thesis. However, at the inception o f  
this work, little was known regarding the intracellular molecules and signalling pathways 
involved in P2X7 receptor-mediated cell death, or the mechanisms involved in receptor 
regulation. A further aim o f my thesis was to utilize a cell expression system to investigate 
these features o f the P2X7 receptor at the single cell level.
Previous studies o f P2X7 have largely utilised endogenously expressing cells o f the 
immune system, cells that also express other purinergic receptor types. In this study I have 
characterised the expression o f the rat P2X7 receptor in a unique expression system, the 
DT40 cell. The two major potential benefits o f this cell line when compared with other 
expression systems are, firstly, the lack o f any functional native receptors, as assessed by 
lack o f physiological responses to ATP, and secondly, the genetic tractability o f the DT40 
cell. This should allow the study o f P2X7 function without confounding effects o f other 
receptor types, and also facilitate the investigation o f regulatory or downstream pathways 
o f P2X7, by the genetic manipulations o f target molecules.
Initially, transfection o f rat P2X7 cDNA into the DT40 cell was carried out using 
electroporation, and expressing clones were identified functionally: clones that responded 
to ATP by undergoing phenotypically apoptotic cell death were selected. Expression o f
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the receptor was confirmed using western blot, and cell lines stored for functional studies. 
Characterization o f the P2X7-expressing DT40 was undertaken using standard techniques 
used by other groups using either endogenously expressing cell lines, or other expression 
systems such as HEK 293 or Xenopus oocytes [Nihei et al., 2000].
The properties o f rat P2X7 expressed in DT40 cells were similar to those observed in other 
expression systems [Bianchi et al., 1999;Surprenant et al., 1996]. Using 
spectrofluorimetric methods, I demonstrated a rapid and sustained rise in intracellular 
calcium and manganese in response to either ATP or BzATP. This was a result o f influx 
across the membrane, and was attenuated by the addition o f cations such as magnesium. 
The use o f patch-clamp methods to analyse these responses at the single cell level was 
undertaken by collaborators: under voltage clamp, P2X7-expressing cells responded to 
ATP and BzATP with a rapidly activating and sustained inward current. The EC50 values 
for ATP and BzATP were 305 and 15 pM respectively.
The demonstration o f blockade o f the receptors using known inhibitors o f P2X7 was 
limited, due in part to the interference o f several o f the molecules with fluorimetric 
signals, but inhibition o f both the inward current and increasing intracellular calcium 
levels was seen in response to oxidised ATP and calmidazolium.
Prolonged activation o f the P2X7 receptor in low divalent cation-containing solution at 
physiological temperature has been reported to lead to the opening o f a cytolytic pore 
[Virginio et al., 1999a]. As in several other cell types, the coupling o f  P2X7 activity with 
pore formation in the P2X7-expressing DT40 was weak [Schilling et al., 1999b]. Using the 
influx o f the 314 Da molecule, ethidium bromide as a marker o f  pore activity, I observed a
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small effect in response to 100 pM BzATP, that was attenuated by oATP, but this was not 
confirmed by parallel electrophysiological studies at the single cell level. Pore function 
has been detected in other cell types by the shift in reversal potential in NMG+-containing 
solution [Virginio et al., 1999a], and, although the relative permeability o f the channel to 
NMG was very similar to that reported by Virginio et al. [Virginio et al., 1999a] we did 
not observe a time-dependent increase in NMG permeability to support the formation o f a 
cytolytic pore [Hillman et al., 2003]. The discrepancy between these techniques used to 
assess pore formation may be explained in part by the conditions under which cells were 
investigated. The ethidium bromide influx, albeit small, was induced by BzATP in cells 
studied at physiological temperature, 40 °C, whereas patch clamp studies were performed 
at room temperature. The mechanisms by which the P2 X7 receptor forms pores is still not 
understood, but if  recruitment, or activation o f other membrane proteins is required 
[Schilling et al., 1999a;Schilling et al., 1999b], or pore formation is a conformational 
change o f the receptor itself, these effects may be affected by temperature.
Finally, the characterisation o f this novel P2X7-expressing cell line may provide a useful 
tool for the investigation o f the downstream signalling events linked to receptor activation. 
In this study I demonstrated P2X?-induced apoptotic cell death, as described in other 
systems [Ferrari et al., 1999a;Zanovello et al., 1990]. Initially, levels o f apoptosis were 
assessed visually and by the percentage o f the cell population with phenotypically 
pyknotic nuclei, stained with propidium iodide and counted using flow cytometry. 
Although ATP and BzATP induced apoptosis, and this was inhibited by oATP, it was 
difficult to proceed to further investigation o f this pathway, due to the loss o f viability o f  
the transfected clones at this point. However, investigations carried out using similar
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clones stored by collaborators were more detailed [Hillman et al., 2003]. Cells undergoing 
BzATP-induced death exhibited exposure of surface phosphatidylserine and DNA 
laddering, as well as the activation o f caspase-3, further evidence for apoptotic cell death. 
At present it is still unclear how this cell death, occurring over many hours, is related to 
the almost immediate changes in membrane ion permeability and elevation in intracellular 
calcium. In this study it was not possible to determine the dependence o f the apoptotic 
signal on the initial influx o f calcium, although it has been shown in hepatocytes, that 
ATP-induced death is dependent on a rise in intracellular calcium with subsequent 
accumulation o f mitochondrial calcium and loss o f the mitochondrial membrane potential 
[Zoetewij et al., 1996]. This may lead to cytochrome c release and the activation o f  
cysteine proteases, caspases known to be involved in apoptosis [Salvesen and Dixit,
1997]. It has been demonstrated that elevation o f intracellular calcium produces 
mitochondrial swelling in DT40 cells [Hawkins et al., 2002], and using the P2X7- 
expressing DT40, we demonstrated activation o f caspase-3 [Hillman et al., 2003]. 
However, the critical importance o f these features in the apoptotic process remain to be 
elucidated: although blocking caspase activation reduced the DNA laddering and 
phosphatidylserine extemalization, this did not affect the overall reduction in cell viability 
induced by P2X7 agonists in this transfected cell line. There may be caspase-independent 
pathways involved in P2X7-mediated apoptosis. Further elucidation o f the mechanisms by 
which P2X7 induces apoptosis is vital to the interpretation o f future studies o f the role of  
P2X7 in the kidney.
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In conclusion, I have generated a novel cell line o f  DT40 avian B lymphocytes stably 
transfected with the rat P2X7 receptor, and, with collaboration have characterised its 
properties in detail. Since these cells are highly genetically tractable [Buerstedde and 
Takeda, 1991] they should prove a very useful model for elucidating the physiological 
role o f the P2X7 receptor, its downstream signalling pathways, particularly those linked to 
cell death, and in the future, aid the development o f selective agonists and antagonists. 
This will, in turn, increase our understanding o f the biological importance o f P2X7 in 
specific organs, for example the kidney, both in normal physiology and in disease, and aid 
in the development o f therapeutic ligands for the receptor.
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The potential relevance o f P2X7-mediated apoptosis in the kidney
The findings o f  my thesis do not support a major role for P2X7-mediated apoptosis in the 
kidney at least in the mouse model o f ARPKD studied. As discussed, P2X7 is expressed in 
both normal kidney development and ARPKD and further study o f these conditions may 
reveal other receptor-mediated functions o f biological importance, for example ion and 
solute transport or induction o f inflammatory pathways. It is also possible that the 
significance o f P2X7-mediated apoptosis in the kidney was underestimated in this study. 
During nephrogenesis, P2X7 expression correlated spatially and temporally with a period 
o f  prominent cell proliferation and apoptosis within the condensing mesenchyme, 
although this work did not examine the functional importance o f the receptor in this 
condition. It will be interesting to assess the impact o f modulation o f P2X7 signalling, 
either pharmacologically using organ culture, or genetically, exploiting the knock out 
mouse models, on development o f the kidney, and correlate any developmental anomaly 
with changes in rates o f cell turnover or apoptosis.
Examination o f the functional importance o f P2X7 expression in cyst epithelia o f ARPKD 
was undertaken, but did not support a major role for receptor-mediated apoptosis in the in 
vitro model used. The design o f the study may have resulted in under-estimating the 
importance o f P2X7-mediated apoptosis; the assessment o f  markers o f cell turnover, 
including caspase-3 activation were all carried out after 24 hours in culture, and although 
found not to be significantly increased, could have been peaked earlier in time, at 6 to 10
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hours after initial agonist exposure. Further studies are required to investigate these earlier 
time points, although the use o f zVAD-fmk as a pan-caspase inhibitor, present prior to 
agonist exposure, did not significantly affect P2X7-mediated reduction in cyst numbers, in 
a small number o f experiments. It will be important to repeat the latter conditions with 
more rigorous assessment o f the blockade o f caspase activity by zVAD-fmk. This 
preliminary data suggested that, at least caspase-dependent apoptosis may not be 
important in P2X7 function in the in vitro cyst model. It should also be considered that 
P2X7 may activate caspase-independent apoptosis: although receptor ligation is associated 
with caspase 3 activation in many cell types [Hillman et al., 2003], in the DT40 cell line 
used in my thesis, blocking caspase activation does not affect the overall reduction in cell 
viability induced by P2X7 activation [Hillman et al., 2003], and in previous studies, 
caspase inhibitors have only partially blocked P2X7-mediated apoptosis [Coutinho-Silva et 
al., 1999], supporting the existence o f both caspase-dependent and caspase-independent 
death pathways. Further study o f the role o f P2X7-mediated apoptosis in polycystic kidney 
disease is required, firstly examining early time points in cyst generation, and secondly 
using different methods for identification and quantification o f apoptosis.
The selection o f mouse kidney development and ARPKD for investigation in this thesis 
was based on well-documented and functionally significant phases o f apoptosis in their 
pathogenesis. Apoptosis has been demonstrated in many other renal conditions in which 
P2X7 may therefore be implicated. These studies include simple observational studies, 
describing markers o f apoptotic cell death in the kidney, and also those that demonstrate 
functional correlation o f apoptotic death with pathological states. Apoptosis has been 
detected in a number o f acute renal insults such as acute tubular necrosis [Matsuno et al.,
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1994;Shimizu and Yamanaka, 1993] and crescentic glomerulonephritis [Shimizu et al., 
1996b]. More chronic conditions such as diabetic nephropathy [Zhang et al., 1997b], 
transplant rejection [Ito et al., 1995], polycystic kidney disease [Woo, 1995] and 
glomerulosclerosis and renal scarring [Sugiyama et al., 1996;Thomas et al., 1998] have all 
been shown to involve apoptosis, although the extent and overall importance o f this 
phenomenon are difficult to assess from those descriptions based on histological findings; 
pathognomonic pyknotic nuclei are often scarce compared with control tissues, probably 
reflecting the rapid clearance o f apoptotic bodies by neighbouring cells. In addition to 
histological observations, further evidence for the occurrence o f apoptosis o f renal cells 
comes from in vitro studies. For example, direct induction o f apoptosis o f mesangial cells 
is seen as a result o f exposure to the anti-Thy 1 monoclonal antibody, the agent used to 
induce the mouse equivalent o f proliferative glomerulonephritis [Sato et al., 1996]. 
Apoptosis has thus been observed in vivo and in vitro in a number o f situations, involving 
a range o f cell types, for example mesangial cells in glomerulonephritis, proximal tubular 
cells in ATN, epithelial cells o f renal cysts and also glomerular endothelial cells. The 
latter undergo apoptosis in developing glomerulosclerosis o f the subtotal nephrectomised 
rat model [Kitamura et al., 1998] and progressive anti-GBM nephritis o f the WKY rat 
[Shimizu et al., 1996a], suggesting that apoptosis is important in progression o f  
glomerular sclerosis, but also during capillary regeneration in the reversible Thy-1 model, 
a situation in which apoptosis appears to play a role in the recovery o f  damaged glomeruli 
[Shimizu et al., 1996a].
In determining the biological and clinical importance o f  apoptosis in the kidney, in 
particular when considering identification o f therapeutic targets in the manipulation o f cell
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turnover, it is important to identify firstly, conditions in which apoptosis is a normal 
response to cell injury, or necessary for maintenance o f cell number and tissue 
architecture, or secondly, those in which uncontrolled apoptosis may underlie the 
pathological state. Manipulation o f apoptosis in the latter group o f conditions may lead to 
amelioration o f predicted renal insults. Another example o f  normal, or ‘beneficial’ 
apoptosis is in IgA nephropathy, an immune glomerular disorder. A study o f patients with 
IgA nephropathy shows a correlation between severity o f renal dysfunction and the 
presence o f apoptosis, but also demonstrates that those patients with obvious apoptotic 
cells, correlate with those most likely to recover renal function, probably by inducing 
removal o f  excess proliferative or infiltrative cells [Tashiro et al., 1998]. Likewise, the 
resolution o f anti-Thy 1 glomerulonephritis in mice is dependent on apoptotic deletion o f  
proliferative mesangial cells [Baker et al., 1994], in addition to the capillary regeneration 
involving endothelial apoptosis [Shimizu et al., 1996a]. The role o f  apoptosis is essential 
to the maintenance o f normal renal structure and function in such conditions, but may still 
provide a useful therapeutic target: identification o f molecules promoting apoptosis of 
these cells may allow the development o f therapeutic tools aimed at increasing the rate o f  
renal recovery.
Studies demonstrating alteration, either amelioration or worsening, o f renal injury by 
manipulating the apoptotic pathways, lend stronger support to the importance o f  this form 
o f cell death in renal disease. For example, in the cpk/cpk mouse model o f recessive 
polycystic kidney disease, in addition to propidium iodide and TUNEL labeling o f  
apoptotic nuclei [Winyard et al., 1996a], it has been shown that there is up-regulated 
expression o f caspases 3 and 4 [Ali et al., 2000]. The occurrence o f fulminant apoptosis in
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the cystic kidneys o f bcl2 deficient mice also lends functional support to the importance of 
cell death in cystogenesis [Sorenson et al., 1996;Veis et al., 1993]. An example o f  acute 
tubular necrosis induced by cisplatin can be shown to involve apoptosis, but importantly, 
apoptosis and renal dysfunction can be ameliorated by pre-treatment with uranyl acetate, 
which induces up regulation o f expression o f the anti-apoptotic protein bcl-2 [Zhou et al., 
1999].
Despite the lack o f support for P2X7-induced apoptosis in the cpk/cpk model in this thesis, 
it is possible that this mechanism is important in other renal insults as listed above. The 
study o f these conditions must first, place the receptor protein in cell types known to 
undergo apoptosis and then assess the effects of manipulation o f P2X7 activity on disease 
severity and progression. Whether this work supports a role for P2X7-mediated apoptosis 
in the kidney, or reveals alternative biologically important receptor-mediated pathways, 
such studies may lead to the identification o f a therapeutic target in a range o f renal 
conditions.
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Future Work
Further experiments are required to clarify both the precise intracellular location o f  the 
protein and the functional role o f the P2X7 receptor in kidney development and in 
polycystic kidney diseases, but also its potential importance in other renal disorders. The 
expression o f P2X7 protein in the condensing mesenchyme in early nephrogenesis (E 13- 
El 5) might implicate the receptor in early nephron formation, and hence, manipulation o f  
the nucleotide-P2X7 signalling pathway may affect normal development. An in vitro 
approach to this question is to assess kidneys taken from mouse embryos and grown in 
culture, i.e. organ culture. Addition o f P2X7 agonists or antagonists to the culture medium 
can then be used to assess the effects o f receptor activity on the growth o f kidneys. 
Histological assessment o f the resulting organs will provide details o f  the effects o f P2X7 
activity on kidney growth, for example the number o f nephrons forming. There are 
however limitations to this approach: the uniformity with which nucleotide agents can be 
applied to the growing organs is poor, with questionable activity deep within the organ, 
although this could be assessed. An in vivo approach to the investigation o f  the role o f  
P2X7 in kidney development is the analysis o f the transgenic knock out mouse. These 
have been developed [Solle et al., 2001], with apparently normal renal phenotype, arguing, 
perhaps, against a major role for P2X7 in kidney development. However, subtle changes, 
such as overall nephron number are yet to be examined and may reveal important effects 
o f the ablation o f P2X7 function on murine kidney development. There may be some 
overlap, or compensation by other P2X receptors, and it may be possible to reveal the
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importance for the P2X7 receptor by stressing the animal in some way, for example, 
exposing to nephrotoxin.
The work in this thesis provides evidence o f P2X7 expression in the cpk/cpk mouse and 
has gone some way to establishing a functional role for the protein in this setting. My 
work demonstrated measurable ATP concentrations within the fluid extracted from cystic 
mouse kidneys at 3 weeks o f age, although there were limitations in terms o f accuracy of 
the levels found. The removal o f fluid from intact cysts without damage o f surrounding 
tissue would require micropuncture o f individual cysts and the analysis o f small volumes 
o f fluid. Capillary electrophoresis, a method o f nucleotide detection based on UV 
detection [Qurishi et al., 2002] was kindly performed on some o f the samples collected in 
my experiments, confirming the presence o f ATP, and the application o f this technique to 
small volumes o f fluid extracted by micropuncture o f  cpk/cpk cysts may provide valuable 
information in the future. The in vitro studies, based on modifications o f  the techniques o f  
Woo et al [Woo et al., 1994], all used a twenty-four hour end point. Although a significant 
effect on cyst number in response to BzATP was seen at this time point, no significant 
differences in markers o f cell turnover were found in samples after twenty-four hour 
incubation. This could be a negative result, but it is possible that, if  P2X7 is important at 
the initial or early stages o f cyst development, any associated effects on either 
proliferation or cell death, may no longer be noticeable by the end o f  the experiment. 
Caspase activity for example would be expected to peak at between six and ten hours after 
initial induction o f  apoptosis, and might be undetectable again by twenty-four hours. 
Future experiments will require the simultaneous assessment o f earlier time points and 
markers o f cell turnover: preliminary time-lapse photo-microscopy o f the cyst cultures
used in this thesis revealed the presence o f cysts from as early as 4 hours after plating, and 
may be a useful tool for more detailed study o f the effects o f P2X7 agonists on cyst 
growth.
The use o f transgenic animals will again be useful in providing definitive evidence for the 
importance o f P2X7 in the development and growth o f  renal cysts in the cpk/cpk mouse. 
The genetic ablation o f P2X7 function in the cpk/cpk mouse, by crossbreeding the cpk/+ 
heterozygotes and P2X7 null mutants will provide this information. It will also be 
interesting to investigate the role o f P2X7 in other models o f PKD.
The broad range o f functions o f the P2X7 receptor makes it an interesting molecule for 
study in many other renal disorders. The inflammatory role o f P2X7 was not a focus o f this 
study, but may implicate the receptor in arrange o f inflammatory renal disease. It will be 
interesting to examine changes in the expression of P2X7 protein in inflammatory models 
such as the anti-Thy model o f glomerulonephritis, and also to investigate the progression 
o f this renal lesion in the P2X7 null mutant mouse, as evidence o f the biological 
importance o f this receptor. Such experimental strategy can be applied to other 
inflammatory diseases, but also to non-inflammatory conditions, for example acute tubular 
necrosis or other experimental models o f acute renal failure, such as folic acid 
nephropathy.
An alternative approach to the study o f the role o f the P2X7 receptor in the kidney is to 
utilise findings o f polymorphisms that alter receptor function. Polymorphisms in the gene 
causing amino-acid changes in the putative death domain o f the C-terminus have been 
demonstrated to affect receptor function [Wiley et al., 2002]. Despite conflicting evidence
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for the effects o f this polymorphism on progression rates o f chronic lymphocytic 
leukaemia [Starczynski et al., 2003;Thunberg et al., 2002;Wiley et al., 2002;Zhang et al., 
2003], it will be interesting to investigate the correlation between human polymorphisms 
o f the P2X7 receptor and, for example progression rates o f polycystic kidney diseases. 
Current knowledge o f the biological sequelae o f P2X7 activation makes this a potential 
modifying gene in this context. If P2X7 is found to be important in animal models of, for 
example acute tubular necrosis, or inflammatory glomerulonephritis as proposed above, it 
may also be interesting to examine the incidence human gene polymorphisms and relate 
them to variable progression or recovery rates o f these renal insults.
In the future, the knowledge o f P2X7 activity in the normal and abnormal kidney may lead 
to the development o f therapeutic strategies by which this receptor can be manipulated for 
the amelioration o f renal disease. In vitro models as used in this work will be useful tools 
for the development and assessment o f these agents, which may then be o f benefit for a 
host o f renal conditions. In addition, broadening our knowledge o f the effects o f  
polymorphisms o f P2X7 on receptor function and the progression o f various renal diseases 
adds a further dimension to medical management o f such patients and the prognostic 
information available to them and their families and carers.
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